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SUMMARY.
The aim of the studies reported in this thesis was to evaluate the 
suitability of siChromium-labelled ethylenediaminetetraacetate 
(5iCr-EDTA) as a marker for the assessment of intestinal permeability in 
the horse.
Initial studies were performed in apparently healthy ponies. The 
percentages of orally administered siCr-EDTA measured in urine were 
found to be consistent and not significantly affected by alterations on 
intestinal motility following premedication with atropine or bethanecol.
Absorption of a proportion of siCr-EDTA from the large intestine 
was confirmed following intracaecal administration of test doses in two 
animals with permanent caecal fistulation.
The 5iCr-EDTA test was used to investigate alterations in intestinal 
permeability in ponies following induction of enteropathy by experimental 
cyathostome infection and by prolonged phenylbutazone administration. 
Alterations of intestinal permeability were detected in cyathostome- 
infected animals but similar changes were not seen following 
phenylbutazone administration. To some extent these results confirm the 
reliability of the test since parasitic typhlitis/colitis was detected at 
post-mortem examination in two animals whereas there were no clinical 
or laboratory evidence of phenylbutazone toxicity in the animals studied.
Intestinal permeability was investigated by use of the 51Cr-EDTA 
test on three clinical cases with naturally-occurring chronic enteropathy 
and found to be increased in one horse.
XVII
To my wee Heather
CHAPTER I. GENERAL INTRODUCTION.
l
INTRODUCTION.
The equine gastrointestinal tract has caused great consternation to 
the clinican for centuries. However, current knowledge of the conditions 
which affect this body system is extremely limited, particularly when it is 
compared to the advances achieved in other animal species. An area 
which has received relatively little attention is that of the equine chronic 
enteritides. Cases of chronic enteropathy are not uncommon in equine 
medicine but frequently they cannot be definitively diagnosed. It is 
believed that progress in the understanding of the aetiopathogenic 
mechanisms involved in these conditions will bring about realisation of 
their importance and it will create a basis for specific therapy of affected 
animals.
The following review highlights the main features of the aetiology, 
pathogenesis, clinical signs, pathological findings and therapy of those 
equine chronic enteropathies in which alterations of intestinal 
permeability are believed to be of significance in the pathogenesis. 
Subsequently, the currently available diagnostic techniques are discussed.
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EQUINE CHRONIC ENTEROPATHIES.
ALIMENTARY LYMPHOSARCOMA.
Lymphosarcoma (LSA) is a neoplastic disease characterized by 
lymphatic tissue enlargement or invasion of non-lymphatic tissue by cells 
of lymphoblastic character (Bruere, Sutton and Davis, 1970). 
Lymphosarcoma in the horse is the most common neoplastic condition 
affecting the haemopoietic system (Jeffcott, 1977) and probably the most 
frequently encountered malignant neoplasia associated with death in this 
species (Rebhun and Bertone, 1984). Although different associations 
occur, it has generally been classified into 4 groups: multicentric, 
alimentary, thoracic and cutaneous (Van den Hoven and Franken, 1983; 
Madewell and Theilen, 1987). The alimentary tract, liver, spleen and 
associated lymph nodes appear to be involved most frequently in equine 
lymphosarcoma (Jeffcott, 1977).
Although a viral origin has been demonstrated in cases of feline 
lymphosarcoma (Theilen and Madewell, 1987) and enzootic bovine 
leukosis (Ferrer, 1980), similar investigations have not been undertaken in 
equine LSA (Neufeld, 1973; Madewell and Theilen, 1987). No age, breed, 
and sex predisposition have been established for equine haemopoietic 
neoplasms (Madewell and Theilen, 1987) and genetic resistance or 
susceptibility to the disease has not been studied in the horse (Neufeld,
1973).
The age of the reported cases of alimentary LSA ranges from two 
months to 23 years but the approximate mean is stated to be around 10 
years (Neufeld, 1973; Van den Hoven and Franken, 1983). Marked weight 
loss, depression and inappetence are the most commonly reported signs 
and the clinical course is protracted with a history of illness over several 
weeks or even months. Affected animals may have signs of intermittent, 
mild colic (Neufeld, 1973; Van den Hoven and Franken, 1983) and,
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usually of a chronic nature, may be the major presenting sign when the 
large intestine is involved (Wiseman, Petrie and Murray, 1974; Roberts 
and Pinsent, 1975; Wilson, Sutton, Groenendyk and Seawright, 1985). 
Ventral oedema may result from both hypoalbuminaemia and/or 
lymphatic obstruction (Roberts and Pinsent, 1975; Schalm and Carlson, 
1982; Van den Hoven and Franken, 1983; Humphrey, Watson, Edwards 
and Wood, 1984).
Enlarged mesenteric lymph nodes may be palpated on rectal 
examination (Wiseman and others, 1974; Van den Hoven and Franken, 
1983; Rebhun and Bertone, 1984; Wilson and others, 1985; Crawley, 1985; 
Madewell and Theilen, 1987) although it is possible that only thickened 
intestinal loops be present which render this observation quite difficult 
(Roberts and Pinsent, 1975). Non-specific skin lesions, probably due to an 
immune-mediated response, have also been associated with alimentary 
LSA (Wilson and others, 1985).
In cases of alimentary LSA fibrinous peritonitis (Reef, Dyson and 
Beech, 1984) and fibrous adhesions between intestinal loops and the 
omentum (Platt, 1987) have been reported. The mesenteric lymph nodes 
are almost invariably found to be enlarged (Neufeld, 1973; Wiseman and 
others, 1974; Van den Hoven and Franken, 1983; Madewell and Theilen, 
1987; Platt, 1987). Patchy or diffuse thickening and mucosal ulceration of 
the small intestine are common findings (Platt, 1987). The large intestine 
may appear oedematous and reddened, with some serosal splash 
haemorrhages (Roberts and Pinsent, 1975) and mucosal ulcerations 
(Crawley, 1985).
Platt (1987) described the histopathology and cytology of the 
alimentary lymphomas in the horse. In all cases diffuse pleomorphic 
lymphoid cell infiltration of the small intestinal mucosa, particularly in the 
ileum, resulted in villous atrophy and in some animals it formed small 
crypt abscesses.
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Most mesenteric lymph nodes showed extensive extracapsular 
spread and nodular neoplastic follicles and /or diffuse lymphoid 
infiltration disrupted the nodal architecture. Lymphatic obstruction and 
subsequent increase in the mucosal hydraulic pressure may, in addition to 
the alterations observed in the intestinal wall, impair normal absorption 
processes and enhance loss of proteins into the gastrointestinal tract 
(Roberts and Pinsent, 1975; Palmer, 1983; Roberts, 1984).
In Platt’s case series (1987) the large intestine was rarely infiltrated 
but others have recorded large bowel thickening due to lymphocytic 
infiltration of the lamina propia and massive submucosal oedema 
(Wiseman and others, 1974; Roberts and Pinsent, 1975).
Equine LSA is considered to be a fatal disease and no specific 
successful treatment has been reported (Ward and Whitlock, 1967; 
Madewell and Theilen, 1987). Although treatment in other species has 
been widely reported (Gorman and White, 1987), the poor outlook and 
the expense involved preclude any attempt of treatm ent in the horse. 
Animals suffering from this disease are most commonly dealt with by 
euthanasia on humane grounds.
GASTRIC SQUAMOUS CELL CARCINOMA.
Squamous cell carcinoma (SCC) is the primary neoplasm involving 
the equine stomach although it represents a very small proportion of all 
equine carcinomas (Whitlock, 1980). The tumour appears to originate 
from the oesophageal region of the stomach, but the aetiology remains 
unknown although environmental and/or dietary factors have been 
suggested (Tennant, Keirn, White, Bentinck-Smith and King, 1982).
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The approximate mean age of reported cases was 10 years, but no 
age, sex or breed predisposition was ascertained and the main clinical 
complaints described by different authors were similar (Meagher, Wheat, 
Tennant and Osburn, 1974; Wrigley, Gay, Lording and Haywood, 1981; 
Tennant and others, 1982). Affected cases were anorectic with chronic 
weight loss for weeks or months, and pale mucous membranes and fever 
were usually noticed. Mild, intermittent colic and diarrhoea were 
occasionally observed, dysphagia was apparent in one reported animal. 
Ventral oedema and/or ascites were present in some cases. On rectal 
examination, metastatic nodules or masses were palpated in most animals. 
In some cases, spread of the tumour to the thoracic cavity was responsible 
for signs of respiratory distress. Anaemia and neutrophilia were 
demonstrated by haematological analysis, and hypoalbuminaemia was a 
feature of the biochemical investigation but only occasionally were 
neoplastic cells observed in abdominal or thoracic fluid.
Tennant and his colleagues (1982) gave a full pathological 
description of equine gastric SCC: the gross appearance of the stomach 
was characterized by a nodular luminal surface with a cauliflower-like 
appearance, mainly in the oesophageal region of the stomach, presenting 
fissures or ulcers and covered by necrotic debris, and clearly demarcated 
from the normal gastric epithelium. Multiple metastases were present on 
the serosal surface of the stomach and infiltrated the liver, diaphragm, 
spleen, intestines, peritoneum and pleurae. Adhesions between abdominal 
organs were not uncommon. Under the microscope, these neoplastic 
structures were formed by cords of polyhedral or oval epithelial cells with 
prominent nucleoli within pale, vesicular nuclei, and which were 
separated by connective tissue.
Deterioration is progressive and most horses are euthanatized on 
humane grounds (Meagher and others, 1974; Wrigley and others, 1981; 
Tennant and others, 1982).
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CHRONIC INFLAMMATORY ENTEROPATHIES.
Several conditions will be discussed under this heading, all of which 
are characterized by severe focal or diffuse inflammatory reactions in the 
lamina propia, submucosa, or the entire wall of a part or the whole 
gastrointestinal tract (Roberts, 1984). The clinical syndrome observed 
with these diseases is a consequence of malabsorption and/or 
hypoalbuminaemia (Merritt, Cimprich and Beech, 1976; Lindberg, 1984; 
Platt, 1986). In the review by Roberts (1984) the chronic infiltrative 
enteritides listed in addition to alimentary lymphosarcoma were 
granulomatous enteritis, chronic eosinophilic enteritis, tuberculosis, and 
histoplasmosis.
GRANULOMATOUS ENTERITIS.
Granulomatous enteritis was first described in the USA (Cimprich,
1974) and since then there have been a few reports of the condition from 
the USA (Merritt and others, 1976; Sweeney, Sweeney, Saik and 
Lichtensteiger, 1986), Canada (Meuten, Butler, Thomson and Lumsden, 
1978), South Africa (Bester and Coetzer, 1978), Australasia (Roberts and 
Kelly, 1980; Hodgson and Allen, 1982), Sweden (Lindberg, 1984), and the 
UK (Platt, 1986).
To date, no clear aetiology for granulomatous enteritis has been 
ascertained but the condition has been likened to Crohn’s disease and 
intestinal tuberculosis in man (Cimprich, 1974). Merritt and others (1976) 
reported the clinical features of nine cases of granulomatous enteritis and 
they isolated Mycobacterium avium from samples of faeces and rectal 
mucosa of only one animal while Lindberg (1984) isolated bacteria of the 
group Mycobacterium avium-intracellulare from the bowel of one horse 
and from a mesenteric lymph node of another, but he concluded that the 
significance of this findings was unclear. Current hypotheses held on the
7
aetiopathogenesis of Crohn’s disease implicate environmental factors such 
as chemicals in food and water, type of diet, or infective agents which 
could trigger off an aberrant immune response in the host, possibly in 
genetically susceptible patients (Lennard-Jones, 1980) and similar 
theories have been proposed for equine granulomatous enteritis (Merritt 
and others, 1976; Roberts and Kelly, 1980; Lindberg, 1984; Sweeney and 
others, 1986). The latter authors reported on three sibling standardbred 
horses suffering from granulomatous enteritis.
The alterations observed in granulomatous enteritis result in 
malabsorption and protein-losing enteropathy: increased protein loss into 
the gastrointestinal tract has been demonstrated by studies with 
radioisotopes (Merritt and others, 1976) and decreased absorption of 
carbohydrates and lipids has also been established (Merritt and others, 
1976; Meuten and others, 1978; Roberts and Kelly, 1980). 
Immunologically mediated mechanisms have been involved in the origin 
of the skin lesions observed in some cases (Argenzio and Whitlock, 1980).
The history in all the reported cases of granulomatous enteritis was 
of progressive weight loss over several weeks or months and the mean age 
of the cases recorded on the literature was four years. Progressive 
anorexia or a capricious appetite was a common complaint. Pitting 
subcutaneous oedema and pale mucous membranes were frequently seen. 
Slight intermittent fever has been reported (Merritt and others, 1976; 
Bester and Coetzer, 1978) but did not appear to be a consistent finding 
although there are reports of horses with granulomatous enteritis which 
initially had presented with "fever of unknown origin" (Hodgson and 
Allen, 1982; Mair, Taylor and Pinsent, 1989). Scant but formed faeces 
were frequently observed (Merritt and others, 1976; Roberts and Kelly, 
1980) although some cases presented with soft, unformed faeces, or 
occasionally watery diarrhoea (Merritt and others, 1976; Sweeney and 
others, 1986). Mild colic was present in some cases (Merritt and others, 
1976) and diffuse thickening of intestinal loops, and firm, small masses in
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the mesentery and on the wall of the bowel, and enlarged mesenteric 
lymph nodes could be palpated per rectum in many cases (Merritt and 
others, 1976; Roberts and Kelly, 1980; Hodgson and Allen, 1982; Sweeney 
and others, 1986). Reduced phagocytic activity of cells in the peritoneal 
fluid, and pruritus and alopecia have been reported (Merritt and others, 
1976).
The pathological features of equine granulomatous enteritis have 
been described by Cimprich (1974), Lindberg (1984), Lindberg and 
Karlsson (1985) and Platt (1986). Horses appeared to be thin or 
emaciated and ventral oedema was commonly noticed. A great variability 
of features was observed macroscopically. Signs of chronic peritonitis and 
adhesions between omentum, intestinal loops and body wall were 
frequently observed. The mucosa appeared granular and thickened with 
raised and flattened areas and a "cobblestone" pattern. Mesenteric lymph 
nodes were wet, firm and mottled.
Histologically, the ileum was the most severely affected region and 
the large intestine the least. Many areas which appeared grossly normal 
were abnormal under the microscope. Marked villous atrophy and 
superficial erosions were frequently encountered. A few granulomas were 
scattered in the submucosa of the small intestine and crypt abscesses were 
associated with degeneration or necrosis of the basal crypt epithelium. 
There was a diffuse infiltration by mononuclear cells and oedema of the 
lamina propia and submucosa was apparent. A similar infiltrate, often 
enclosed by fibrous tissue, was the most marked alteration in the 
mesenteric lymph nodes and it was also observed in some animals in other 
parts of the gastrointestinal tract such as the pharynx, stomach and large 
intestine. Mycobacterium spp. were only found in the bowel and/or 
mesenteric lymph nodes of three reported cases.
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Electron microscopic studies showed a consistent shortening of the 
microvilli of surface enterocytes probably associated with cellular injury 
and degeneration which may be responsible for intestinal permeability 
alterations (Lindberg and Karlsson, 1985).
In addition to symptomatic, supportive treatment therapeutic 
regimens similar to those used in cases of Crohn’s disease, with 
salicylazosulfapyridine and/or corticosteroids and the use of 
metronidazole and azathioprine have been advocated (Merritt and others, 
1976; Meuten and others, 1978). In human regional enteritis surgical 
removal of affected intestine is commonly necessary, but the widespread 
involvement in equine cases precludes this possibility (Merritt and others, 
1976). The prognosis appears to be poor and most horses are euthanased 
on humane grounds.
CHRONIC EOSINOPHILIC GASTROENTERITIS.
Equine chronic eosinophilic gastroenteritis is a rare condition 
which was reported for the first time in Australia (Pass and Bolton, 1982). 
The aetiology remains obscure although the most popular hypothesis 
held considers an immediate-type hypersentivity reaction to antigens 
absorbed from or excreted into the gut which might originate from some 
diet components, parasites or enteric pathogens (Gibson and Alders, 
1987).
The clinical presentation was one of chronic weight loss and/or 
diarrhoea but skin lesions in the form of nodules of different sizes or 
coronitis, with patchy areas of alopecia, thickening and mild 
hyperkeratosis were common (Pass and Bolton, 1982; Breider, Kiely and 
Edwards, 1985; Gibson and Alders, 1987). Hypoalbuminaemia was a 
feature in all the cases reported and carbohydrate malabsorption was 
demonstrated by Pass and Bolton (1982).
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Post-mortem findings were, with the exception of the skin lesions, 
limited to the gastrointestinal tract and associated organs (Pass and 
Bolton, 1982). Grossly, thickening of the wall of the whole alimentary 
canal was characteristic. The intestinal mucosal surface appeared smooth 
although some ulceration was occasionally evident and multiple firm 
nodules were observed scattered throughout the bowel, around pancreatic 
ducts, throughout the hepatic parenchyma, on the serosa of the small 
intestine, and in mesenteric lymph nodes.
Histopathology revealed diffuse infiltration, primarily by 
eosinophils, of the lamina propia, submucosa, muscularis and serosa of 
the gastrointestinal tract accompanied by villous atrophy, fibrosis of the 
lamina propia and hypertrophy of the muscularis mucosae. The nodules 
generally consisted of masses of eosinophils. In the cutaneous lesions foci 
of degenerate keratinocytes, eosinophils and neutrophils were present 
within the epidermis and at the epidermal-dermal junction in the areas 
with acanthosis and hyperkeratosis (Pass and Bolton, 1982). Pancreatitis 
in one case was due to periductal fibrosis and diffuse eosinophilic 
infiltration but there was no evidence of parasites (Breider and others, 
1985).
Administration of corticosteroids together with symptomatic, 
supportive therapy and topical medication of skin lesions with a 
combination of corticosteroids and antibiotics has been used successfully 
in two reported cases (Gibson and Alders, 1987).
TUBERCULOSIS.
Tuberculosis (TB) appears to occur very rarely in the horse and 
although most old reports of this condition implicated Mycobacterium 
tuberculosis, in recent years bacteria belonging to the Mycobacterium
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avium-intracellulare-scrofulaceum (MAIS) group have been incriminated, 
probably due to the programme of erradication of TB in cattle (Mair, 
Taylor, Gibbs and Lucke, 1986; Mair and Jenkins, 1990c).
Tuberculosis may be localized or generalized and the bacteria 
generally enter the body via ingestion (Dungworth, 1985). The mesenteric 
lymph nodes may present tuberculous ulcers or uniform tubercles which 
resemble a sarcoma on macroscopic examination and histologically they 
consist of macrophages, epithelioid cells and giant cells (Dungworth, 
1985). MAIS organisms have been isolated in three reported cases of 
granulomatous enteritis (Merritt and others, 1976; Lindberg, 1984). 
Clinically, the most common complaint appears to be chronic weight loss 
and subsequent weakness and lethargy (Beech, 1990).
Although rifampin, isoniazid and streptomycin may be used for the 
treatment of equine tuberculosis (Beech, 1990), the prognosis appears to 
be poor and the prolonged therapy required would only be warranted in 
very valuable horses and should be instituted under strict isolation due to 
the public health risks.
HISTOPLASMOSIS.
Histoplasmosis has been recorded in association with 
granulomatous colitis in a horse (Dade, Lickfeldt and McAllister, 1973). 
The authors suggested that Histoplasma capsulatum had gained entry 
orally and the signs reported were progressive weight loss, lethargy, 
ventral oedema and sudden onset of chronic, profuse diarrhoea.
On post-mortem examination a large amount of serous fluid was 
recovered from all body cavities. The mesenteric lymph nodes were 
enlarged and the walls of the caecum and colon were thickened and the
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mucosa appeared reddened and ulcerated. Microscopically, the normal 
architecture of the mesenteric lymph nodes was distorted by diffuse 
proliferation of cells of the reticuloendothelial system within which there 
were many structures identical to H. capsulatum. The mucosa and 
submucosa of the caecum and colon were infiltrated by macrophages 
containing similar structures. Oedema of the submucosa was marked.
The therapeutic protocol was not recorded but the animal did not 
respond to treatment. Amphotericin B and ketoconazole are the 
recommended drugs for equine histoplasmosis (McCullough, 1983).
STRONGYLOSIS.
The most common and clinically significant parasites of horses 
associated with chronic gastrointestinal disease are the intestinal 
nematodes of the family Strongylidae. Until recently, Strongylus spp. (the 
large strongyles) were considered to be the most harmful equine internal 
parasites under normal field conditions (Drudge and Lyons, 1983; 
Ogbourne and Duncan, 1985) but there have been several recent reports 
of clinical disease in horses due to cyathostome infection (Chiejina and 
Mason, 1977; Jasko and Roth, 1984; Giles, Urquhart and Longstaffe, 
1985; Church, Kelly and Obwolo, 1986; Love, 1990). Indeed, in a report 
of 66 cases of equine diarrhoea, the most commonly identified cause was 
larval cyathostomiasis (Mair, de Westerlaken, Cripps and Love, 1990a). 
Mixed populations of small and large strongyles occur under natural 
conditions and faecal strongyle eggs cannot be differentiated to species by 
microscopic examination but third-stage larvae obtained by culture of 
faecal samples can be differentiated to the level of subfamily i.e. 
Strongylinae vs. Cyathostominae (Drudge and Lyons, 1983).
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Strongylus vulgaris, S. edentatus and S. equinus are the main species 
of the large strongyles and they all migrate (Drudge, Lyons and Tolliver,
1989) during their larval stages: S. vulgaris in walls of arteries, particularly 
in those that supply the gastrointestinal tract; S. edentatus in the veins to 
invade the liver and other abdominal organs; and S. equinus larvae 
migrate into the liver and pancreas. The approximate pre-patent periods 
for these species are six, eleven and nine months, respectively (Drudge 
and Lyons, 1983). The adult stages are attached to the mucosa of the large 
intestine.
The subfamily Cyathostominae is composed of over 40 species and 
they have been grouped into eight genera (Lichtenfels, 1975). Details of 
the cycles of individual species are not available but Reinemeyer (1986) 
summarised the presumed direct life cycle of these species: third-stage 
larvae are ingested by the host and exsheath to invade the large intestinal 
wall where they develop to the fourth larval stage within a mucosal cyst. 
Subsequently, fourth-stage larvae emerge into the lumen of the caecum 
and large colon, and develop to the fifth-stage and finally achieve full 
sexual maturity. Although the pre-patent period usually ranges from six to 
fourteen weeks, arrested or inhibited development of third- and 
fourth-stage larvae in the large intestinal wall has been reported (Smith, 
1976; Eysker, Jansen and Mirck, 1984; Eysker, Boersema and Kooyman,
1990).
The pathogenesis of the large strongyles involves both larvae and 
adult parasites (Argenzio and Whitlock, 1980). Larvae migrating along 
mesenteric arteries may induce arteritis and thromboembolism 
(Slocombe, McCraw, Pennock and Llewellyn, 1981). Interference with the 
blood supply to the gastrointestinal tract, probably resulting from 
vasoconstriction as a consequence of the release of vasoactive substances 
by aggregating platelets (Becht, 1984; White, 1986) or by an immune 
response triggered off by parasitic antigens (White, 1981), has been 
associated with the focal intestinal ischaemia observed in infected
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animals. Altered intestinal motility has been demonstrated by studies on 
the ileal myoelectrical activity in ponies experimentally infected with S. 
vulgaris third-stage larvae (Bueno, Ruckebusch and Dorchies, 1978; Berry, 
Merritt, Burrows, Campbell and Drudge, 1986; Clark, 1990).
Adult S. vulgaris parasites attach to the mucosa of the caecum and 
large colon and produce bleeding ulcerations due to their feeding by 
sucking blood, and secondary bacterial invasions may lead to a catarrhal 
enteritis and diarrhoea may result (Greatorex, 1975; Argenzio and 
Whitlock, 1980). Duncan and Dargie (1975) demonstrated an increased 
loss of albumin and red blood cells into the gastrointestinal tract of 
animals to which adult S. vulgaris had been transplanted.
The life cycle of the cyathostomes is presumed to be non-migratory 
and, in consequence, the pathological processes are limited to the 
gastrointestinal tract (Ogbourne, 1978). No attempt has been made to 
define the pathogenic effects of individual species and all studies carried 
out experimentally were based on mixed infections (Love, 1990). The cysts 
containing developing larvae in the large intestinal mucosa and 
submucosa are surrounded by a mononuclear infiltrate and /or a thick 
fibrous capsule, and hypertrophy and hyperplasia of goblet cells are 
present in the nearby mucosa (Ogbourne, 1978) which might to a certain 
extent impair the normal physiological functions of caecum and large 
colon (Blackwell, 1973; Church and others, 1986). In northern temperate 
climates mass emergence of inhibited larvae into the gut lumen, usually 
during the early months of the year, is accompanied by a severe 
inflammatory reaction which has been associated with the distinct clinical 
syndrome of larval cyathostomiasis (Ogbourne, 1978; Giles and others, 
1985) which is considered to be a protein-losing enteropathy (Blackwell, 
1973; Roberts, 1984; Giles and others, 1985; Church and others, 1986; 
Love, 1990).
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A reduced motility of the gastrointestinal tract was demonstrated in 
ponies experimentally infected with cyathostomes (Bueno and others, 
1979) although Church and others (1986) reported clinical evidence of 
continuous, intense muscular activity in the caecum of a pony with larval 
cyathostomiasis from which intestinal biopsies were being taken via 
laparotomy.
Adult cyathostomes are attached to the mucosa of the caecum and 
large colon by their buccal capsules (Ogbourne, 1978) but although 
ulceration of the large intestinal mucosa may occur it is thought that 
mature parasites do not cause clinical disease unless present in very high 
numbers, or a secondary bacterial infection occurs (Ogbourne, 1978; 
Al-Mashat and Taylor, 1986). Generally, mixed strongyle populations take 
place in most natural infections and therefore it is difficult to attribute 
specific clinical signs to adult cyathostomes (Reinemeyer, 1986).
The clinical course of strongylosis may be protracted in horses of 
all ages and characterized by recurrent colic, anorexia, weight loss, 
diarrhoea, and chronic depression (Platt, 1986; Mair, Hillyer and Pearson, 
1991; Robertson, 1990). The diarrhoea may be acute and associated with 
shock, or it may become chronic, either profuse and continuous or 
alternating between cow-pat faeces and episodes of severe diarrhoea 
(Argenzio and Whitlock, 1980). Anaemia, poor performance and 
unthriftiness have been ascribed to the presence of adult strongyle 
parasites in the large intestine of horses (Ogbourne and Duncan, 1985) 
and Roberts (1984) considered S. vulgaris larval infection to be a 
protein-losing enteropathy. Adult cyathostominae may contribute to these 
chronic signs but a specific entity has been reported to be caused by larval 
small strongyles in which a chronic diarrhoea of sudden onset in late 
winter with progressive but rapid weight loss, emaciation and eventually 
death occur if not treated promptly (Giles and others, 1985; Love, 1990). 
Although larval cyathostomiasis appears to occur more frequently in
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young animals, there have been reports of affected horses at up to 16 
years of age (Giles and others, 1985; Love, 1990). In addition to these 
clinical signs, ventral oedema may be a feature of the condition.
Bleeding intestinal ulcerations may be found with both large and 
small strongyle adult infections but the major pathological changes are 
due to the larval stages. Penetration of strongyle larvae into the intestinal 
mucosa and submucosa results in an infiltration by neutrophils, 
mononuclear cells and eosinophils in association with submucosal 
haemorrhage (Ogbourne, 1978; Ogbourne and Duncan, 1985). The larval 
migration of S. vulgaris produces considerable thickening of the wall of the 
anterior mesenteric artery and of its branches due to an intense 
inflammatory reaction and may result in thrombus formation and 
proliferation of the intima, and cellular infiltration of the arterial wall 
with plasma cells, lymphocytes, macrophages and neutrophils (Ogbourne 
and Duncan, 1985). Intestinal infarction and inflammation may result 
from the impaired blood supply (Platt, 1986; Mair and others, 1991). 
Strongylus edentatus larvae migrating through the hepatic parenchyma and 
peritoneum induce the formation of foci of inflammatory reaction 
probably related to antigens released by the larvae and scars and tags of 
fibrous tissue may be observed on the hepatic capsule (Barker and van 
Dreumel, 1985) and S. equinus larvae may induce similar lesions in their 
migration through liver and hepatic ligament into the pancreas and 
peritoneal cavity. Subserosal haemorrhagic plaques known as 
haemomelasma ilei composed of oedema, haemorrhage, different 
leucocytes, and macrophages ingesting erythrocytes are frequently 
associated with migrating strongyle larvae (Barker and van Dreumel,
1985).
Animals with larval cyathostomiasis may show different degrees of 
emaciation, with liquid large intestinal contents in which large numbers of 
cyathostome parasites are usually observed and the oedematous caecal 
and colonic walls may appear congested and containing cyathostome
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nodules within the mucosa (Giles and others, 1985). On histopathology, 
cyathostome larvae may be seen encysted in the large intestinal mucosa 
deforming the Lieberkuhn glands, and surrounded by lymphocytes,
eosinophils and some plasma cells. Larvae in the submucosa induce the
formation of a thicker capsule and a similar cellular infiltrate
(Reinemeyer, 1986). Emerging larvae cause an intense inflammatory 
reaction, predominantly eosinophils, as well as haemorrhagic foci and 
oedema, and numerous erosions may be observed (Ogbourne, 1978).
Treatment of strongylosis is by elimination of larval and adult 
strongyles by administration of larvicidal dosages of the modern
anthelmintic agents, although one has to bear in mind the existence of 
anthelmintic resistance in a number of cyathostome species (Drudge, 
Lyons and Tolliver, 1979; Herd, 1990) and the apparent lack of efficacy of 
these compounds against inhibited cyathostome larval stages (Church and 
others, 1986). Successful management of larval cyathostomiasis has been 
recorded by a combined course of corticosteroids and ivermectin at the 
recommended dosage (Church and others, 1986).
PHENYLBUTAZONE TOXICITY.
Phenylbutazone (PBZ) is a widely used nonsteroidal 
antiinflammatory drug (NSAID) for the treatment of soft tissue 
inflammation (Tobin, Chay, Kamerling, Woods, Weckman, Blake and 
Lees, 1986). In recent years, its potential toxicity in the equine patient has 
been demonstrated both experimentally (Snow, Bogan, Douglas and 
Thompson, 1979; Snow, Douglas, Thompson, Parkins and Holmes, 1981; 
Lees, Creed, Gerring, Gould, Humphreys, Maitho, Michell and Taylor, 
1983; Meschter, Maylin and Krook, 1984; Collins and Tyler, 1985; 
Meschter, Krook, Maylin and Corradino, 1990) and in clinical reports 
(Gunson and Soma, 1983; Read, 1983; Traub, Gallina, Grant, Reed, 
Gavin and Paulsen, 1983; Behm and Berg, 1987).
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The dosage regimen generally recommended for PBZ is 8 
mg/kg/day for one day; then 3.3 m g/kg/day for five days; finally 3.3 
mg/kg on alternate days for four days. Phenylbutazone is generally 
considered a safe drug at a normal dose and toxicity in the horse is most 
commonly associated with excessive dosage of the compound, 
combination with other NSAIDs, administration to dehydrated animals or 
those with reduced water intake, or to those suffering from liver 
dysfunction (Murray, 1990b).
Phenylbutazone possesses an ulcerogenic effect in the alimentary 
tract which appears to result from its inhibition of prostaglandin synthesis 
(Tobin and others, 1986) and/or subsequent local vasoconstriction, 
hypoxia and necrosis (Lees and Higgins, 1985) and/or decreased 
production of protective mucus (Collins and Tyler, 1985). These 
hypotheses are supported by the results of studies by Collins and Tyler 
(1985) which found that concurrent administration of PBZ and synthetic 
PG E2 prevented the development of ulcers and hypoproteinaemia, 
although there is recent evidence that other processes such as bacterial 
invasion might be involved in the formation and perpetuation of 
gastrointestinal erosions (Meschter and others, 1990). A vasculopathy has 
been suggested as the primary lesion in PBZ toxicity (Meschter and 
others, 1984; Meschter and others, 1990). Snow and others (1981) 
demonstrated an increased loss of proteins into the gastrointestinal tract 
by studies with radioisotopes and the authors concluded that this loss was 
most likely associated with the gastrointestinal ulcerations; however 
protein-losing enteropathy (PLE) was also observed in animals which 
lacked such lesions but were found to have a characteristic mucosal 
atrophy (Collins and Tyler, 1985). Other toxic effects of PBZ in the horse 
include nephrotoxicity (Gunson and Soma, 1983; Read, 1983; Behm and 
Berg, 1987) and hepatotoxicity (Lees and others, 1983).
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The first signs of PBZ toxicity are depression, inappetence and 
weight loss (Snow and others, 1981; Tobin and others, 1986). Oral ulcers 
may be present and diarrhoea may be a feature of the condition (Snow 
and others, 1981; Collins and Tyler, 1985). Moderate to severe abdominal 
discomfort has been reported (Snow and others, 1981; Byars, 1990; 
Murray, 1990b; Meschter and others, 1990) and ventral oedema may be 
present (Murray, 1990b). Some cases present in hypovolaemic shock or 
with endotoxaemia (Snow and others, 1981; Collins and Tyler, 1985) and 
septicaemia may occur (Murray, 1990b). Oliguria or haematuria may 
indicate renal disease (Read, 1983; Behm and Berg, 1987; Byars, 1990).
At post-mortem examination ulcers, erosions and areas of necrosis 
may be seen along the gastrointestinal tract, and submucosal oedema may 
be evident (Snow and others, 1981; Collins and Tyler, 1985; Meschter and 
others, 1990). On histopathology, oral ulcers generally appear well 
demarcated whereas lesions in other portions of the alimentary tract may 
range from mucosal atrophy to erosions or ulcerations with cellular 
infiltrates, and a reduced number of cells may be apparent (Collins and 
Tyler, 1985). Sloughed epithelium may be separated from the lamina 
propia by subepithelial clefts containing fibrin strands and cellular debris 
(Meschter and others, 1990) and alterations in the submucosa include 
oedema and congestion of veins and lymphatics (Collins and Tyler, 1985).
In his review Murray (1990b) gives guidelines for treatment of 
cases with PBZ toxicity: administration of the drug should be stopped 
immediately. Symptomatic therapy is required for animals presenting in 
shock but care should be taken where crystaloid fluids are administered - 
plasma or colloids may be necessary to correct the hypoproteinaemia; if 
septicaemia is present, broad-spectrum antibiotics should be 
administered, and narcotic analgesics may be used to alleviate pain; 
healing of ulcers may be promoted by histamine H2 antagonist 
administration, and synthetic prostaglandins might be helpful, although 
currently they are at a experimental stage.
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OTHER CONDITIONS OF THE ALIMENTARY SYSTEM RESULTING
IN CHRONIC WEIGHT LOSS AND/OR DIARRHOEA.
Other chronic enteropathies described in equine medicine may 
result in chronic weight loss and/or diarrhoea. However it is unlikely that 
the pathogenesis of such conditions involve alterations of intestinal 
permeability.
Several bacterial pathogens have been suggested to be involved in 
the origin of enteric lesions in the horse (reviewed by Al-Mashat and 
Taylor, 1986). Abdominal abscesses and other causes of chronic 
peritonitis have been associated in horses with chronic weight loss, 
chronic or intermittent colic, depression, anorexia, intermittent fever, 
ventral oedema, decreased borborygmi and diarrhoea (Dyson, 1983; 
Rumbaugh, 1983; Spier, Carlson, Nyland, Snyder and Fischer, 1986; Mair, 
Hillyer and Taylor, 1990b; Semrad, 1990). Rhodococcus equi infection may 
produce a chronic progressive inflammation of the gastrointestinal tract 
and associated lymph nodes which may result in chronic diarrhoea 
(Merritt, Bolton and Cimprich, 1975; Hillidge, 1986).
Protozoal organisms such as Globidium (.Eimeria) leuckarti 
(Wheeldon and Greig, 1977) or Tritrichomonas spp. (Laufenstein-Duffy, 
1969) have been associated with cases of equine chronic diarrhoea.
Chronic gastritis (Whitlock, 1980), chronic pancreatitis (Pass and 
Bolton, 1982; Morris, 1983; Barker and van Dreumel, 1985) and exocrine 
pancreatic adenocarcinoma (Church, West and Baker, 1987) may result in 
horses in chronic weight loss, depression, mild intermittent colic and 
diarrhoea. Similar abnormalities may be observed in cases of chronic liver 
disease (Byars, 1987; Milne, 1990), chronic sand enteropathy (Colahan, 
1987; Scrutchfield, 1987; Murray, 1990a) and chronic grass sickness 
(Edwards, 1987).
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APPROACH TO THE DIAGNOSIS OF EQUINE CHRONIC 
ENTEROPATHIES.
Chronic enteropathies in the horse present a considerable 
diagnostic challenge to clinicians due to the similarity in their clinical 
presentation and extensive and expensive investigative procedures may be 
required in order to reach a definitive diagnosis.
CASE HISTORY.
To some extent the case history and clinical presentation may 
enable the clinician to focus attention to the gastrointestinal tract. For 
example, inadequate parasite prophylaxis may suggest parasitism as the 
cause of the problem and a history of recent administration of 
phenylbutazone may be ascertained, but in many instances nonspecific 
history of chronic weight loss and/or diarrhoea, and possibly anorexia, 
depression and oedema may be all that can be obtained.
PHYSICAL EXAMINATION.
On physical examination of a case of equine chronic enteropathy, 
the findings are rarely pathognomonic of a specific condition. However, 
some clinical features may be indicative of certain diseases. For example, 
enlarged peripheral lymph nodes may occasionally be present in cases of 
alimentary lymphosarcoma (Rebhun and Bertone, 1984; Madewell and 
Theilen, 1987) and enlarged lymph nodes, abnormal nodules or masses 
and diffuse thickening of intestinal loops may also be palpated per rectum 
in horses with alimentary LSA (Wiseman and others, 1974; Roberts and 
Pinsent, 1975; Van den Hoven and Franken, 1983; Crawley, 1985; 
Madewell and Theilen, 1987). Similar abnormalities may be present in 
other conditions including granulomatous enteritis (Merritt and others,
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1976; Roberts and Kelly, 1980; Hodgson and Allen, 1982; Sweeney and
others, 1986), intra-abdominal abscesses (Spier and others, 1986) or
gastric SCC (Meagher and others, 1974; Wrigley and others, 1981; 
Tennant and others, 1982) such that they have low specificity. A useful 
clinical finding is the presence of small strongyle parasites on the rectal 
sleeve or in faeces which is a diagnostic feature of larval cyathostomiasis 
(Giles and others, 1985; Love, 1990). Although appreciation per rectum of 
cranial mesenteric arteritis may be indicative of migrating strongyle 
larvae, reliability and actual significance of this finding is doubtful (Dyson, 
1983). Skin lesions have been described in horses with granulomatous 
enteritis (Merritt and others, 1976), chronic eosinophilic gastroenteritis 
(Pass and Bolton, 1982; Breider and others, 1985; Gibson and Alders, 
1987), strongylosis (Thomsett, 1985) and alimentary LSA (Wilson and
others, 1985). Oral ulcers may be present in animals with PBZ toxicity
(Snow and others, 1981; Collins and Tyler, 1985). Dysphagia has been 
reported in a horse with gastric squamous cell carcinoma (Tennant and 
others, 1982).
As a result of the difficulty of making a specific diagnosis on the 
basis of case history and physical findings it is common practice to further 
investigate these cases by analyses of samples of blood and/or faeces 
and/or peritoneal fluid. In some animals additional investigative 
procedures such as intestinal function tests, radiography or endoscopy 
may be undertaken.
HAEMATOLOGY.
Anaemia is a nonspecific finding in many chronic equine 
enteropathies, but immune-mediated haemolytic anaemia positive to a 
Coombs’ test has been described in horses with LSA (Farrelly, Collins and 
Collins, 1966; Reef and others, 1984; Mair, Taylor and Hillyer, 1990d).
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Thrombocytopaenia, probably immune-mediated, has also been reported 
in equine LSA (Reef and others, 1984; Rebhun and Bertone, 1984; Platt, 
1987).
Neutrophilia is a common feature in many chronic enteropathies in 
horses including LSA (Wiseman and others, 1974; Roberts and Pinsent, 
1975; Reef and others, 1984; Humphrey and others, 1984; Wilson and 
others, 1985; Sheeran, 1987), chronic eosinophilic gastroenteritis (Gibson 
and Alders, 1987), large or small strongyle infections (Ogbourne and 
Duncan, 1985; Giles and others, 1985), PBZ toxicity (Lees and others, 
1983) and gastric SCC (Wrigley and others, 1981; Tennant and others, 
1982).
Eosinophilia is said to occur in parasitised animals, although this 
finding is inconsistent (Ogbourne and Duncan, 1985; Giles and others,
1985). Eosinophilia associated with chronic eosinophilic gastroenteritis 
has been recorded (Gibson and Alders, 1987).
Lymphocytopaenia was reported in only one animal with 
granulomatous enteritis (Roberts and Kelly, 1980). Leukaemia may 
occasionally be encountered in equine LSA (Theilen and Fowler, 1962; 
Madewell, Carlson, MacLachlan and Feldman, 1982) but lymphopaenia 
has been reported in alimentary LSA (Wilson and others, 1985).
Plasma fibrinogen levels were found to be increased in 
inflammatory processes such as internal abscesses (Spier and others,
1986), LSA (Schalm and Carlson, 1982) or peritonitis of various origins 
(Mair and others, 1990b), but fibrinogen is a nonspecific acute phase 
protein and it might be more useful to monitor recovery rather than as a 
diagnostic tool (Allen and Kold, 1988; Taylor, 1990).
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BLOOD BIOCHEMISTRY.
By far the most common biochemical abnormality found in horses 
with chronic enteropathies is low plasma albumin levels as recorded in 
clinical reports of LSA (Wiseman and others, 1974; Roberts and Pinsent, 
1975; Van den Hoven and Franken 1983; Humphrey and others, 1984; 
Crawley, 1985; Sheeran, 1987), granulomatous enteritis (Merritt and 
others, 1976; Meuten and others, 1978; Roberts and Kelly, 1980; Hodgson 
and Allen, 1982; Sweeney and others, 1986), chronic eosinophilic 
gastroenteritis (Pass and Bolton, 1982; Breider and others, 1985; Gibson 
and Alders, 1987), tuberculosis and histoplasmosis (Roberts, 1984), 
strongylosis (Round, 1970; Patton, Mock, Drudge and Morgan, 1978; 
Giles and others, 1985; Church and others, 1986; Love, 1990), PBZ 
toxicity (Snow and others, 1981; Lees and others, 1983; Collins and Tyler,
1985), gastric SCC (Wrigley and others, 1981; Tennant and others, 1982) 
and pancreatic adenocarcinoma (Church and others, 1987). However, 
since hypoalbuminaemia may occur in so many different intestinal 
diseases it clearly has no diagnostic specificity. In gastrointestinal 
disorders low plasma albumin levels may arise as a result of a variety of 
mechanisms including: increased losses of protein into the gastrointestinal 
tract due to mucosal cell erosion; mucosal ulceration; active secretion or 
altered metabolism; passive intercellular diffusion due to lymphatic 
obstruction; increased capillary pressure and permeability; or 
ultrastructural separation of junctional complexes (Roberts, 1984; Clark, 
Morris, Allen and Tyler, 1988), but it may be exacerbated by concurrent 
decreased absorption due to inappetence and/or malabsorption of amino 
acid precursors (Coffman, 1979; Dargie, 1975; Pearson, 1990).
Increased total plasma globulin level is a nonspecific finding in 
many disease processes including enteropathies (Coffman, 1979) and may 
accompany hypoalbuminaemia if there is concurrent chronic 
inflammation, hepatic dysfunction or during the prepatent period in 
strongylosis (Roberts, 1984). Serum protein electrophoresis may be more
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informative (Matthews, 1982) and it is the method of choice to assess 
protein levels since the chemical assays by dye methods may be inaccurate 
when albumin levels are low, and the concentration of other proteins is 
elevated (Blackmore, Henley and Mapp, 1983). Hyperalpha- 
globulinaemia is a common feature of chronic equine enteropathies, 
although it is often found in animals with severe inflammation of any type 
(Coffman, 1984), and may appear together with hyperbetaglobulinaemia. 
Increased plasma betaglobulin levels have been commonly reported in 
animals infected with strongyles (Round, 1970; Ogbourne and Duncan, 
1985; Giles and others, 1985; Church and others, 1986; Reinemeyer, 1986) 
which is generally due to raised levels of gammaglobulin G (T) which 
migrate in the betaglobulin fraction. Hypergammaglobulinaemia may be 
caused by concurrent infection or liver disease (Coffman, 1979; Schalm 
and Carlson, 1982; McLaughlin, 1990).
Electrolyte alterations are generally nonspecific and the 
hyponatraemia, hypochloraemia and hypokalaemia frequently noticed in 
horses with chronic diarrhoea (Murray, 1990a) are of more use as a base 
for the symptomatic management of affected animals rather than to 
clarify their aetiologic diagnoses. Hypocalcaemia may result from 
inappetence (Murray, 1990a), but it may be associated with protein loss 
into the gastrointestinal tract (Collins and Tyler, 1985; Crawley, 1985). 
Hypomagnesaemia was recorded in animals with PBZ toxicity (Lees and 
others, 1983).
Analyses of plasma enzyme levels are useful to rule out 
involvement of other organs such as liver or pancreas (Coffman, 1984; 
Humphrey and others, 1984; Church and others, 1987; Taylor, 1990). 
Increased alkaline phosphatase activity, particularly the intestinal 
phosphatase, may indicate enteric damage (Taylor, 1990) but otherwise 
plasma enzymes do not add more specific information.
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Measurements of plasma levels of urea and creatinine may be 
helpful in detecting renal disease from PBZ nephrotoxicity or other 
causes (Read, 1983) but they might also indicate pre-renal azotaemia 
(Taylor, 1990).
PERITONEAL FLUID ANALYSIS.
Abdominal paracentesis is a straightforward and generally safe 
procedure which is useful as an aid to the diagnosis of abdominal disease 
in horses (Hamilton and Hardenbrook, 1973; Bach and Rickets, 1974; 
Cowell, Tyler, Clinkenbeard and MacCallister, 1987). Peritonitis is 
considered when the total white blood cell count in the peritoneal fluid 
(PF) is at least 1010/litre and the predominant cell type is the neutrophil 
(Dyson, 1983; Mair and others, 1990b). Increased numbers of normal or 
abnormal lymphocytes may be observed in peritoneal fluid from cases of 
equine LSA (Bach and Ricketts, 1974; Schalm and Carlson, 1982; 
Sweeney, 1987). Increased numbers of PF eosinophils have been recorded 
in chronic eosinophilic gastroenteritis (Gibson and Alders, 1987) and they 
might also occur as a result of strongyle larvae migrating in the intestinal 
wall (Bach and Ricketts, 1974; Merritt, 1983). A reduced phagocytic 
activity of mesothelial cells in PF was considered to be a significant 
finding for the diagnosis of equine granulomatous enteritis (Merritt and 
others, 1976). Other tumour cells may be evident on examination of PF 
(Bach and Ricketts, 1974; Tennant and others, 1982; Fulton, Brown and 
Yamini, 1990).
FAECAL ANALYSIS.
Various analyses of faeces from cases with chronic enteric disease 
may be helpful to diagnosis.
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Bacteriological culture of faeces should be carried out on several 
occasions to increase the chances of isolating Salmonella spp., which may 
be intermittently shed (Murray, 1990a) although the significance of 
positive cultures is doubtful (Smith, 1983). Other bacteria which might be 
of possible significance if isolated in faecal samples include 
beta-haemolytic Escherichia coli, Clostridium perfringens A , Actinobacillus 
equuli, Campylobacter coli, C. jejuni, Aeromonas hydrophila, Pseudomonas 
spp., Bacteroides vulgatus, Mycobacterium paratuberculosis and other 
Clostridium spp. (Al-Mashat and Taylor, 1986). Occult blood may be a 
feature in some cases of ulcerated LSA (Reef and others, 1984; Rebhun 
and Bertone, 1984; Crawley, 1985), PBZ toxicity (Byars, 1990) or gastric 
SCC (Whitlock, 1980). An alteration in numbers of protozoa - either 
increased or decreased - observed in direct faecal smears may indicate an 
altered gastrointestinal environment, but they are not diagnostic per se of 
any specific condition (Merritt, 1983). The presence of neutrophils in 
faeces may be associated with bacterial colitis (Roberts, 1987).
Small strongyle parasites may be observed directly in faeces from 
heavily parasitized animals (Giles and others, 1985; Love, 1990). 
Strongyle faecal worm egg counts should always be carried out in horses 
with suspected chronic enteropathies, although the most important 
clinical conditions are induced by larval parasitic stages such that a 
negative or very low egg count in faeces does not rule out a diagnosis of 
parasitism (Giles and others, 1985; Church and others, 1986; Reinemeyer, 
1986; Love, 1990). Although faecal worm egg counts may not closely 
correlate to size of worm burdens they may give some indication of the 
efficacy of parasite control programmes (O’Brien, 1985; Herd, 1986; 
Wescott, 1986).
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HISTOPATHOLOGY.
Histopathology of biopsy specimens of abdominal organs obtained 
at laparotomy will be diagnostic in many cases. Chronically ill and
hypoalbuminaemic horses are at high risk for post-operative
complications and consequently this method of investigation is frequently 
avoided (Roberts, 1984; Sweeney, 1987). As equine medical and
anaesthetic techniques continue to improve it is likely that clinicians will 
be less reluctant to use this investigative procedure since it offers the most 
reliable method of reaching a definitive diagnosis.
Rectal mucosal biopsies may be obtained relatively safely by means 
of uterine biopsy punch (Palmer, 1987) or rectal biopsy forceps (Traver 
and Thacker, 1978). Although the rectum may frequently show no changes 
in animals with chronic enteropathies, histopathology of specimens taken 
by this technique has proved of value in cases of granulomatous enteritis 
(Merritt and others, 1976; Hodgson and Allen, 1982; Sweeney and others,
1986), chronic eosinophilic gastroenteritis (Gibson and Alders, 1987) and 
larval cyathostomiasis (Church and others, 1986). Acid-fast organisms 
were observed in rectal biopsy material obtained from a horse with 
granulomatous enteritis (Merritt and others, 1976). Various authors also 
recommend that biopsy specimens should be cultured for bacteria (Traver 
and Thacker, 1978; Palmer, 1987).
Skin biopsies may be useful in cases of chronic eosinophilic 
gastroenteritis (Breider and others, 1985; Gibson and Alders, 1987).
ENDOSCOPY.
Endoscopy may be used to examine the equine stomach for gastric 
SCC (Tennant and others, 1982).
29
RADIOLOGY.
Radiology is of very limited use in the investigation of 
gastrointestinal diseases of adult horses, but it may contribute to the 
diagnosis of TB (Mair and others, 1986) or gastric SCC (Wrigley and 
others, 1981). Fluoroscopy may be routinely used for the assessment of 
oesophageal function in suspected cases of grass sickness (Greet and 
Whitwell, 1986).
INTESTINAL FUNCTION TESTS.
Routine laboratory analyses may be normal in some cases of 
malabsorption and specific carbohydrate or lipid absorption tests may be 
necessary to demonstrate intestinal disease in such animals (Sweeney,
1987). Radioisotope tracer studies are required for the assessment of 
intestinal permeability and protein loss into the gastrointestinal tract 
(Roberts, 1984).
ORAL MONOSACCHARIDE TOLERANCE TESTS.
Tests to assess small intestinal function have been described in the 
horse by using either glucose (Roberts and Hill, 1973) or D( + ) xylose 
(Roberts, 1974; Roberts and Norman, 1979). These tests have been used 
successfully to demonstrate carbohydrate malabsorption due to villous 
atrophy, oedema or necrosis of the small intestinal lamina propia (Bolton, 
Merritt, Cimprich, Ramberg and Streett, 1976) in cases of alimentary LSA 
(Roberts and Pinsent, 1975; Wilson and others, 1985), granulomatous 
enteritis (Merritt and others, 1976; Meuten and others, 1978; Roberts and 
Kelly, 1980; Hodgson and Allen, 1982; Sweeney and others, 1986), chronic 
eosinophilic gastroenteritis (Pass and Bolton, 1982; Gibson and Alders,
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1987) and in two horses with exocrine pancreatic adenocarcinoma and 
associated diffuse lymphocytic infiltration of the small intestine (Church 
and others, 1987).
Recently the specificity of oral glucose tolerance tests to small 
intestinal dysfunction have been studied by Mair and others (1991). These 
authors found the test to have good specificity for detecting small 
intestinal disease but they emphasized the need to interpret results of 
monosaccharide absorption tests with caution since it has been suggested 
that these tests may be influenced, in addition to actual disease processes, 
by gastric emptying, intestinal transit time, mucosal blood flow (Roberts 
and Norman, 1979), bacterial population in the small intestine, diet, and 
liver and kidney function (Jacobs, Norman, Hodgson and Cymbaluk, 1982; 
Sweeney, 1987) and, when glucose is used, insulin levels, stress and length 
of fasting should be taken into account (Bolton and others, 1976).
RADIOISOTOPE TRACER STUDIES.
Standard laboratory methods may show no abnormalities in the 
chemical composition of blood and tissues of horses with chronic 
enteropathy and only in a few instances can the mechanisms responsible 
for any changes observed be ascertained. Currently the most informative 
approach to the understanding of the pathophysiological mechanisms of 
intestinal disease is brought about by radioisotope tracer techniques.
Intravenous administration of radioisotope-labelled albumin (with 
12slodine or siChromium) or siChromium-chloride and subsequent 
measurement of radioactivity in plasma, faeces and urine have been used 
in the horse to investigate altered protein metabolism and/or protein loss 
into the gastrointestinal lumen in cases of granulomatous enteritis 
(Merritt and others, 1976; Merritt, Kohn, Ramberg, Cimprich, Reid and 
Bolton, 1977; Meuten and others, 1978) and PBZ toxicity (Snow and
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others, 1981) and this method has also been used to study naturally 
occurring and experimental strongyle infections (Duncan and Dargie, 
1975; Dietz and Nielsen, 1980; Love, 1990).
Loss of red blood cells into the gastrointestinal tract has been 
confirmed in foals experimentally infected with adult Strongylus vulgaris 
and in naturally infected ponies, in which faecal excretion of radioisotope 
was found to be higher than in control animals after the intravenous 
injection of 51Cr-labelled red blood cells (Duncan and Dargie, 1975).
Decreased intestinal absorption of fat has been demonstrated in a 
horse with granulomatous enteritis following administration by stomach 
tube of a capsule containing tritiated oleic acid and measuring 
radioactivity counts in plasma (Meuten and others, 1978).
INTESTINAL PERMEABILITY STUDIES.
With such similarity of many of the clinical, pathological and 
laboratory aspects of many cases of chronic enteropathy in the horse it is 
frequently difficult to diagnose a specific condition.
The difficulties of reaching a definitive diagnosis in chronic 
alimentary diseases of horses and ponies have important implications to 
the treatment or management of affected animals in that these are often 
made on empirical judgements. In part, the difficulty of making definitive 
diagnoses in such cases is due to a lack of detailed knowledge of the 
pathogenesis of most chronic enteropathies. These diseases often manifest 
as an apparent abnormal absorption or increased secretion of metabolites 
across the bowel wall although the mechanisms of these dysfunctions are 
not well defined.
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In human patients with chronic enteropathy it is thought that 
alterations of intestinal permeability may be important in the
pathogenesis of various conditions. Consequently, attention has been 
given to developing techniques of assessing intestinal permeability using 
marker substances such as mannitol, lactulose and siChromium-labelled 
ethylenediaminetetraacetate (siCr-EDTA). Various properties of 
siCr-EDTA make it suitable as a marker of transmucosal diffusion: it has 
been confirmed to be stable and physiologically inert (Stacy and 
Thorburn, 1966); it is confined to an extracellular location and is not 
bound by plasma proteins; it is not taken up or metabolised by 
erythrocytes or organs other than the kidneys (Garnett, Parsons and
Veall, 1967; Aurell, 1968; Favre and Wing, 1968; Chantler, Garnett, 
Parsons and Veall, 1969). Within 24 hours following intravenous 
administration of 5iCr-EDTA about 98% of the dose is excreted via the 
kidneys (Garnett and others, 1967; Favre and Wing, 1968; Aurell, 1968) 
such that urinary excretion of 5iCr-EDTA provides a method of assessing 
glomerular filtration rate (Chantler and others, 1969; Granerus and 
Aurell, 1981)
In addition to its use for investigating renal function, siCr-EDTA 
has been successfully applied to the investigation of chronic enteropathies 
in man (Bjarnason, Peters and Veall, 1983a; Bjarnason, O’Morain, Levi 
and Peters, 1983b; O’Morain, Abelow, Chervu, Fleischnen and Das, 1986; 
Maxton, Bjarnason, Reynolds, Catt, Peters and Menzies, 1986; Behrens, 
Szaz, Northrop, Elia and Neale, 1987; Jenkins, Jones, Goodacre, Collins, 
Coates, Hunt and Bienenstock, 1987; Elia, Behrens, Northrop, Wraight 
and Neale, 1987; Jenkins, Ramage, Jones, Collins, Goodacre and Hunt,
1988), dogs (Hall, Batt and Brown, 1989; Hall and Batt, 1990), gerbils and
lambs (Sinski, Maclean and Holmes, 1987; Maclean, Sinski and Holmes,
1989), rats (Bjarnason, Smethurst, Levi and Peters, 1985; Ramage, 
Stanisz, Scicchitano, Hunt and Perdue, 1988) and ponies (Love, 1990). 
The technique involves the administration to fasted patients of a solution 
of 51Q--EDTA and the amount of tracer detected in urine is used to
33
calculate the percentage of the administered dose absorbed from the 
bowel which would be an estimation of intestinal permeability. Such a 
technique may be of use to detect intestinal mucosal damage in, to study 
the pathophysiology of, and to monitor the response to treatment of, 
equine chronic enteropathies.
The objectives of the studies reported in this thesis were to validate 
siChromium-labelled ethylenediaminetetraacetate as a marker for the 
assessment of intestinal permeability in normal ponies and to study 
alterations in intestinal permeability in ponies with either 
experimentally-induced or naturally occurring chronic enteropathy.
34
CHAPTER II. GENERAL MATERIALS AND METHODS.
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CHAPTER 11. GENERAL MATERIALS AND METHODS.
EXPERIMENTAL ANIMALS.
Four British native-breed female pony yearlings were used in 
Experiments 1, 2, 3, 5 and 6. These ponies were reared indoors with their 
dams which received repeated doses of ivermectin. They were considered 
to be helminth-naive and they were between 10 and 14 months old at the 
time the studies were carried out.
Before being weaned at four or five months of age, the ponies 
suckled their dams and were fed on hay and a coarse mix. Following 
weaning, animals received a commercially-produced diet (Complete 
Cubes, Spillers). Both food and water were available ad libitum. They 
were kept in individual stalls on woodshavings which were cleaned out 
daily and they were regularly exercised on concrete. For two days prior to, 
and during the time at which the experiments were carried out, the foals 
were tethered and kept on rubber matting. The animals were allowed two 
days to acclimatise to the collection apparatus and they were fasted for 
ten hours previous to and then for two hours after the administration of 
the radioisotope.
Two British native-breed five year-old ponies with permanent 
caecal fistulation were used in Experiment 4 and, in Experiment 7, the 
test was applied to three horses with suspected chronic enteropathy 
referred to the Department of Veterinary Medicine of the University of 
Glasgow Veterinary School. A detailed account of the history and 
management of the fistulated ponies, and of the history, clinical, 
laboratory and pathological findings and management of the clinical cases 
is given in the appropriate sections of Experiments 4 and 7 in Chapters III 
and IV, respectively.
3 6
RADIOISOTOPE TECHNIQUE.
51CHROMIUM-ETHYLENEDIAMINETETRAACETATE
(51Cr-EDTA) PREPARATION.
An injectable commercial preparation of siCr-EDTA (Chromium 
(5iCr)-EDTA Injection, Amersham International, Amersham), commonly 
utilised for the assessment of glomerular filtration rate, was used in each 
of the experiments. The product is available in 10 ml (37 MBq ±  10%) 
multidose vials containing 1% benzyl alcohol as bacteriostat. According to 
the data sheet, each ml of Chromium (siCr)-EDTA Injection contains 
0.3-0.7 mg of chromium EDTA and 0.9-2.4 mg of sodium edetate, 
depending on the specific activity and radioactive concentration of the 
batch.
ADMINISTRATION OF 51Cr-EDTA.
Four vials containing 10 ml of Chromium (si)-EDTA were used on 
each occasion. The contents of the four vials were emptied into a beaker 
and thoroughly mixed. After taking a sample of 1 ml which subsequently 
was used to make up the standard solution (vide infra), four equal volumes 
were dispensed into syringes. These syringes were accurately weighed 
when they were containing the siCr-EDTA solution and again once they 
had been emptied.
These doses of 5iCr-EDTA were administered via nasogastric 
intubation by means of a two metre long, one centimetre diameter, 
stomach tube. The 5iCr-EDTA solution was then flushed through the tube 
with 300 ml of water.
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SAMPLES.
Urine.
The design described by Harris (1988) was modified to construct 
urine collection funnels from rubber, aluminium strips and metal rivets. 
The funnels and harnesses are shown in Figures 1.1 and 1.2. (Chapter III). 
Urine was collected directly into polythene bags after flowing down the 
funnel. These bags were fixed to the neck of the funnel by rubber bands 
and held within canvas bags which were hanging from the harnesses. 
Movement of the harnesses or leakage from the funnels were checked for 
regularly and re-adjustments made when required. Total urine collections 
were performed for 72 hours: the urine bags were changed every six hours 
and urine weights were recorded for 6-hour periods on the first day and 
12-hour periods thereafter. The bulked total collection for each interval 
was thoroughly mixed before four 1-ml samples were taken.
Faeces.
The faeces produced by the ponies in 72 hours were collected at 
intervals of six hours on the first day and of 12 hours on the second and 
third days. The weight of the collections at each interval was recorded. 
Collection was directly into polythene bags suspended within canvas bags 
which were held over the anus of the ponies by attachments to the 
harnesses. Five faecal samples of approximately 10 mg were taken 
following thorough mixing of the bulked total from each collection period.
Blood.
In Experiment 5, blood samples were collected 6-hourly to look for 
the presence of the radioisotope in the peripheral circulation. Blood was 
taken from left jugular veins into heparinised, vacuum tubes via 1", 21G 
needles. The samples were centrifuged and 4 ml of plasma taken into 
counting vials.
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RADIOACTIVITY MEASUREMENTS.
STANDARD SOLUTIONS.
Standard solutions were made up by adding water to accurately 
weighed samples of approximately 1 ml of the isotope-labelled 
preparation to give a total volume of 1000 ml. Ten 1-ml samples of the 
standard solution were then pipetted into separate counting vials and 9 ml 
dilute NaOH were added to each one. The standard solution samples 
were used to calculate the injected doses of isotope once the exact weight 
of Chromium (5iQr)-EDTA administered to each animal was known, and 
to detect variations in counting sensitivity of the gamma counter. They 
also served as correction factors for radioactive decay.
FAECES AND URINE SAMPLES.
Each of the four 1-ml urine samples was accurately weighed and 
then made up to 10 ml with dilute NaOH. Five samples of approximately 
10 g from each faecal collection were packed into a volume of 10 ml and 
then accurately weighed.
RADIOACTIVITY COUNTING.
Radioactivity counting of faeces and urine samples was carried out 
in an automatic gamma counter (Minaxi Auto-Gamma Counter 5000 
Series, Canberra-Packard). Each sample was measured for one minute 
and the result was expressed as counts per minute (c.p.m.).
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CALCULATION OF INTESTINAL PERMEABILITY.
The percentages of administered 51Cr-EDTA recovered in urine 
and faeces collected during 6-hour and 12-hour periods were calculated by 
dividing the siCr activities within these periodic collections by the total 
administered activity, and multiplying the result by a factor of 100.
BIOCHEMICAL TECHNIQUES.
Serial blood samples were taken into vacutainers containing 
lithium heparin and all assays were performed by the laboratory of the 
Department of Clinical Biochemistry. Continuous flow analysis 
(Technicon Auto Analyser) by standard biuret and bromcresol green 
methods was used for measurement of total plasma protein and plasma 
albumin respectively. The level of serum globulin was calculated as the 
difference between the values of total protein and albumin.
As a degree of renal toxicity was expected in Experiment 5, blood 
samples were obtained during the period of phenylbutazone 
administration and the levels of blood urea nitrogen, creatinine and 
plasma electrolytes were determined by standard methods. Renal 
clearance and fractional excretion of sodium, potassium, chloride, calcium 
and phosphate (Morris, Divers and Whitlock, 1984; Kohn and Chew, 
1987; Harris and Colles, 1988) were calculated to evaluate the influence 
of renal dysfunction on the excretion of the radioisotope tracer.
HAEMATOLOGICAL TECHNIQUES.
Vacuum tubes containing ethylenediaminetetraacetic acid were 
used to collect the blood samples by jugular puncture. The haematological 
investigations were carried out in the Department of Veterinary
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Pathology. Total red and white blood cell counts were obtained by means 
of an automated Coulter-counter (Coulter ZF6 plus C100 Channelyzer, 
Coulter Electronics Ltd.) and differential cell counts were performed on 
blood films stained by the May-Grunwald Giemsa staining technique.
PARASITOLOGICAL AND PATHOLOGICAL TECHNIQUES.
FAECAL WORM EGG COUNTING.
The modified McMaster technique described by Gordon and 
Whitlock ( 1939) was used to examine the faecal samples. Forty-two ml of 
water were added to three grams of faeces which were homogenized to 
form a suspension that was passed through a 250 micron sieve and the 
filtrate collected into a plastic bowl. A 15 ml sample of the filtrate was 
taken into a flat bottomed tube and centrifuged at 2000 revolutions per 
minute for three minutes after which the supernatant which had formed 
was poured off. The pellet of faeces within the tube was agitated (Vortex 
Junior Mixer, Scientific Industries Inc., New York) and then resuspended 
in a saturated solution of sodium chloride. A plastic pipette was used to 
fill both chambers of a McMaster worm egg counting slide (Gelman 
Hawksley Ltd., Northampton) with this final suspension. The worm eggs 
under both grids of the slide were counted by means of a dissecting 
microscope (Wild M5 stereomicroscope) and the number multiplied by 50 
to give the number of eggs per gram (epg).
LARVAL CULTURE.
Cyathostome larvae for the experimental infection were obtained 
from a naturally infected mare. Freshly voided faeces were collected and 
placed into plastic pots to occupy two thirds of their 500 ml volume. The 
pots were covered with loosely fitting lids and incubated at 23° C for 10-14
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days. Recovery of larvae was performed in four stages. First, the cultures 
pots were filled with lukewarm water and left for 2-3 hours. Secondly, the 
fluid from the pots was passed through a coarse sieve and collected as a 
pooled sample. Thirdly, the pooled sample was passed through two milk 
filter pads (Maxa Milk Filters, A. McCaskie Ltd., Stirling) in a Buchner 
funnel. Finally, the filters containing the larvae, were placed onto a 
Baermann apparatus which was filled with lukewarm tap water. Larvae 
migrated out of the filter papers and down into the clamped neck of the 
funnel from where they were collected after six hours.
The suspension was examined microscopically in order to confirm 
that only larvae of cyathostome species were present and to calculate the 
larval concentration. A total of 1 ml of the suspension was examined, in
0.025 ml aliquots, and the number of larvae per ml was then used to 
calculate the volume required for the individual larval doses. Immediately 
prior to administration, individual doses were pipetted from the 
well-mixed larval suspension into glass universal bottles.
NECROPSY AND SAMPLING.
Two animals were examined post-mortem: Pony number 64 was 
found dead one night and examined the following morning; Pony number 
63 was shot using a free bullet from a pistol. After death the carcases and 
viscera were examined for gross pathological changes, which were 
recorded, prior to separation of the gastrointestinal tract. In each animal 
the caecum, ventral colon and dorsal colon were collected separately 
along with their contents, which were washed with water into separate 
buckets and then made up to standardised volumes. The diluted contents 
were thoroughly mixed before samples of 10% volume were taken into 
plastic containers to which formalin was added as a preservative. The 
caecum, ventral colon and dorsal colon were weighed separately and
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samples of 10% by weight were cut as longitudinal strips from the haustra 
between taenial bands; taking approximately equal amounts from 
proximal, middle and distal parts of each organ.
WORM COUNTING.
In order to count lumenal worms 5 ml aliquots of the intestinal 
contents were pipetted into Petri dishes. Each aliquot was stained for a 
few minutes with a few drops of 45% iodine solution, then decolourised 
with 5% sodium thiosulphate solution and the worms counted under a 
dissecting microscope. For each animal, 10% subsamples of the 10% 
samples of the contents of the separate intestinal segments were examined
i.e. the worms in a one per cent of the intestinal contents were counted 
and the total values obtained by multiplying by a factor of one hundred.
A method of mural transillumination similar to that described by 
Reinemeyer and Herd (1986) was used to count mucosal cyathostome 
larval stages. When possible, mucosa of the 10% samples of caeca, ventral 
and dorsal colons was manually stripped from the serosa and placed in 
small pieces into grid-marked Petri dishes. The tissue was examined at xl5 
magnification with a dissecting microscope and the mucosal cyathostome 
larvae within the whole sample were counted.
STATISTICAL METHODS.
The cumulative percentages of 5iCr-EDTA measured in urine in 
each experiment at 24 and 72 hours were tested statistically by one-way 
analysis of variance and differences were investigated by use of the 
Newman-Keuls Range Test. The level of significance was chosen to be 
probability values of p < 0.05.
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CHAPTER 111. VALIDATION OF siCHROMJUM-ETHYLENE 
DIAMINE TETRAACETATE (siCr-EDTA) AS A TEST TO 
STUDY INTESTINAL PERMEABILITY IN THE HORSE.
INTRODUCTION.
Intestinal function tests have been widely used in horses for the 
investigation of chronic enteropathies. Those presently available are 
based on the absorption of sugars i.e. oral glucose (Roberts and Hill, 
1973) and oral D( + )-xylose tolerance tests (Roberts and Norman, 1979). 
They are generally of most use in detecting small intestinal dysfunction 
because they are specifically absorbed in that part of the alimentary tract.
It has been well-recognised that the large intestine plays an 
essential role in the metabolic processes of horses (Argenzio, 1975). Many 
chronic enteropathies are either localised to, or involve part of, the 
posterior bowel and consequently there will often be disturbances of large 
intestinal metabolism such that a method of assessment of equine large 
intestinal function would complement the small intestinal function tests.
Chronic enteropathies are relatively common in human medicine 
and the so-called "inflammatory bowel diseases" (Crohn’s disease and 
ulcerative colitis) or coeliac disease have some similar features to those of 
chronic enteritides in horses. For example, affected human and equine 
cases are frequently found to have a decrease in the serum albumin levels 
which may result from an increase in the permeability of intestinal 
mucosa to plasma protein molecules. Alterations in the intestinal 
permeability have also been proposed as important mechanisms in the 
pathogenesis of these conditions (Chadwick, Phillips and Hofmann, 1977; 
Bjarnason and Peters, 1984; Jenkins and others, 1988) and may contribute 
to the increased incidence of neoplasia in patients with coeliac disease 
(Walker and Isselbacher, 1974), Crohn’s disease (Gyde, Prior, MacArtney,
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Thompson, Waterhouse and Allan, 1980) and ulcerative colitis 
(Lennard-Jones, Morson, Ritchie, Shore and Williams, 1977). Thus,
compromise of mucosal integrity may contribute to both cause and effect 
of certain intestinal enteritides.
To investigate alterations in intestinal permeability, several probes 
have been used in human medicine including polyethylene glycols 
(Chadwick and others, 1977), lactulose, mannitol and L-rhamnose
(Maxton and others, 1986; Elia and others, 1987). Although all appear to 
fulfill the requirements for probes of passive intestinal permeation the 
awkward analytical techniques needed for their quantitation to some 
extent limit their usefulness. Pathophysiological studies using 
radioisotopes such as 3H-cellobiotol, i4C-mannitol or
5iCr-Ethylenediaminetetraacetate (Sandhu and Fraser, 1982; Behrens and 
others, 1987; Fotherby, Wraight and Neale, 1988) are increasingly 
acquiring more importance in gastroenterology as they are simple,
reproducible and they can be easily quantitated without any specimen 
preparation. Of these, siCr-EDTA seems to be the most widely accepted 
marker both in vivo (Bjarnason and others, 1983a; Bjarnason and others, 
1983b; O’Morain and others, 1986; Elia and others, 1987; Jenkins and 
others, 1987; Jenkins and others, 1988; Fotherby and others, 1988) and in 
vitro (Bjarnason and Peter, 1984).
In the preliminary clinical studies undertaken using 5iCr-EDTA in 
human patients with inflammatory bowel disease (IBD) it was considered 
that the absorption of the tracer was limited to the small intestine and, 
consequently, increased siCr-EDTA urinary excretion would specifically 
indicate disease in this portion of the gastrointestinal tract (Bjarnason and 
others, 1983a, b). However, recent studies confirmed that significant 
amounts of siCr-EDTA were in fact absorbed from the large intestine in 
patients with IBD (Elia and others, 1987; Jenkins and others, 1987 and
1988). The latter observation may be of relevance in developing a
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sensitive test to demonstrate alterations in large intestinal permeability in 
horses with enteropathy when small intestinal function tests detect no 
abnormalities.
These experiments were designed to validate siCr-EDTA as a test 
of intestinal permeability in ponies: first, under control conditions; then 
following both increased and decreased intestinal motility which it was 
thought might influence the values obtained; and the test was also carried 
out in ponies with caecal fistulation in order to quantify the absorption of 
siCr-EDTA from the large intestine.
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EXPERIMENT 1. INTESTINAL PERMEABILITY TO 
siCr-EDTA IN CONTROL PONIES.
INTRODUCTION.
51Chromium-Ethylenediaminetetraacetate (siCr-EDTA), administered 
orally and measured in urine as a reflection of the amount absorbed from 
the gastrointestinal tract, has been successfully used for the diagnosis and 
investigation of a variety of conditions affecting the alimentary tract of 
human patients (vide supra). Preliminary studies involving the use of 
5iCr-EDTA have also been undertaken in rats (Bjarnason and others, 
1985; Ramage and others, 1988), lambs and gerbils (McLean and others,
1989), dogs (Hall and others, 1989; Hall and Batt, 1990) and ponies 
(Love, 1990) in which the results suggested that siCr-EDTA urinary 
excretion was a suitable method for investigating intestinal permeability in 
these animals.
The objective of this experiment was to provide further data for 
5iCr-EDTA excretion in healthy ponies under control conditions.
MATERIALS AND METHODS.
Four female British native-pony yearlings were administered a 
solution of 5iCr-EDTA by stomach tube following a period of fasting of 10 
hours. The solution was washed through the tube with 300 ml of water. 
The animals were fasted for a further period of two hours following 
administration of the test solution.
Total faeces and urine produced in 72 hours were collected at 
12-hour intervals. The system used for these collections is illustrated in 
Figures 1.1 and 1.2.
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FIGURE 1.2. Urine and faeces collection apparatus in 
position.
FIGURE 1.1. Urine collection apparatus.
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RESULTS.
The amounts of 51Cr excreted in urine were calculated both as the 
mean percentage during each collection interval and as the mean 
cumulative percentage and are illustrated in Figures 1.3 and 1.4, 
respectively. The same system was used to express radioactivity found in 
faeces as shown in Figures 1.5 and 1.6. A detailed account of the values 
obtained at each interval and of the daily subtotals is given in Appendices 
1.1 for urine and 2.1 for faeces.
The results obtained for urine in 72 hours ranged from 3.93% to 
9.02% of the administered dose with a mean value of 6.64% (SD + 2.36). 
The amount of 51Cr recovered in faeces ranged from 85.51% to 92.99% of 
the total radioactivity administered, with a mean of 89.85% (SD ± 3.47).
Approximately 85% of the total siCr excreted in urine was detected 
in urine collected during the first 24 hours following administration of the 
test dose whereas only 50% of the total amount found in faeces was 
voided in the same time interval.
DISCUSSION.
In the present study, the mean percentage excretion of siCr-EDTA 
for consecutive 24 hour periods were 5.24 + 1.93, 1.11 + 0.42 and 0.29 + 
0.06, respectively (mean ± SD) which are comparable to the values 
recorded for siCr-EDTA excretion in previous studies in ponies (Love,
1990). Interestingly, in that study only approximately 50% of the total 
amount of siCr excreted in urine was detected in the first 24 hour 
collection, in contrast to approximately 85% recovered in the present 
study. This difference might be explained by the protocol used: in the 
present study experimental animals were fasted for a total of 12 hours
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FIGURE 1.3. Experiment 1: Mean percentage of administered 5iCr-EDTA
measured in urine in control ponies.
FIGURE 1.4. Experiment 1: Mean cumulative percentage of administered 
51Cr-EDTA measured in urine in control ponies.
FIGURE 1.3.
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FIGURE 1.5. Experiment 1: Mean percentage of administered 5iCr-EDTA
measured in faeces in control ponies.
FIGURE 1.6. Experiment 1: Mean cumulative percentage of administered 
5iCr-EDTA measured in faeces in control ponies.
FIGURE 1.5.
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around the time of administration of the marker whereas in Love’s study, 
there was no food withdrawal at all. It has been reported (Bjarnason and 
others, 1985) that the osmolarity and composition of the test dose affects 
the absorption of siCr-EDTA from the gut and it could be hypothesized 
that the same factors might play a role in the absorption pattern of this 
marker.
In studies of intestinal permeability, values obtained for 24 hour 
urinary excretions reported in normal human patients have ranged from 
0.61% to 2.82% (Bjarnason and others, 1983a; Bjarnason and others, 
1983b; O ’Morain and others, 1986; Elia and others, Wraight and Neale, 
1987; Fotherby and others, 1988) and values recorded in healthy dogs 
were between 2.3% and 17.6% with a median of 13% (Hall and others,
1989). The values obtained from ponies in the present work and in 
previous equine studies were similar to those in man and generally lower 
than those in dogs. Hall and others (1989) suggested that the high values 
recovered in urine in dogs might indicate either a greater rate of 
enterocyte turnover or a major difference in the total surface area of the 
intestine in this animal species. These differences may reflect the relative 
importance within each species of the large intestine as a site of 
absorption of EDTA - which has been presumed to be low in most 
monogastric animals. However, in horses the large intestine is pivotal to 
nutrient, electrolyte and water absorption. It was demonstrated by 
Argenzio, Lowe, Pickard and Stevens (1974) that 68% of a soluble marker 
was within the caecum two hours after being administered intragastrically 
and its subsequent retention of about 50 hours in the colon gives support 
to the idea of a greater absorption of EDTA in this part of the bowel in 
the equine species.
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EXPERIMENT 2. INTESTINAL PERMEABILITY TO 
siCr-EDTA IN PONIES AFTER PREMEDICATION WITH 
ATROPINE SULPHATE.
INTRODUCTION.
When studying patterns of intestinal permeability, one has to bear 
in mind that gastric emptying, luminal dilution, intestinal transit time, 
mucosal surface area, blood and lymphatic flow and renal excretion as 
well as mucosal permeability determine the absorption of the different 
markers (Bjarnason and Peters, 1984). When permeability is assessed in 
normal, ’healthy’ animals it is assumed that these factors, with the 
exceptions of gastric emptying, intestinal transit time and motility 
patterns, would have no major influence in standardised experimental 
protocols. However, minor differences in motility may occur in control 
animals due to the individual endocrine system function and the activity of 
the autonomic nervous system and reflex neural pathways (Clark, 1990). 
Further, alterations in intestinal motility have been demonstrated in 
horses with acute abdominal disease (Gerring, 1989) and strongylosis 
(Bueno, Ruckebusch and Dorchies, 1979; Berry, Merritt, Burrows, 
Campbell and Drudge, 1986) and although similar abnormalities have not 
been reported for the equine chronic enteropathies one must assume that 
they may be important features of these conditions. In relation to 
intestinal permeability, motility changes may alter the thorough mixing of 
the intestinal contents as well as the time the digesta is in contact with the 
mucosa for optimal absorption (Roger and Ruckebusch, 1987) and thus 
they might influence the pattern of absorption of intestinal markers.
During the last 15 years much work has been carried out to study 
the intestinal motility patterns in horses, principally by means of 
electrodes and strain gauge force transducers, to try to correlate the 
myoelectrical activity with the mechanical intestinal contractions. These 
methods have been used to study changes of equine intestinal motility
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resulting from feeding (Ruckebusch and Bueno, 1977; Davies and 
Gerring, 1983; Ross, Cullen and Rutkowsky, 1990) and also following 
strongyle parasitic infections (Bueno and others, 1979; Berry and others, 
1986). There have also been some reported studies on the effect of 
various drugs on the intestinal motility with special reference to 
post-prandial motility patterns (Adams, Lamar and Masty, 1984; Roger 
and Ruckebusch, 1987; Merritt, Campbell-Thompson and Lowrey, 1989; 
Rutkowsky, Ross and Cullen, 1989).
In the present study healthy, fasted ponies were used and there was 
only limited data relating to pharmaceutical modulation of intestinal 
motility in such animals.
Atropine sulphate has been considered to be the prototypical 
muscarinic blocking agent, preventing acetyl choline (ACh) from affixing 
to the receptor area in a competitive manner (Adams, 1988). In this way, 
atropine causes relaxation of gastrointestinal smooth muscle by inhibiting 
contractile effects of endogenous ACh throughout the length of the bowel. 
Reduced electrical activity of equine gastrointestinal tract following 
administration of atropine sulphate at dose rates of 0.05 mg/kg 
subcutaneously (Roger and Ruckebusch, 1987) and of 0.044 mg/kg 
intravenously (Adams, 1984) has been recorded in experimental studies in 
horses. Thus, following administration of this drug it might be expected 
that transit time of ingesta along the gastrointestinal tract would be 
prolonged (Roberts and Argenzio, 1986). For the present work it was 
decided to administer 0.06 mg/kg atropine sulphate subcutaneously 30 
minutes before the oral administration of the radioisotope.
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MATERIALS AND METHODS.
Four female British native-pony yearlings were administered a 
solution of siCr-EDTA by stomach tube following a period of fasting of 10 
hours. The solution was washed through the tube with 300 ml of water. 
The animals were fasted for a further period of two hours following 
administration of the test solution.
Total faeces and urine produced in 72 hours were collected at 
6-hour intervals on the first day and subsequently at 12-hour intervals.
Thirty minutes before the administration of the siCr-EDTA 
solution, 0.06 mg/kg of atropine sulphate (Bimeda U.K. Limited, 
Liverpool) was injected subcutaneously. Repeat abdominal and cardiac 
auscultation was carried out and signs of abdominal pain and evidence of 
mydriasis were checked for as subjective parameters to quantitate the 
effect of atropine.
RESULTS.
The amounts of siCr excreted in urine were expressed both as the 
mean percentage for each collection period and as the mean cumulative 
percentage and they are illustrated in Figures 2.1 and 2.2, respectively. 
Radioactivity counts found in faeces are shown in Figures 2.3 and 2.4. 
Details of the values obtained at each interval and of the daily subtotals 
are given in Appendices 1.2 and 2.2.
Values obtained in urine in the 72 hours collection ranged between 
3.60% and 8.80% with a mean of 5.60% (SD ± 2.39). Approximately 60% 
of the total amount was excreted during the first 24 hours following
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FIGURE 2.1. Experiment 2: Mean percentage of administered 51Cr-EDTA 
measured in urine in ponies following premedication with 
0.06 m g/kg atropine sulphate subcutaneously.
FIGURE 2.2. Experiment 2: Mean cumulative percentage of administered 
5iCr-EDTA measured in urine in ponies following 
premedication with 0.06 m g/kg atropine sulphate
subcutaneously.
FIGURE 2.1.
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FIGURE 2 3 . Experiment 2: Mean percentage of administered 51Cr-EDTA 
measured in faeces in ponies following premedication with 
0.06 m g/kg atropine sulphate subcutaneously.
FIGURE 2.4. Experiment 2: Mean cumulative percentage of administered 
51Cr-EDTA measured in faeces in ponies following 
premedication with 0.06 mg/kg atropine sulphate 
subcutaneously.
FIGURE 2.3.
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5iCr-EDTA administration. The amount of s i q - measured in faeces 
ranged from 63.53% to 85.81%, with a mean value of 79.36% (SD ± 
10.65) of which approximately 43% was collected on the first day.
DISCUSSION.
None of the ponies showed any of the signs reported to be 
associated with the administration of atropine to horses (Ducharme, 
1983), apart from one of the animals (number 70) which seemed to have a 
slight, transient pupillary dilation. Borborygmi appeared to be normal and 
no evidence of increased heart rate or abdominal pain wTas observed. 
Interestingly, there was an apparently increased faecal water content (with 
the exception of Pony number 70). This observation agrees with the 
results of experimental investigations reported by Alexander (1978). Only 
63.53% of the administered dose was recovered in the faeces of pony 
number 70 in the total time of collection, whereas the mean faecal 
excretion for the rest of the ponies was 84.64%. The latter figure was 
slightly lower than a mean of 89.85% observed in control animals in 
Experiment 1 which might indicate a slower transit time in animals 
premedicated with atropine sulphate and that this effect was greatest in 
Pony number 70.
In this study, one individual animal (Pony no. 70) showed a more 
protracted excretion of 51Cr in urine over the three days of the experiment 
- 44% on the first day and 35% on the second day - compared with the 
excretion of approximately 70% of the administered dose on the first day 
in the other ponies. This finding implies that there was significant 
absorption of EDTA from the large intestine of pony no. 70, in which the 
intestinal transit time was apparently prolonged.
59
However, no significant differences were found between the values 
of 5iCr-EDTA excretion obtained in this experiment (mean, 5.60%; SD + 
2.39) and those obtained earlier in the same ponies with no treatment 
(mean, 6.64%; SD + 2.36). In conclusion, it would appear that a slight 
prolongation of the intestinal transit time did not significantly affect the 
absorption of EDTA from the gastrointestinal tract and this finding is in 
agreement with the work conducted in rats by Bjarnason and others 
(1985).
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EXPERIMENT 3. INTESTINAL PERMEABILITY TO 
siCr-EDTA IN PONIES AFTER PREMEDICATION WITH 
BETHANECHOL.
INTRODUCTION.
This experiment was designed to evaluate the influence that the 
stimulation of the gastrointestinal motility might have on the absorption 
of siCr-EDTA.
There are many parasympathetic compounds which increase the 
rate of transit of ingesta through the gastrointestinal tract. Adams (1988) 
classified these agents into two main groups: those acting directly on the 
muscarinic and/or nicotinic receptors such as methacholine, carbachol 
and bethanecol, or those which inhibit cholinesterase including 
physostigmine, neostigmine, edrophonium and organophosphate 
derivatives.
Many of these compounds also have other parasympathetic 
activities. For example, carbachol acts on both muscarinic and nicotinic 
receptors and consequently it effects the cardiovascular system, uterine 
smooth muscle, skeletal muscle and, particularly, the autonomic ganglia 
and the chromaffin cells of the adrenal medulla as well as the 
gastrointestinal tract (Adams, 1988). Similarly, compounds which inhibit 
cholinesterase do not specifically act upon the gastrointestinal tract and 
they may also have undesired effects, such as abdominal discomfort 
associated with neostigmine injection to ponies (Adams, Lamar and 
Masty, 1984; Gerring, 1989). By contrast, administration of bethanecol has 
been reported to modify gastrointestinal motility without side effects 
when given at a dose rate of 0.05 mg/kg (Roger and Ruckebusch, 1987).
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Due to this reported specificity of action of bethanecol this 
compound was considered most suitable to increase gastrointestinal 
motility in the ponies in this experiment.
MATERIALS AND METHODS.
Four female British native-pony yearlings were administered a 
solution of 5iCr-EDTA by stomach tube following a period of fasting of 10 
hours. The solution was washed through the tube with 300 ml of water. 
The animals were fasted for a further period of two hours following 
administration of the test solution.
Total faeces and urine produced in 72 hours were collected at 
6-hour intervals on the first day and subsequently at 12-hour intervals.
Thirty minutes prior to the administration of the siq -EDTA  
solution, each animal was given a subcutaneous injection of 0.05 mg/kg of 
bethanecol (Carbamyl-b-Methyl-Choline Chloride, SIGMA Chemical 
Company).
No equipment was available for the study of the myoelectrical 
activity of the alimentary tract after premedication with bethanecol and 
abdominal auscultation was the clinical parameter used to monitor this 
response.
RESULTS.
A slight increase in the audible borborygmi was noticed in the 
animals as a result of the administration of bethanecol, although no 
increase in defaecation frequency was observed. No other abnormalities 
were noticeable on clinical examination of the ponies.
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The amounts of 51Cr excreted in urine were expressed both as the 
mean percentage for each collection period and as the mean cumulative 
percentage and they are illustrated in Figures 3.1 and 3.2, respectively. 
Radioactivity counts found in faeces are shown in Figures 3.3 and 3.4. 
Details of the values obtained at each interval and of the daily subtotals 
are given in Appendices 1.3 and 2.3.
The total amount of siCr measured in urine ranged from 3.05% to 
8.01%, with a mean of 4.56% (SD + 2.32). Approximately 60% of this 
amount was excreted during the first 24 hours. The values of siCr-EDTA 
obtained in faeces ranged from 85.87% to 93.55% and the mean excretion 
was 91.26% (SD ± 3.65). The mean faecal excretion calculated for the first 
day accounted for approximately 47% of the total amount in 72 hours.
DISCUSSION.
The mean percentage urinary excretion of administered 
siCr-EDTA for consecutive 24 hour periods obtained in this experiment 
were 2.72%+ 0.63, 1.47% ± 1.31 and 0.38% ± 0.53, respectively. Although 
slightly lower, these values were not significantly different to those 
obtained in Experiments 1 and 2. The values obtained in faeces for all the 
animals in 72 hours (91.26% ± 3.65) show an increase in the amount of 
5iCr excreted when compared to those obtained in both Experiments 1 
and 2 (89.85% ± 3.47 and 79.36% ± 10.65, respectively). This finding was 
taken to indicate an increase in the activity and propulsion of the 
gastrointestinal tract which was in agreement with previous studies carried 
out with bethanecol in ponies (Gerring and Hunt, 1986; Roger and 
Ruckebusch, 1987).
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FIGURE 3.1. Experiment 3: Mean percentage of administered 51Cr-EDTA 
measured in urine in ponies following premedication with 
0.05 mg/kg bethanecol subcutaneously.
FIGURE 3.2. Experiment 3: Mean cumulative percentage of administered
5iCr-EDTA measured in urine in ponies following
premedication with 0.05 mg/kg bethanecol subcutaneously.
FIGURE 3.1.
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FIGURE 3.3. Experiment 3: Mean percentage of administered 5iCr-EDTA 
measured in faeces in ponies following premedication with 
0.05 m g/kg bethanecol subcutaneously.
FIGURE 3.4. Experiment 3: Mean cumulative percentage of administered
siCr-EDTA measured in faeces in ponies following
premedication with 0.05 mg/kg bethanecol subcutaneously.
FIGURE 3.3.
%
60
50 -
40
30 -
20
10
I ^  ^  ^  !
0 -6  h. 6-12 h. 12-18 h. 18-24 h. 24-36 h .36-48  h .48-60  h .60-72 h.
Time (hrs.)
I SD Mean %
FIGURE 3.4.
%
100
90
80
70
60
50
40
30
20
12 18 24 30 36 42 48 54 60 66 72
TIME (hours)
I SD Mean cum. %
65
In conclusion, the results obtained in the present experiment 
indicated that a moderate increase in the motility of the gastrointestinal 
tract of horses did not have a significant influence on the amount of 
5iCr-EDTA absorbed.
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EXPERIMENT 4: INTESTINAL PERMEABILITY TO 
siCr-EDTA IN PONIES WITH CAECAL FISTULATION.
INTRODUCTION.
The techniques currently in use for the assessment of equine 
intestinal function have several inherent limitations. Oral monosaccharide 
tolerance tests have proved of value for the detection of small intestinal 
dysfunction (Roberts and Pinsent, 1975; Bolton and others, 1976; Merritt 
and others, 1976; Meuten and others, 1978; Roberts and Kelly, 1980; 
Hodgson and Allen, 1982; Pass and Bolton, 1982; Mair and others, 1991). 
However, the absorption of these carbohydrate markers may be 
influenced by gastric emptying, intestinal transit time, mucosal blood flow 
(Roberts and Norman, 1979), small intestinal flora and diet (Jacobs and 
others, 1982) and, further, carbohydrate absorption only reflects function 
of the anterior portion of the gastrointestinal tract. Radioisotope tracer 
techniques have been applied to horses with enteropathy to demonstrate 
loss of proteins into the bowel (Merritt and others, 1976; Merritt and 
others, 1977; Meuten and others, 1978; Snow and others, 1981; Duncan 
and Dargie, 1975; Dietz and Nielsen, 1980; Love, 1990). These tests may 
be of use in assessing intestinal permeability alterations but they cannot 
be utilised to localise these changes within the gastrointestinal tract. Thus, 
other methods must be developed which are more sensitive and 
informative with regard to the site of intestinal dysfunction.
When 5iCr-EDTA was first used by human medical workers 
(Bjarnason and others, 1983a, b; Bjarnason and others, 1985) it was 
concluded that 5iCr-EDTA specifically indicated small intestinal disease. 
By contrast, Elia and others (1987), in studies on intestinal permeability 
with 5iCr-EDTA in healthy human patients, suggested that differences in 
the temporal pattern of excretion in urine of orally administered markers 
might reflect their absorption from different sites and confirmed that 
significant amounts of 51Cr-EDTA were absorbed from the colon. Jenkins
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and others (1987, 1988) further substantiated this finding and they 
demonstrated that the increased urinary excretion of orally administered 
5iCr-EDTA was directly proportional to inflammation of the colon.
The objective of the present study was to evaluate the pattern of 
absorption of siCr-EDTA from the equine large intestine.
MATERIALS AND METHODS.
Two female British native-breed five-year-old ponies were used on 
this occasion. Both ponies had been kept indoors and dosed at four- 
monthly intervals with ivermectin (Eqvalan paste, MSD AGVET, 
Hertfords.) for at least three years. They were kept in individual stalls on 
woodshavings, and were fed on hay and water ad libitum. Five months 
prior to the experiment a permanent caecal fistula was created in both 
animals by a modified version of the method described by Simmons and 
Ford (1988). The design of the acetyl homopolymer plastic cannula is 
shown in Figure 4.1 and the exact location of the cannula can be 
appreciated in Figure 4.2. The ponies had been trained to be tethered and 
to carry the urine collection bags, and during the period of 
experimentation the floor of the stalls was covered with rubber mats.
Urine was collected by means of Foley catheters (7.33 mm 
diameter; 40 cm length; 30 cc balloon volume) which were connected to 
polythene bags contained within canvas bags hanging from the back of the 
animals by two canvas strips. Faeces were allowed to pass onto the floor 
from where they were swept up and bagged.
Following a 10-hour fasting period, a solution of 51Cr-EDTA was 
injected directly into the caecum through the indwelling cannula. A length 
of plastic tube was connected to the syringe containing the solution in
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order to ensure that the radioistope was deposited well away from the 
cannula and was washed with 300 ml of water. The ponies were allowed to 
eat two hours following the administration of the solution.
Total urine and faeces produced in 72 hours were collected at 
6-hour intervals on the first day and at 12-hour intervals thereafter.
RESULTS.
The amounts of 5iCr-EDTA excreted in urine were expressed both 
as the percentage for each collection period and as the cumulative 
percentage and they are illustrated in Figures 4.3 and 4.4, respectively. 
The same system was used to express siCr-EDTA collections in faeces 
(Figures 4.5 and 4.6). Details of the results obtained at each interval and 
of the daily subtotals are listed in Appendices 1.4 for urine and 2.4 for 
faeces.
The total amount of siCr-EDTA measured in urine was 1.75% in 
Pony number 1 and 1.56% in Pony number 2 (mean, 1.66%). The 
intervals of maximal excretion varied in both animals: approximately
45% of the total urine collection was recovered during the first 24 hours 
in Pony number 1 whereas approximately 75% was so in the second 
animal. A similar trend was observed in the faecal excretion of the tracer: 
although the total excretion was comparable in both animals (73.90% and 
76.94%, respectively) only 8.57% of the administered dose was collected 
during the first 24 hours in Pony number 1, compared to 61.28% in animal 
number 2.
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FIGURE 4.1. Experiment 4: Plastic cannula.
FIGURE 4.2. Experiment 4: Plastic cannula in place.
70
FIGURE 4.3. Experiment 4: Percentage of administered siCr-EDTA 
measured in urine in ponies with permanent caecal 
fistulation.
FIGURE 4.4. Experiment 4: Cumulative percentage of administered
5iCr-EDTA measured in urine in ponies with permanent
caecal fistulation.
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FIGURE 4.5. Experiment 4: Percentage of administered 51Cr-EDTA 
measured in faeces in ponies with permanent caecal 
fistulation.
FIGURE 4.6. Experiment 4: Cumulative percentage of administered
5iCr-EDTA measured in faeces in ponies with permanent
caecal fistulation.
FIGURE 4.5.
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DISCUSSION.
The results obtained here confirmed the equine large intestine as a 
site of absorption of 51Cr-EDTA assuming there was no reflux of marker 
into the small intestine. In previous studies, when a liquid marker was 
injected directly into the caecum of ponies with permanent caecal 
fistulation no marker was found in the ileum (Argenzio and others, 1974). 
The amounts of 5iCr-EDTA measured in urine were relatively low but 
one has to consider the possibility that the amount of marker collected in 
urine in both fistulated ponies (1.66% ± 0.13) might have been influenced 
to some extent by partial loss of the administered dose in that there was 
slight leakage from the caecal cannula in both animals. The relatively low 
values obtained in faeces would further support this possibility. However, 
it has been suggested that absorption of 5iCr-EDTA from normal human 
large intestine is low but it increases markedly when inflammation of this 
portion of the alimentary tract occurs (Jenkins and others, 1988) and a 
similar theory may be true for horses.
The marked differences in intestinal transit time observed in the 
two animals appeared to have no influence in the pattern of absorption of 
5iCr-EDTA and this finding further supports the conclusions of previous 
experiments that alterations of intestinal motility do not affect 
permeability of the marker from the gastrointestinal tract.
Argenzio and others (1974) reported that approximately 68% of a 
liquid marker was recovered in the caecum within two hours following 
intragastric administration. The temporal pattern of 51Cr-EDTA
excretion in urine might be of great assistance for the assessment of 
equine large intestinal permeability in that the urinary excretion values 
for specific time periods may relate to the permeability of discrete 
anatomical regions of the gastrointestinal tract.
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CHAPTER IV. STUDIES ON siCr-EDTA URINARY 
EXCRETION FOR THE ASSESSMENT OF INTESTINAL 
PERMEABILITY IN EQUINE CHRONIC ENTEROPATHIES.
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CHAPTER IV. STUDIES ON siCr-EDTA URINARY
EXCRETION FOR THE ASSESSMENT OF INTESTINAL 
PERMEABILITY IN EQUINE CHRONIC ENTEROPATHIES.
INTRODUCTION.
The suitability of the use of 51Cr-EDTA for the assessment of 
intestinal permeability has been reported in humans (Bjarnason and 
others, 1983a, b; Bjarnason and Peters, 1984; O’Morain and others, 1986; 
Elia and others, 1987; Fotherby and others, 1988), rats (Bjarnason and 
others, 1985), gerbils and lambs (Sinski and others, 1987; McLean and 
others, 1989), dogs (Hall and others, 1989; Hall and Batt, 1990) and 
ponies (Love, 1990).
In Chapter III of this thesis there are details of experiments carried 
out with the objective of further validating siCr-EDTA as a marker of 
intestinal permeability in ponies. In those experiments there were no 
significant differences in the amounts of siCr-EDTA excreted in urine 
collected from untreated, control animals and then in the same animals 
following premedication with either atropine or bethanecol. Thus, it was 
concluded that 5iCr-EDTA urinary excretion in ponies was not affected by 
alterations of intestinal motility. It was also confirmed that siQ -EDTA is 
absorbed from the large intestine such that it may be used in the 
assessment of large intestinal permeability.
In equine medicine, the present knowledge of both the 
aetiopathogenesis and the approach to the diagnosis of the chronic 
enteritides is limited (Roberts, 1984). Alterations in the gastrointestinal 
permeability have been reported to play an important role in the chronic 
human enteropathies (Chadwick and others, 1977; Bjarnason and Peters, 
1984; Jenkins and others, 1988) and it seems likely that this might also be 
an important factor in the pathogenesis of certain equine enteropathies.
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The objective of these studies was to investigate the usefulness of 
siCr-EDTA as a marker for the assessment of intestinal permeability in 
ponies with experimentally-induced chronic enteropathy. To achieve this, 
either prolonged oral administration of phenylbutazone or infection with 
cyathostome larvae were used to induce protein-losing enteropathies in 
ponies. Additionally, 5iCr-EDTA absorption and urinary excretion were 
studied in clinical cases with naturally-occurring enteropathy which were 
referred to the Department of Veterinary Medicine, University of 
Glasgow Veterinary School.
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EXPERIMENT 5. INTESTINAL PERMEABILITY TO 
siCr-EDTA IN PONIES FOLLOWING PROLONGED ORAL 
ADMINISTRATION OF PHENYLBUTAZONE.
INTRODUCTION.
Phenylbutazone (PBZ) has been widely used in equine medicine 
for many years for its effects as an anti-inflammatory, anti-pyretic and 
analgesic agent (Tobin, 1979; Lees and Higgins, 1985). For a long time it 
was considered to be nontoxic to horses (Jeffcott and Colles, 1977) but 
more recently there have been several reports which demonstrate the 
toxicity of PBZ in horses both experimentally (Snow and others, 1979; 
Snow and others, 1981; Lees and others, 1983; Meschter and others, 1984; 
Collins and Tyler, 1985; Meschter and others, 1990) and in clinical 
reports (Gunson and Soma, 1983; Read, 1983; Traub and others, 1983; 
Behm and Berg, 1987).
Symptoms associated with PBZ toxicosis in horses include 
anorexia, depression, weight loss, diarrhoea, cyanotic mucous membranes, 
ventral oedema, and hypoalbuminaemia. At necropsy, marked mucosal 
atrophy, focal erosions and ulcers can be found in the alimentary tract. 
Nephrotoxicity, hepatotoxicity, leucopaenia and subsequent leucocytosis, 
and vasculopathy have also been reported consequent to the 
administration of PBZ for prolonged periods or at higher dose levels than 
those recommended by the manufacturers.
In experimental studies in ponies, signs of PBZ toxicity were 
observed following the oral administration of either 10 to 12 mg/kg/day 
PBZ in two equal doses for eight to 10 days (Snow and others, 1981) or 
8.8 m g/kg/day in two equal doses at 12-hour intervals for 10 days. 
(Collins and Tyler, 1985). The latter approach resulted in less severe 
clinical and biochemical effects.
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Snow and others (1981) used radioisotope tracer techniques to 
confirm that the condition constituted a protein-losing enteropathy (PLE).
On the basis that PBZ toxicity has been experimentally reproduced 
and it results in deranged intestinal mucosal integrity it was considered to 
be a suitable condition for the study of the usefulness of 5iCr-EDTA in the 
assessment of altered intestinal permeability in ponies.
MATERIALS AND METHODS.
Four female British native-pony yearlings were given PBZ paste 
(Phenyzene Oral Paste, C-Vet Limited, Suffolk) at a dose rate of 8.8 
mg/kg/day by mouth in 2 equal doses 12 hours apart to effect. When this 
medication regimen had been maintained for 28 consecutive days the 
ponies were given a solution of siCr-EDTA by stomach tube following a 
period of fasting of 10 hours. The solution was washed through the tube 
with 300 ml of water. The animals were allowed to eat two hours 
following administration of the test solution.
Total faeces and urine produced in 72 hours were collected at 
6-hour intervals on the first day and at 12-hour intervals thereafter.
Detailed clinical monitoring of each pony was carried out with 
particular reference to attitude, appetite, and nature of faeces and urine. 
A thorough physical examination of each animal was performed daily and 
the animals were weighed on alternate days.
Haematological and biochemical analyses of blood and plasma 
were carried out sequentially over the period during which PBZ was 
administered. The variables which were monitored included: Total and 
differential white blood cell counts, red blood cell count, packed cell 
volume, haemoglobin concentration, creatinine, urea, total plasma
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proteins, albumin, globulins, alkaline phosphatase, gamma-glutamyl 
transferase and aspartate aminotransferase. Fractional excretion and 
renal clearance values of electrolytes were calculated by the method 
reported by Morris and others (1984) for the two collection periods of the 
last day of the experiment in order to assess renal function.
RESULTS.
The amounts of 51Cr excreted in urine were calculated both as the 
mean percentage during each collection interval and as the mean 
cumulative percentage and are illustrated in Figures 5.1 and 5.2, 
respectively. The same system was used to express radioactivity found in 
faeces as shown in Figures 5.3 and 5.4. A detailed account of the values 
obtained at each interval and of the daily subtotals is given in Appendices 
1.5 and 2.5.
The amount of 5iCr-EDTA excreted in urine in 72 hours ranged 
from 4.20% to 8.25% with a mean total excretion of 6.21% (SD + 1.66). 
The percentages recovered in faeces ranged from 67.53% to 119.71%, 
with a mean value of 90.20% (SD + 21.70). Approximately 61% of the 
total urinary excretion was collected on the first day whereas about 37% 
of the total amount recovered in faeces was voided during the same time 
interval.
None of the signs reported for equine PBZ toxicosis were observed 
in any of the ponies and no haematological or biochemical abnormalities 
were detected in the blood samples which were analysed. Details of the 
calculated fractional excretion (FE) and renal clearance (RC) of 
electrolytes are shown in Appendices 3.1 and 3.2. Both the FE and RC 
values of sodium, calcium and phosphate were slightly above the reported 
reference values.
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FIGURE 5.1. Experiment 5: Mean percentage of administered siCr-EDTA 
measured in urine in ponies following oral administration 
of 8.8 m g/kg/day phenylbutazone for 28 days.
FIGURE 5.2. Experiment 5: Mean cumulative percentage of administered 
siCr-EDTA measured in urine in ponies following oral 
administration of 8.8 m g/kg/day phenylbutazone for 28 
days.
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FIGURE 5.3. Experiment 5: Mean percentage of administered 51Cr-EDTA 
measured in faeces in ponies following oral administration 
of 8.8 m g/kg/day phenylbutazone for 28 days.
FIGURE 5.4. Experiment 5: Mean cumulative percentage of administered 
5iCr-EDTA measured in faeces in ponies following oral 
administration of 8.8 m g/kg/day phenylbutazone for 28 
days.
FIGURE 5.3.
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DISCUSSION.
In the present experiment, the mean percentage excretions of 
5iCr-EDTA for consecutive 24 hour periods were 3.78% ± 2.19, 2.12% ± 
0.84 and 0.31% + 1.65, respectively which were similar to the results 
obtained Experiments 1, 2 and 3.
Ponies with PBZ toxicosis would be expected to have increased 
intestinal permeability (Collins and Tyler, 1985) such that increased 
urinary excretion of siCr-EDTA was anticipated in the animals but none 
was detected. Interestingly, clinical signs of toxicosis were not observed in 
any of the experimental animals despite the prolonged period (28 days) of 
administration of PBZ at high dose levels (8.8 mg/kg/day) which contrast 
with the observations of Collins and Tyler (1985) who recorded clinical 
disease of PBZ toxicity following a similar experimental protocol. Several 
reports on PBZ toxicosis following oral administration in ponies and 
horses recorded hypoproteinaemia (Snow and others, 1981; Collins and 
Tyler, 1985), increased blood urea nitrogen and creatinine levels (Read, 
1983) and initial leucopenia followed by leucocytosis (Lees and others, 
1983) but comparable abnormalities were not found in the present study. 
The only abnormalities found in the laboratory data were increased renal 
clearance and fractional excretion of sodium, calcium and phosphate. 
However, the reference values presently available were calculated for the 
horse, and it it is possible that the values of these tests for ponies might 
be different.
The explanation for the lack of evidence of toxic effects of PBZ in 
this study was unclear, but the diet of the experimental ponies might have 
been a contributing factor. Certainly, different absorption patterns of PBZ 
have been reported in relation to the type and nature of the feed given to 
horses or ponies during pharmacokinetic studies of oral medication with
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this compound (Lees and Higgins, 1985; Tobin and others, 1986). In those 
studies, in animals which received hay in their diets, the absorption of 
PBZ was delayed and reduced compared with that in animals given 
concentrated feeds. In the present study the ponies were given a 
proprietary complete, cubed diet such that these animals might have been 
expected to be predisposed to PBZ toxicity. However, signs of PBZ 
toxicity in these ponies were absent, which might reflect reduced 
absorption of the compound but this could not be confirmed because 
plasma levels of PBZ were not measured. Another possibility to consider 
is that the time of contact of PBZ with the intestinal mucosa might have 
been reduced as a result also of the type of feed and, consequently, the 
direct toxicity that PBZ might have on the mucosa might have been 
minimised.
Although pathological investigations were not performed, from the 
clinical and laboratory findings it was concluded that toxicity was not 
induced in this experiment by the administration of PBZ. The fact that 
the values obtained for the urinary excretion of 51Cr-EDTA, were not 
significantly different from those of the previous experiments, was further 
evidence that the gastrointestinal permeability of these ponies was not 
altered. The apparent correlation of clinical and experimental results 
supports the view that siCr-EDTA is a reliable marker for the assessment 
of intestinal permeability in ponies.
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EXPERIMENT 6. INTESTINAL PERMEABILITY TO 
siCr-EDTA IN PONIES WITH EXPERIMENTAL 
CYATHOSTOME INFECTION.
INTRODUCTION.
Until recently it was considered that Strongylus spp. including S. 
vulgaris, S. edentatus and S. equinus were the most pathogenic parasites in 
horses (Ogbourne and Duncan, 1985). However, the advent of the 
modern anthelmintic agents together with their widespread usage in 
modern parasite prophylactic programmes have caused a marked 
reduction in the significance of infections by these worms. On the other 
hand, the clinical importance of cyathostomes has become more evident 
with an increasing prevalence of clinical cyathostomiasis in the horse 
reported in recent years (Chiejina and Mason, 1977; Jasko and Roth, 
1984; Giles and others, 1985; Church and others, 1986; Love, 1990). The 
development of resistance of cyathostome species to benzimidazole 
anthelmintic agents has been widely recognized (Drudge and others, 1979; 
Herd, 1990) and this phenomenon has to some extent increased the 
importance of these parasites in equine medicine.
Equine larval cyathostomiasis is distinguished clinically by the 
sudden onset of chronic diarrhoea in late winter or early spring, resulting 
in progressive weight loss and eventually death if radical therapy is not 
instituted promptly (Giles and others, 1985; Love, 1990). Haematological 
and blood biochemical findings in cases of cyathostomiasis include a 
moderate leucocytosis due primarily to neutrophilia, increased levels of 
beta-globulins, raised alkaline phosphatase activity, and 
hypoalbuminaemia but these are not specific features (Round, 1968; 
Round, 1970; Blackwell, 1973; Giles and others, 1985; Church and others, 
1986; Love, 1990). Larval cyathostomiasis appears to be induced by mass
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emergence of inhibited fourth-stage larvae into the gut lumen (Ogbourne, 
1978; Giles and others, 1985) which is accompanied by a severe 
inflammatory response consisting of an infiltration of the intestinal 
mucosa and submucosa by eosinophils, lymphocytes and some plasma 
cells, and haemorrhagic foci, submucosal oedema and erosions are 
generally apparent (Ogbourne, 1978; Reinemeyer, 1986).
Diagnosis of equine chronic enteropathies may present a serious 
challenge and this is particularly true in cases in which the pathological 
alterations are limited to the large intestine, as occurs in larval 
cyathostomiasis, because routine laboratory analyses and small intestinal 
function tests may show no abnormality. Prompt diagnosis of treatable 
conditions such as larval cyathostomiasis is of crucial importance for the 
outcome of the affected animals and it may be extremely difficult if 
examination of the histopathology of intestinal biopsy samples taken via 
laparotomy is not practicable (Church and others, 1986; Love, 1990). 
Although it would be unlikely that a definitive diagnosis could be made on 
the basis of knowledge of large intestinal dysfunction, a test which 
quantified the pathophysiology of large bowel enteropathy would be 
useful in case assessment and prognosis.
Radioisotope tracer techniques used in ruminants for the 
investigation of the pathogenesis of experimental parasitic infections 
characterized by marked hypoalbuminaemia have confirmed that the 
major reason for the reduced plasma levels of albumin is increased losses 
of proteins as a consequence of altered intestinal mucosal permeability 
(Nielsen, 1968; Holmes and Mclean, 1971; Mulligan, 1973; Dargie, 1975; 
Abbott, Parkins and Holmes, 1986). It has been suggested that the 
pathogenesis of larval cyathostomiasis is similar to some of the parasitic 
enteropathies of ruminants (Ogbourne, 1978) such that assessment of 
intestinal permeability might aid in the investigation of this condition.
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131Iodine- or 125Iodine-labelled albumin appear to be reliable 
tracers to assess protein catabolism in animals with gastrointestinal 
parasitism (Nielsen, 1968; Holmes and Mclean, 1971; Mulligan, 1973; 
Dargie, 1975; Duncan and Dargie, 1975; Dietz and Nielsen, 1980; Abbott 
and others, 1986) but it cannot be employed for the quantitation of 
protein loss into the bowel because of partial reabsorption of the 
radioisotope following enzymatic degradation of the protein in the 
intestine (Nielsen, 1968; Mulligan, 1973). This problem may be overcome 
by the use of radioisotope labels which are not absorbed from the 
intestine such as siChromium, or by administering other compounds which 
are not broken down in the alimentary tract e.g. polyvinylpyrrolidone 
(Nielsen, 1968; Mulligan, 1973). Detection of radioactivity in faeces 
following intravenous administration of either siChromium (5iCr)-labelled 
albumin or siCr-chloride has been used in horses to confirm 
protein-losing enteropathies (Merritt and others, 1976; Merritt and 
others, 1977; Meuten and others, 1978; Snow and others, 1981; Love, 
1990).
siChromium-ethylenediaminetetraacetate (siCr-EDTA) is routinely 
employed in human medicine for the measurement of glomerular 
filtration rate on the basis that siCr-EDTA is not metabolised and it is 
excreted immediately in urine (Chantler and others, 1969; Granerus and 
Aurell, 1981). A more recent application of 5iCr-EDTA has been in the 
assessment of unmediated intestinal permeability by measuring siCr in 
urine following its administration per os. siCr-EDTA has proved valuable 
in the assessment of cases of coeliac disease and inflammatory bowel 
disease in man (Bjarnason and others, 1983a; Bjarnason and others, 
1983b; O’Morain and others, 1986; Elia and others, 1987; Jenkins and 
others, 1987; Jenkins and others, 1988; Fotherby and others, 1988), in 
dogs with wheat-sensitive enteropathy, small intestinal bacterial 
overgrowth and giardiasis (Hall and Batt, 1990), in gerbils and lambs 
experimentally infected with Trichostrongylus spp. (Sinski and others, 
1987; Maclean and others, 1989) and in experimental nippostrongylosis in
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rats (Ramage and others, 1988). Preliminary investigations on the use of 
siCr-EDTA to investigate intestinal permeability of ponies were carried 
out by Love (1990).
The objective of these studies was to test the suitability of 
51Cr-EDTA for the assessment of intestinal permeability alterations in 
chronic enteropathies by experimental cyathostome infection of ponies.
MATERIALS AND METHODS.
Four female British native-pony yearlings which had been reared 
indoors and were presumed to be helminth-naive were administered a 
solution of 5iCr-EDTA following a period of fasting of 10 hours which was 
continued for two further hours. The solution was given per stomach tube 
and the tube was washed through with 300 ml of water. Initially all four 
animals were studied under control conditions. Subsequently three ponies 
were chosen randomly for ’trickle’ experimental cyathostome infection by 
administration per stomach tube of 250,000 cyathostome third-stage 
larvae per day for 46 days. siCr-EDTA was administered on three 
occasions: First, when 5.5 million larvae had been dosed (Day 22); 
secondly, after the administration of 11.5 million larvae (Day 47) and 
finally, on Day 88 following first infection with 11.5 million larvae when 
patency was expected to have occurred.
Total faeces and urine produced in 72 hours were collected at 
6-hour intervals on the first day and subsequently at 12-hour intervals.
All animals were weighed regularly throughout the period of the 
studies. Sequential blood samples were collected into vacutainers 
containing either heparin or EDTA in order to monitor alterations in 
total and differential white blood cell counts, packed cell volume, total
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plasma proteins, albumin and globulins. Faeces were submitted three 
times weekly for strongyle faecal egg counts to determine the onset of 
patency of the infections.
RESULTS.
The amounts of 51Cr excreted in urine and faeces were calculated 
both as the mean cumulative percentage and as the mean percentage 
during each collection interval and are illustrated in Figures 6.1 to 6.14. 
Cumulative percentages of siCr-EDTA obtained in 72 hours in urine and 
faeces are listed in Tables 6.1 and 6.2, respectively. A detailed account of 
the values obtained at each interval and of the daily subtotals is given in 
Appendices 1.6 to 1.9 for urine and 2.6 to 2.9 for faeces.
All infected animals lost weight during the experimental infection 
(Appendix 3.9). Two ponies developed watery diarrhoea which contained 
large numbers of cyathostome parasites and both also became 
hyperlipaemic. One of these ponies (number 64) died on Day 53 and the 
other (number 63) was killed on Day 94. At post-mortem examination 
both animals were found to have enlarged, pale, friable livers. In both 
ponies, large intestinal contents were scant and markedly fluid, whilst the 
caecal and colonic mucosae were oedematous, containing large numbers 
of 2-3 millimetre cyathostome nodules. Microscopic examination revealed 
fatty change in the liver in both cases. On microscopy, the large intestinal 
mucosa was found to contain a very high number of parasitic larvae within 
cysts which were surrounded by an infiltrate of mononuclear and 
polymorphonuclear cells in the mucosa and lamina propia. Interestingly, 
few eosinophils could be observed in the large intestinal mucosa of both 
animals. Diagnoses of larval cyathostomiasis and hepatic lipidosis were 
made. The worm burdens counted post-mortem are listed in Table 6.3. 
Figures 6.15 and 6.16 show the gross appearance of the large intestinal 
mucosa of Pony numbers 64 and 63, respectively.
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FIGURE 6.9. Experiment 6: Mean percentage of administered siCr-EDTA 
measured in urine in control ponies and in the same ponies 
following trickle infection with 5.5 million cyathostome 
third-stage larvae (Day 22).
FIGURE 6.10. Experiment 6: Mean percentage of administered 
5iCr-EDTA measured in urine in control ponies and in the 
same ponies following trickle infection with 11.5 million 
cyathostome third-stage larvae (Day 47).
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FIGURE 6.11. Experiment 6: Mean percentage of administered
siCr-EDTA measured in urine in control ponies and in the 
same ponies following trickle infection with 11.5 million 
cyathostome third-stage larvae (Day 88).
FIGURE 6.12. Experiment 6: Mean percentage of administered
siCr-EDTA measured in faeces in control ponies and in the 
same ponies following trickle infection with 5.5 million 
cyathostome third-stage larvae (Day 22).
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FIGURE 6.13. Experiment 6: Mean percentage of administered
5iCr-EDTA measured in faeces in control ponies and in the 
same ponies following trickle infection with 11.5 million 
cyathostome third-stage larvae (Day 47).
FIGURE 6.14. Experiment 6: Mean percentage of administered
siCr-EDTA measured in faeces in control ponies and in the 
same ponies following trickle infection with 11.5 million 
cyathostome third-stage larvae (Day 88).
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FIGURE 6.15. Macroscopic appearance of the mucosa of the dorsal colon 
of Pony no. 64. Note autolytic changes - necropsy carried out 
on Day 54.
FIGURE 6.16. Macroscopic appearance of the mucosa of the ventral 
colon of Pony no. 63. Necropsy carried out on Day 94.
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TABLE 6.1.
Experiment 6: Cumulative percentage of administered 5iCr-EDTA 
recovered in urine in ponies under control conditions and at three stages 
of experimental cyathostome infection.
ANIMAL NUMBER
CONDITIONS
68 63 64 70
MEAN
Control 4.55 5.09 4.35 6.10 5.18
5.5 million L3 
(Day 22)
4.17 6.45 7.58 5.05 6.36
11.5 million L3 
(Day 47)
3.97 9.01 28.34 10.55 15.97
11.5 million L3 
(Day 88)
1.90 11.08 8.19 9.64
Infected animals: 63, 64 and 70.
Mean and standard deviation (SD) refer to infected animals. 
L3: Third-stage cyathostome larvae.
SD
0.88
1.27
10.74
2.04
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TABLE 6 2 .
Experiment 6: Cumulative percentage of administered 5iCr-EDTA 
recovered in faeces in ponies under control conditions and at three stages 
of experimental cyathostome infection.
ANIMAL NUMBER
CONDITIONS
68 63 64 70
MEAN
Control 93.74 90.23 91.10 98.01 93.11
5.5 million L3 
(Day 22)
74.78 91.98 67.20 56.16 71.80
11.5 million L3 
(Day 47)
93.91 91.43 55.71 79.42 75.50
11.5 million L3 
(Day 88)
78.06 84.78 78.68 81.73
Infected animals: 63, 64 and 70.
Mean and standard deviation (SD) refer to infected animals. 
L3: Third-stage cyathostome larvae.
SD
4.26
18.40
18.20
4.31
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TABLE 63.
Experiment 6: Cyathostome worm burdens.
ANIMAL NUMBER 63 64
Total worm count. 1,208,370 254,870
Percentage of establishment
of infected dose. 10.51 2.22
Mucosal larval count. 684,170 210,470
Percentage of total worm
count in mucosa. 56.62 82.58
Infective dose: 11.5 million cyathostome third-stage larvae. 
Post-mortem examination: Pony number 64, Day 53; Pony number 
63, Day 94.
Percentage of establishment of the infective dose refers to the 
percentage of the infective dose of larvae which was recovered at 
necropsy.
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Strongyle faecal egg counts remained negative in all infected 
animals with the exception of pony number 70 - the animal which 
survived the infection - which had a positive count of 700 eggs per gram of 
faeces on one occasion only (Day 53). This pony (number 70) started to 
put on weight from approximately Day 110 onwards and seven months 
after the experimental infection it was clinically normal. On the basis of 
repeatedly negative faecal worm egg counts it was considered that the 
entire cyathostome population which established in this animal have 
undergone inhibited development.
Details of the values obtained for total white blood cell, blood 
neutrophil and blood lymphocyte counts, packed cell volume, plasma 
albumin and globulins are given in Appendixes 3.3 to 3.8, respectively. 
Total white blood cell counts showed a significant increase between Days 
20 and 60 of infection which was primarily due to an increase in 
neutrophil numbers whereas numbers of lymphocytes and eosinophils 
remained relatively unchanged. Packed cell volume remained unaltered 
throughout the infection but albumin levels decreased progressively from 
approximately Day 45 onwards with the exception of the pony that died on 
Day 53 (number 64) which had lower albumin levels from Day 30 
onwards. In the surviving animal the plasma albumin levels remained 
consistently low throughout the seven month period following infection 
(25 grams per litre). Plasma globulin levels did not show notable changes 
in response to cyathostome infection in the animals in this study.
DISCUSSION.
On the first two occasions in the present study, the amounts of 
siCr-EDTA excreted in urine during 72 hours (5.18% ± 0.88 and 6.36% ± 
1.27, respectively) were similar to those obtained under control conditions 
in Experiment 1 (6.64% ± 2.36). On the first occasion, the test was carried 
out under control conditions and the results further confirm 51Cr-EDTA
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as a reliable tracer to assess equine intestinal permeability. Comparable 
results were obtained when the siCr-EDTA solution was administered on 
Day 22 of the experimental trickle cyathostome infection i.e. after dosing 
with 5.5 million third-stage larvae. These results indicate either, that no 
significant changes in the intestinal permeability had occurred at the time 
the test was carried out or that the technique failed to detect alterations 
of intestinal permeability. In contrast to previous reports of experimental 
trickle cyathostome infections (Round, 1970; Love, 1990) in which a 
decrease in plasma albumin levels was detected during the first weeks 
following infection, in the present study hypoalbuminaemia was not 
apparent in any of the animals in the early stages of the infections. 
Considering together the results of the urinary excretion of the 
permeability marker and serial plasma albumin levels in the present 
study, it would appear that intestinal mucosal integrity was not 
compromised during the first three weeks of cyathostome infection. The 
recovery of siCr-EDTA in faeces of the infected animals (71.80% ± 18.40) 
was lower than in the same animals under control conditions (93.11% + 
4.26) which might suggest a reduced intestinal motility. This finding would 
be in agreement with the data recorded by other authors (Bueno and 
others, 1979; Love, 1990) but a similar reduction was observed in the 
uninfected, control animal which prevents more definitive conclusions.
On the next occasion on which the test was carried out, 11.5 million 
third-stage larvae had been given. During the 72 hours following the 
administration of 5iCr-EDTA between Days 47 and 50, the urinary 
excretion of the marker in pony number 64 was 28.34% of the 
administered dose. This animal had been diarrhoeic and anorexic for the 
previous 3 days and died six days later with signs of hyperlipaemia The 
amounts of siCr-EDTA collected in urine in the other infected animals 
was also significantly increased (9.01% and 10.55%) (p < 0.05) when 
compared to the values obtained in the same animals under control 
conditions (5.18 ±  0.88). Thus, increased siCr-EDTA urinary excretion 
appeared to reflect alterations of the intestinal permeability induced by
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the experimental cyathostome infection and emergence of larvae was 
suspected to be the cause of the unusually high excretion recorded in the 
animal which died (number 64).
Finally, the test was repeated on Day 88 on the two remaining 
infected animals, of which one (Pony number 63) exhibited signs of 
diarrhoea and anorexia at the time of study. This animal was killed three 
days after the end of the 72-hour collection. The values of siCr-EDTA 
urinary excretion in the two infected ponies (11.08% and 8.19%) were 
increased when compared to those obtained in the same animals under 
control conditions (5.09% and 6.10%) and also to that of the uninfected 
animal (1.90%). The value for the control was in fact unusually low 
possibly due to incomplete urine collection. The amounts of tracer 
detected in faeces were once more moderately lower than in the control 
situation.
A noticeable decrease in the plasma albumin levels was observed 
in all the cyathostome infected animals. This finding is in agreement with 
the observations reported in naturally occurring cases of larval 
cyathostomiasis (Giles and others, 1985; Church and others, 1986; Love, 
1990). In this study the changes in intestinal permeability detected by 
measurement of siQ-EDTA  excretion in urine were coincident with 
clinical signs and plasma protein abnormalities which suggest that the 
pathogenic effects of the experimental cyathostome infections were a 
result of protein-losing enteropathy.
The most marked increase in the urinary 5iCr-EDTA excretion 
values in cyathostome infected ponies in this study occurred during the 
first 24 hours and, particularly, from six to 24 hours. This finding was to 
some extent predictable since the pathological changes of larval 
cyathostomiasis are limited to the large intestine and in experimental 
studies on intestinal transit times in ponies it was demonstrated that 75% 
of a liquid marker had left the stomach within 0.5 hours after intragastric
1 0 0
administration, and approximately 68% was recovered in the caecum after 
two hours (Argenzio and others, 1974). This finding should be of 
relevance in the future development of a standard 24-hour test using 
5iCr-EDTA to detect alterations in intestinal permeability in horses with 
suspected chronic enteropathies. Similar techniques have been described 
for the assessment of intestinal permeability as a screening test for the 
detection of intestinal mucosal damage and also responses to treatments 
in clinical cases of enteropathy in man (Bjarnason and others, 1983a and 
b; O’Morain and others, 1986; Elia and others, 1987; Jenkins and others, 
1987 and 1988; Fotherby and others, 1988) and dogs (Hall and Batt, 
1990).
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EXPERIMENT 7: INTESTINAL PERMEABILITY TO 
siCr-EDTA IN HORSES WITH NATURALLY-OCCURRING 
CHRONIC ENTEROPATHY.
INTRODUCTION.
In the previous experiments reported in the present thesis, 
siCr-EDTA was validated as a marker for the investigation of equine 
intestinal permeability and its suitability was further substantiated in 
ponies with experimental cyathostome infections.
Three clinical cases of suspected chronic enteropathy referred to 
the Department of Veterinary Medicine, University of Glasgow 
Veterinary School, were used to test the usefulness of siCr-EDTA as a 
marker for intestinal permeability in the clinical situation.
Case 1: 30 year-old Welsh Mountain pony gelding.
History.
The animal had been losing weight for several weeks and it had 
been noticed to have very poor teeth.
Clinical findings.
On presentation, the pony was bright and alert but it was in an 
emaciated condition with generalized muscle atrophy. A full clinical 
examination was carried out of which the most relevant findings were: 
appetite was good but mastication was prolonged; faeces were of 
relatively normal consistency, but contained a large amount of undigested
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fibre; some faecal staining was noticed on the hindlimbs; rectal 
temperature was 36.6° C and heart and respiratory rate were within the 
normal ranges; oral mucous membranes were normal in colour and the 
capillary refill time was approximately two seconds; borborygmi were of 
normal intensity and frequency in all four abdominal quadrants; molar 
teeth were in very poor condition; no abnormality was noticed in other 
body systems and on examination per rectum.
Laboratory findings.
The only abnormality observed in blood biochemical and 
haematological analyses of this animal (Appendix 3.10) was a slight 
lymphopaenia (0.92 x 109/!). Faecal strongyle egg count was 550 
eggs/gram on presentation. An oral glucose tolerance test (Roberts and 
Hill, 1973) revealed evidence of small intestinal malabsorption (Appendix 
3.11).
Clinical diagnosis and management.
A malabsorption syndrome and possibly a protein-losing 
enteropathy, of undefined origin were considered. Oral ivermectin 
(Eqvalan Paste for Horses, MSD AGVET, Hertfords.) was administered 
at a dose of 0.2 mg/kg.bwt.
siCr-EDTA test.
During the period in which the test was carried out, the pony was 
kept in a stall and the floor was covered with rubber mats. Hay and water 
were available ad libitum.
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A solution of 51Cr-EDTA was administered per stomach tube 
following a period of 10-hour fasting. The solution was washed through 
the tube with 300 ml of water and the animal was allowed to eat two hours 
after the experiment was started.
Total urine and faeces produced in 72 hours were collected in 
12-hour intervals. Urine was collected directly into a polythene bag 
contained in a plastic bag fixed to the body of the pony by two canvas 
tapes. Faeces were allowed to pass onto the floor and were swept up and 
bagged.
The amount of siCr-EDTA recovered in urine was expressed as 
both the percentage during each interval and as the cumulative 
percentage of the administered dose (Figures 7.1 and 7.2). The same 
system was used to express data obtained in faeces (Figures 7.3 and 7.4). 
Details of the values of siCr-EDTA measured in urine and faeces are 
given in Appendixes 1.10 and 2.10, respectively.
The pattern of urinary siCr-EDTA excretion for case number 1 was 
abnormal when compared to the previous experiments, although almost 
50% of the total amount excreted in urine (4.73%) was recovered in the 
first 24 hours. Approximately 54% of the administered dose was 
recovered in faeces, which is a low value compared with previous 
experiments and most likely was a result of a marked increase in transit 
time.
Clinical progression.
Although no definitive diagnosis was reached, on the basis of 
malabsorption and considering the age and state of the animal, the 
prognosis was considered to be extremely poor and the animal was 
destroyed.
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FIGURE 7.1. Experiment 7: Percentage of administered 51Cr-EDTA
measured in urine in Case no. 1.
FIGURE 7.2. Experiment 7: Cumulative percentage of administered
siCr-EDTA measured in urine in Case no. 1.
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FIGURE 7.3. Experiment 7: Percentage of administered 51Cr-EDTA
measured in faeces in Case no. 1.
FIGURE 7.4. Experiment 7: Cumulative percentage of administered
51Cr-EDTA measured in faeces in Case no. 1.
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Pathological findings.
Post-mortem examination was carried out in the Department of 
Veterinary Pathology and gross pathology and histopathological 
examination revealed no signs of any specific enteropathy and only 
oedema and a moderate infiltrate with mononuclear cells were found in 
the large intestine. The only abnormality observed was partial gastric 
impaction. No explanation for the malabsorption was found and the 
diagnosis remained inconclusive.
Case 2: 13 year-old Arab-cross mare.
History.
This animal had a confusing five-month history of low grade 
abdominal pain and/or stiffness frequently associated with exercise. 
During the last two months before presentation the mare had started to 
lose weight and the attacks of mild abdominal discomfort appeared to 
occur more frequently.
Clinical findings.
The animal was bright, alert and appetant. The faeces appeared 
fairly dry. Thorough clinical examination revealed no obvious 
abnormalities to explain recurrent colic and weight loss but an excess of 
dry faeces were noticed on examination per rectum. On paracentesis, the 
peritoneal fluid appeared slightly flo'cular, with some increase in viscosity.
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Laboratory findings.
Blood biochemical analysis (Appendix 3.10) revealed no 
abnormality with the exception of slightly low plasma albumin levels (27 
g/1). On haematological examination (Appendix 3.10), moderate 
leucocytosis (9.1 x 109/1) due primarily to neutrophilia (6.96 x 109/1) was 
detected. Examination of faeces for strongyle eggs and bacteriological 
culture gave negative results. Peritoneal fluid obtained on paracentesis 
on three occasions showed an increasing level of total proteins (27 g/1 on 
Day 3; 38 g/1 on Day 11; normal value: 7-20 g/1) and moderate 
leucocytosis (13.9 x 109/1; normal value: < 10 x 109/1) due to neutrophilia 
(12.16 x 109/1). Bacteriological culture of the peritoneal fluid rendered no 
isolation on Day 7 but significant numbers of non-haemolytic Escherichia 
coli and Streptococcus spp. were cultured on Day 12 of hospitalization. An 
oral glucose tolerance test (Roberts and Hill, 1973) showed a partial 
malabsorption (Appendix 3.11).
Clinical diagnosis and management.
A clinical diagnosis of chronic enteropathy and mild peritonitis was 
made and no treatment was attempted.
5lCr-EDTA test.
The mare was kept in an individual stall covered with rubber mats. 
Hay and water were available ad libitum.
A solution of 5iCr-EDTA was administered per stomach tube 
following a period of 10-hour fasting. The solution was washed through 
the tube with 300 ml of water and the animal was allowed to eat two hours 
after the experiment was started.
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Total urine and faeces produced in 72 hours were collected at 
6-hour intervals on the first day and subsequently at 12-hour intervals. 
Urine was collected by means of a Foley catheter (7.33 mm diameter; 40 
cm length; 30 cc balloon volume) into polythene bags and faeces were 
swept up from the floor and bagged.
The amount of 51Cr-EDTA recovered in urine was expressed as 
both the percentage during each interval and as the cumulative 
percentage of the administered dose (Figures 7.5 and 7.6). The same 
system was used to express data obtained in faeces (Figures 7.7 and 7.8). 
Details of the values of 51Cr-EDTA measured in urine and faeces are 
given in Appendixes 1.10 and 2.10, respectively.
The total urinary excretion of siCr-EDTA in 72 hours in case 
number 2 was abnormally low (1.67%) and approximately 66% of this 
amount was recovered in the first 24 hours. Most of the amount of 
51Cr-EDTA recovered in faeces in 72 hours (85.34%) was detected on the 
second day.
Clinical progression.
The mare showed continuous signs of mild colic and laparotomy 
under general anaesthesia was undertaken in the Department of 
Veterinary Surgery which revealed several nodules in the wall of the small 
intestine and some adhesions had been formed between these nodules 
and the mesentery. A diagnosis of intestinal neoplasia was made and 
euthanasia on human grounds was decided during the operation.
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FIGURE 7.5. Experiment 7: Percentage of administered 5iCr-EDTA
measured in urine in Case no. 2.
FIGURE 7.6. Experiment 7: Cumulative percentage of administered
5iCr-EDTA measured in urine in Case no. 2.
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FIGURE 7.7. Experiment 7: Percentage of administered 51Cr-EDTA
measured in faeces in Case no. 2.
FIGURE 7.8. Experiment 7: Cumulative percentage o f administered
siCr-EDTA measured in faeces in Case no. 2.
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Pathological findings.
On post-mortem examination in the Department of Veterinary 
Pathology several fibrous thichenings were observed in the small intestinal 
wall which caused stenosis and dilatation proximally and adhesions had 
been formed between these points and the omentum. The proximal small 
intestinal wall was diffusely thickened and when it was opened two further 
nodules with deeply ulcerated necrotic centres were found. A number of 
ulcers surrounded by scar tissue were present along the mucosa of the 
small bowel. The stomach, large intestine and abdominal lymph nodes 
appeared uninvolved.
Histopathology of nodules and ulcers revealed granulation tissue 
and extensive fibrosis with adjacent epithelioid macrophages. A diffuse 
infiltrate of lymphoid and plasma cells was present in the mucosa, lamina 
propia and muscular layers of the small intestine and the mucosa 
appeared oedematous with either thickened and stunted, or long, 
frond-like villi. A diagnosis of granulomatous enteropathy was made.
Case 3: 16 year-old Hunter mare (Figure 3.9).
History.
The mare had been moderately diarrhoeic and losing weight for 
several weeks. On the last days prior to referral the diarrhoea became 
watery and did not respond to symptomatic treatment.
Clinical findings.
The mare was in very poor condition and weak, but reasonably 
bright. It picked at hay but was* not interested in concentrates when 
offered. There was some ventral oedema and the tail and hind quarters
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FIGURE 7.9. Experiment 7: Case no. 3: 16 year-old Hunter mare, on Day 
19 of hospitalization. Muscle atrophy was evident. Ventral 
oedema had regressed at that stage.
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were stained by faeces, which were of a watery nature. The eyes were 
sunken and there was a decrease in skin turgor, indicative of dehydration. 
Thorough clinical examination revealed: rectal temperature was 38.0° C; 
oral mucous membranes appeared congested; the pulse was slightly 
elevated in frequency (48/minute); fluid borborygmi could be auscultated 
in all four quadrants; per rectum, the intestinal wall appeared oedematous 
and the contents were very fluid.
Laboratory findings.
Blood biochemical investigation (Appendix 3.10) showed 
hyponatraemia (121 mmol/1), hypochloraemia (87 mmol/1) and
hypokalaemia (1.8 mmol/1) and alkaline phosphatase activity was slightly 
increased (480 U /l). Blood levels of urea (15.3 mmol/1) and creatinine 
(168 umol/1) were moderately elevated, most likely a result of pre-renal 
azotaemia. Plasma albumin levels were markedly reduced (12 g/1). 
Haematological analysis (Appendix 3.10) confirmed dehydration and 
revealed a neutrophilia (13.94 x 109/!). Faecal samples were negative for 
strongyle eggs and enteric bacterial pathogens. Biochemical and
cytological analyses of the peritoneal fluid were consistently normal and 
no bacteria were isolated on culture.
Clinical diagnosis and management.
A diagnosis of protein-losing enteropathy was made and
symptomatic therapy was started immediately: initially Hartmann’s 
solution, to which a mixture of sodium and potassium chloride had been 
added, was administered intravenously. Fluid therapy, including plasma 
substitutes (Haemaccel Infusion Solution, Hoechst Animal Health, 
Buckinghams.), was adapted according to the changes detected in the 
animal’s status. Oral administration of codeine phosphate was started at
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one mg/kg.bwt b.i.d.. Flunixin meglumine (Finadyne Solution, 
Schering-Plough Animal Health, Suffolk) was injected at a dose of 0.25 
mg/kg.bwt every eight hours for two days for its antiendotoxic properties. 
Prednisolone (Prednisolone Tablets, Animalcare Ltd., York) tablets were 
administered from Day 3 of hospitalization onwards at one 
mg/kg.bwt/day. The animal was stabilized and fluid therapy was 
discontinued on Day 4.
An oral glucose tolerance test was carried out on Day 5 which 
showed a poor absorption (Appendix 3.11). The blood biochemical and 
haematological parameters improved notably by Day 22 (Appendix 3.10) 
with the exception of plasma albumin levels which were increasing but 
they were still unusually low. Alkaline phosphatase activity remained 
elevated and there was a moderate neutrophilia and lymphopaenia, most 
likely a result of corticosteroid administration. A rectal biopsy revealed no 
abnormality at that site of the gastrointestinal tract.
5iCr-EDTA test.
During the time the procedure was being carried out, the mare was 
kept in an individual stall covered with rubber mats. Hay and water were 
available ad libitum and concentrates were fed twice daily.
A solution of 5iCr-EDTA was administered per stomach tube 
following a period of 10-hour fasting. The solution was washed through 
the tube with 300 ml of water and the animal was allowed to eat two hours 
after the experiment was started.
Total urine and faeces produced in 48 hours were collected at 
6-hour intervals for the first 24 hours and at 12-hour intervals on the 
second day. Urine was collected by means of a Foley catheter (7.33 mm 
diameter; 40 cm length; 30 cc balloon volume) into polythene bags and 
faeces were swept up from the floor and bagged.
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The amount of 51Cr-EDTA recovered in urine was expressed as 
both the percentage during each interval and as the cumulative 
percentage of the administered dose (Figures 7.10 and 7.11). The same 
system was used to report the values obtained in faeces (Figures 7.12 and 
7.13). Details of the values of siCr-EDTA measured in urine and faeces 
are given in Appendixes 1.10 and 2.10, respectively.
The total urinary excretion of siCr-EDTA in 48 hours in Case 
number 3 was 9.19% and approximately 68% of this amount was 
recovered during the first 24 hours. The amount of siCr-EDTA measured 
in faeces in 48 hours was 67.95%.
Clinical progression.
By Day 7, the mare was bright and appetant and was passing 
normal faeces. It started to put on some weight while in the hospital. The 
ventral oedema was regressing progressively. Codeine phosphate 
administration was continued in a reducing dose; a similar protocol was 
followed for prednisolone administration. The differential diagnosis 
considered at this stage was one of malabsorption and protein-losing 
enteropathy, including alimentary lymphosarcoma and chronic infiltrative 
enteropathy. The mare was discharged on Day 33 and the owner was 
requested to bring it two weeks later for re-examination.
Examination was repeated on Day 48 and although no abnormality 
was detected the mare continued to lose weight. An oral glucose tolerance 
test at this stage (Appendix 3.11) showed that plasma glucose levels 
doubled by 120 minutes following oral administration. The mare was 
discharged but it started to deteriorate thereafter and it was decided to 
euthanase it on Day 56 on the basis of continued weight loss.
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FIGURE 7.10. Experiment 7: Percentage of administered 51Cr-EDTA
measured in urine in Case no. 3.
FIGURE 7.11. Experiment 7; Cumulative percentage of administered
5iCr-EDTA measured in urine in Case no. 3.
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FIGURE 7.12. Experiment 7: Percentage of administered siCr-EDTA
measured in faeces in Case no. 3.
FIGURE 7.13. Experiment 7: Cumulative percentage of administered
5iCr-EDTA measured in faeces in Case no. 3.
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Pathological findings.
At necropsy, the large intestinal wall was thickened and 
histopathology showed that this was due to diffuse infiltration by primarily 
eosinophils although significant numbers of mononuclear cells were 
present. The eosinophilic infiltrate was particularly severe around the 
ileocaecocolic valve. Multiple discrete, 1 cm diameter ulcers were found 
in the mucosa of the large bowel in which many fungal colonies were 
observed. Interestingly, the small intestine appeared unaffected. 
Eosinophilic granulomas were observed in most mesenteric lymph nodes 
and chronic eosinophilic pancreatitis was evident. A diagnosis of chronic 
eosinophilic enteritis was made.
DISCUSSION.
The three cases reported in the present study corroborate the view 
that equine chronic enteropathies may present a serious diagnostic 
challenge to the clinician.
Case number 1 presented clinically as a ’wasting horse’ but clinical 
examination and laboratory investigations threw no light to the diagnosis. 
The oral glucose tolerance test (Roberts and Hill, 1973) proved of value 
in detecting small intestinal malabsorption and on the basis of this finding 
it was considered that the prognosis for this animal was poor. Although 
the cumulative percentage of administered 5iCr-EDTA measured in urine 
during 72 hours (4.73%) was comparable to that obtained in ponies in 
Experiment 1 (6.64% ± 2.36), the pattern of intestinal absorption of the 
marker was abnormal. However, its interpretation was very difficult, even 
more so when no signs of enteropathy were found when the animal was 
examined post-mortem. The pattern of 51Cr-EDTA excretion in faeces 
indicated a dramatic increase in intestinal transit time and the observation
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of a full stomach at necropsy appears to confirm this finding. Intestinal 
dysfunction not accompanied by structural changes was suggested in this 
case.
Case number 2 presented with a confusing history of mild 
abdominal discomfort and/or stiffness initially associated with exercise. 
Moderate weight loss had been evident for several weeks prior to referral. 
A full clinical examination and the laboratory findings failed to highlight 
significant alterations, although slight hypoalbuminaemia was detected. 
An oral glucose tolerance test showed a degree of small intestinal 
malabsorption but the result was not definitive. The interpretation of the 
low recovery of siCr-EDTA in urine remains unresolved although it might 
be explained to some extent by the localised pathological lesions observed 
at necropsy.
The third horse in the present study exhibited more specific and 
severe signs of enteropathy. The clinical and laboratory findings suggested 
intestinal mucosal malfunction and this was corroborated by the 
5iCr-EDTA test. The increased urinary excretion of 5iCr-EDTA was most 
likely a result of increased intestinal permeability. Equine chronic 
eosinophilic gastroenteritis was first reported in 1982 (Pass and Bolton) 
and was characterised clinically by chronic weight loss and occasionally 
diarrhoea and, in addition, skin lesions may be observed; it appeared that 
cellular infiltration of the gastrointestinal tract might result in 
malabsorption and protein-losing enteropathy. In Case number 3 
alterations found at necropsy were limited to the large intestine. Although 
small intestinal dysfunction was confirmed by the oral glucose tolerance 
test performed on Day 5, when this was repeated on Day 48 the pattern of 
absorption of glucose was normal which might indicate that corticosteroid 
therapy was effective in restoring normal function of the small intestine.
12 0
In conclusion, the application of the 5iCr-EDTA test may be useful 
in future for the assessment of clinical cases of equine enteropathy. 
However, any judgement must await until the test is performed on more 
animals. Electron microscopic studies, not available in this study, might 
have been of great use in determining the pathophysiology of the 
conditions observed in this animals and its correlation with the results 
obtained.
1 2 1
CHAPTER V: GENERAL DISCUSSION AND 
CONCLUSIONS.
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CHAPTER V: GENERAL DISCUSSION AND 
CONCLUSIONS.
In comparison with other domestic animals, progress in the 
understanding of diseases involving the complex equine gastrointestinal 
tract is exceptionally limited. This situation does not reflect the 
importance that the alimentary system holds, which was reported to be 
involved as the cause of death in one third of cases in a survey of 
post-mortem findings in 480 horses (Baker and Ellis, 1981). In recent 
years much thought and study has been focused at the acute abdominal 
conditions i.e. ’colic’ (Gordon and Allen, 1988; White, 1990) and acute 
enterocolitis (Roberts, 1990; White, 1990). However the limited 
knowledge of the aetiopathogenesis of equine chronic enteropathies, as 
discussed in the first chapter of this thesis, may be best illustrated by the 
results reported in a survey of clinical cases of diarrhoea in adult horses in 
the UK (Mair and others, 1990a) in which 65% of the cases remained 
undiagnosed. Thus the diagnosis and management of equine chronic 
enteropathies present many difficulties for the clinician. This is mainly 
due to the similar pattern of presenting clinical signs of chronic weight 
loss and/or diarrhoea and the lack of specificity of the diagnostic 
techniques currently available.
Human chronic enteropathies exhibit certain similarities to some of 
the equine enteropathies reviewed in the present study. 
Hypoalbuminaemia is a common finding in Crohn’s disease, ulcerative 
colitis and coeliac disease and, in the equine species, it has been recorded 
in cases of alimentary lymphosarcoma (Wiseman and others, 1974; 
Roberts and Pinsent, 1975; Van den Hoven and Franken 1983; Humphrey 
and others, 1984; Crawley, 1985; Sheeran, 1987), gastric squamous cell 
carcinoma (Wrigley and others, 1981; Tennant and others, 1982), 
granulomatous enteritis (Merritt and others, 1976; Meuten and others,
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1978; Roberts and Kelly, 1980; Hodgson and Allen, 1982; Sweeney and 
others, 1986), chronic eosinophilic gastroenteritis (Pass and Bolton, 1982; 
Breider and others, 1985; Gibson and Alders, 1987), tuberculosis and 
histoplasmosis (Roberts, 1984), strongylosis (Round, 1970; Patton and 
others, 1978; Giles and others, 1985; Church and others, 1986; Love, 
1990), PBZ toxicity (Snow and others, 1981; Lees and others, 1983; 
Collins and Tyler, 1985), and pancreatic adenocarcinoma (Church and 
others, 1987). In equine medicine, reduced plasma albumin levels 
generally result from increased loss of proteins into the gastrointestinal 
tract due to increased intestinal permeability (Merritt and others, 1977; 
Coffman, 1979 and 1984; Dietz and Nielsen, 1980; Pearson, 1990).
Alterations in intestinal permeability have been suggested to be 
involved in the pathogenesis of chronic enteropathies both as a 
consequence of a compromised intestinal mucosa, and as a primary defect 
permitting the access through the intestinal epithelium of substances 
which are not absorbed under normal circumstances (Chadwick and 
others, 1977; Bjarnason and others, 1983a; Bjarnason and Peters, 1984; 
Jenkins and others, 1988; Hall and Batt, 1990). Further, abnormalities in 
the intestinal permeability have been shown to be associated with an 
increase in the incidence of neoplasia in patients with coeliac disease 
(Walker and Isselbacher, 1974) and inflammatory bowel disease 
(Lennard-Jones and others, 1977; Gyde and others, 1980). Interestingly, 
alterations in intestinal permeability may not always result in detectable 
changes in plasma variables such as albumin levels when an increase in 
the intake of proteins may compensate for the increased loss from plasma, 
which has been demonstrated in studies on small ruminants 
experimentally infected with helminth parasites (Abbott and others, 
1986). Recent studies in human and veterinary medicine have tried to 
delineate the mechanisms by which alterations in intestinal permeability 
develop and the effect that they have on the gastrointestinal tract.
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The first objective of the present study was to assess the suitability 
of 51Cr-EDTA for the assessment of intestinal permeability in ponies. The 
first four experiments were designed for that purpose. The results 
obtained in ponies under control conditions were between 3.93% and 
9.02% (mean + SD; 6.64% + 2.36) and in the same animals following 
modification of the intestinal motility with either atropine or bethanecol 
there were no significant differences between the percentages of 
siCr-EDTA recovered in urine.
Alterations in intestinal motility have been confirmed in horses 
with strongylosis (Bueno and others, 1979; Berry and others, 1986). It 
would seem likely that similar alterations of motility occur in other equine 
chronic enteropathies which might modify the pattern of absorption of 
intestinal permeability markers, rendering such markers unsuitable. On 
the basis of the results obtained in Experiments 1 to 3 of the present 
study, it was concluded that siCr-EDTA was a reliable tracer to assess 
intestinal permeability in ponies and that minor alterations in intestinal 
motility did not affect the absorption and subsequent urinary excretion 
pattern of the probe. This conclusion is in agreement with the 
observations reported in previous studies using siCr-EDTA in man and 
rats (Bjarnason and others, 1985; Maxton and others, 1986).
Some debate has arisen between human medical research workers 
on the anatomical site of the alimentary tract from which 5iCr-EDTA is 
absorbed. Initial studies concluded that most, if not all, of the 51Cr-EDTA 
absorption occurred in the small intestine (Bjarnason and others, 1983a, 
b; Bjarnason and others, 1985). This is in contrast with more recent 
studies on intestinal permeability in man in which significant absorption 
of the marker was reported to occur in the large intestine (Elia and 
others, 1987; Jenkins and others, 1987 and 1988). The implications of this 
debate in equine medicine are important in that, in cases in which 
histopathological examination of intestinal specimens obtained by 
laparotomy is frequently not practicable, no diagnostic technique has been
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developed to assess large intestinal function. Therefore demonstration of 
5iCr-EDTA absorption from this portion of the gastrointestinal tract 
might be of great interest in the development of a test which could 
demonstrate large intestinal dysfunction in horses. Experiment 4 of this 
series was designed to analyse the pattern of absorption of siCr-EDTA 
from the equine large intestine. Two ponies with permanent caecal 
fistulation were used on this occasion and 1.75% and 1.56% of the 
intracaecally administered 5iCr-EDTA dose was recovered in urine. Thus 
absorption of the probe from the large intestine was confirmed although 
caecal/colonic permeability to 51Cr-EDTA appeared to be relatively low 
in normal ponies, which is in agreement with previous reported studies in 
human patients and dogs (Bjarnason and others, 1985; Hall and others, 
1989). However, a marked increase in the urinary excretion of siCr-EDTA 
was noticed in the cyathostome infected ponies in Experiment 6 of the 
present series which was presumably due to increased absorption of the 
marker through a diseased large intestine with markedly altered 
permeability. Thus, there is evidence from the present studies that 
inflammatory changes of the equine large intestine affect siCr-EDTA 
absorption in a similar way to human enteropathy (Jenkins and others, 
1988).
The objective of Experiment 5 was to study intestinal permeability 
alterations in ponies with phenylbutazone toxicity. Failure to demonstrate 
changes in the permeability of the bowel in these animals might suggest 
that 51Q--EDTA is not a suitable marker to assess this aspect of 
gastrointestinal function in ponies. However three main observations 
oppose this view: first, the consistency of the 5iCr-EDTA recoveries in 
urine in control animals and in the same animals following 
pharmacological modulation of intestinal motility (Experiments 1 to 3) 
appeared to confirm siCr-EDTA as a reliable marker for the assessment 
of intestinal permeability; secondly, urinary excretion of 5iCr-EDTA was 
successfully applied in Experiment 6 of the present thesis to detect 
alterations in intestinal permeability in ponies with experimental
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cyathostome infections; thirdly, no evidence of PBZ toxicity could be 
ascertained in any of the animals after continuous administration of this 
agent for 28 days. Therefore the comparable values of siCr-EDTA urinary 
excretions obtained in Experiment 5 and on the previous occasions in 
which the tracer was tested in the present work further substantiate that 
PBZ toxicity was not achieved and may encourage the use of 51Cr-EDTA 
to assess equine intestinal permeability.
In Experiment 6 of the present study siCr-EDTA was administered 
to ponies at three stages of experimental cyathostome infection. When the 
test was performed under control conditions and shortly (Day 22) after 
the initiation of the administration of cyathostome third-stage larvae, the 
amounts of siCr-EDTA recovered in urine were comparable to control 
values. In contrast, the urinary excretion of the radioisotope increased 
markedly when the test was repeated on Days 47 and 88 of the trickle 
infection and the ponies had received 11.5 million cyathostome larvae. 
The amounts of siCr-EDTA measured in urine appeared to correlate with 
alterations in intestinal permeability and these alterations appeared to 
correspond with the clinical signs observed in the infected animals as well 
as changes in serum albumin and haematological values.
A  major application of a test to assess intestinal permeability in 
horses could be to expand the present knowledge on equine 
enteropathies, both to clarify their aetiopathogenic mechanisms and to 
allow the clinician to diagnose these conditions in the live animal. Three 
horses with chronic enteropathy were tested with siCr-EDTA in the 
present study. One animal (Case number 1) showed an abnormal 
temporal pattern of urinary excretion of the marker which presumably 
reflected the functional derangements of the alimentary tract suggested by 
the post-mortem findings of partial gastric impaction but the exact 
pathogenic mechanisms involved in this condition could not be fully 
ascertained. An equally abnormal result was obtained in Case number 2 
which was found to have a decrease in intestinal permeability as judged by
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the amounts of 51Cr-EDTA detected in urine. The localised pathological 
lesions observed in this animal at necropsy may partially explained this 
finding but a straight explanation was not available.
An increased intestinal permeability was demonstrated in an 
animal with chronic diarrhoea (Case number 3), even when the test was 
performed when the mare was in remission following symptomatic 
anti-diarrhoeic treatment and administration of corticosteroid agents. It is 
felt that a more marked increase in the urinary excretion of 51Cr-EDTA 
would have been detected should the technique have been applied earlier 
in the course of the disease. In previous radioisotope tracer studies it was 
reported that most chronically diarrhoeic horses do not have 
protein-losing enteropathy (Merritt and others, 1977). However the 
results of increased permeability recorded in this animal were strong 
evidence that the extremely low plasma albumin levels detected were due 
to protein-losing enteropathy (PLE). Indeed, the condition diagnosed in 
this animal - chronic eosinophilic enteritis - characterised by diffuse 
cellular infiltration of the gastrointestinal tract by primarily eosinophils 
has been considered to be a PLE (Pass and Bolton, 1982; Roberts, 1984).
In previous studies, siCr-EDTA has been used to investigate 
intestinal transit time in ponies (Argenzio and others, 1974; Clayton and 
others, 1980). Although the primary aim of the present study was to 
quantify the urinary excretion of siCr-EDTA as a reflection of intestinal 
permeability, total faeces produced in 72 hours following intragastric 
administration of the marker were collected and the amounts of 
siCr-EDTA measured in the same way as urine. The results obtained gave 
an estimate of the intestinal transit time and demonstrated alterations in 
this parameter following modifications of intestinal motility by 
pharmacological agents and experimental cyathostome infections. 
However the results were very variable and the conclusions which may be 
drawn from the available data have limited application in the study of 
equine chronic enteropathies.
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For clinical purposes, the 72-hour collection period is likely to be 
impractical. The protocol for the 51Cr-EDTA test used in human patients 
and dogs involves the collection of urine for 24 hours. The results
reported in ponies in the present study clearly indicate that most
absorption occurs during the first 24 hours and consequently should a
clinical 51Cr-EDTA test be developed for horses, a similar approach to
that in man and dogs might be followed. The amount of siCr-EDTA 
recovered in urine in 24 hours in the control ponies was 5.24% + 1.93 
(mean + SD) which may be used as guideline values for future studies but 
verification of reference values would require to be substantiated with 
greater numbers of animals.
Although the total amount of 51Cr-EDTA recovered in urine during 
the 24 or 72 hours following intragastric administration may reliably 
reflect the state of equine intestinal permeability, the study of the 
temporal pattern of the urinary excretion of the probe may also be 
informative. In studies on the intestinal transit time in ponies, Argenzio 
and others (1974) found that 68% of a soluble marker was within the 
caecum within two hours following intragastric administration. However, 
the rate of passage appeared to slow markedly thereafter and the authors 
estimated that the marker was retained in the colon for approximately 50 
hours. If one assumes the same rate of movement for the siCr-EDTA 
solution along the gastrointestinal tract, then the amounts of siQ -ED TA  
excreted in urine between six and 24 hours following the administration 
per stomach tube of the dose solution would be a reflection of the state of 
large intestinal permeability.
Repeatability of the 5iCr-EDTA test was not studied in the present 
series and it would be of interest to assess this in future, with a larger 
number of experimental animals, to confirm the sensitivity of this 
technique. Recent studies in human medicine reported an increase in the 
diagnostic specificity of the 5iCr-EDTA test when it was used in
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combination with other probes. For example, siCr-EDTA and 
14C-mannitol were administered simultaneously per os and urine was 
collected for six hours; the ratio of the percentage urinary excretion of the 
probes was reported to clearly separate patients with coeliac disease or 
inflammatory bowel disease from control subjects (Behrens and others, 
1987; Fotherby and others, 1988). Alternatively, siCr-EDTA has been 
administered separately per os and per rectum to human beings with 
inflammatory bowel disease to differentiate small intestinal from colonic 
disease (O’Morain, 1986; Jenkins and others, 1988). Similar protocols may 
be developed for the equine species.
It has been demonstrated in studies in man and rats (Bjarnason 
and others, 1985; Maxton and others, 1986) that osmolarity and 
composition of the siQ -EDTA  solution administered influence the 
intestinal absorption of the marker; this appears to be associated with 
water absorption via intercellular pathways or through areas of cell 
extrusion (Bjarnason and others, 1983a; Bjarnason and others, 1985; 
Maxton and others, 1986; Ramage and others, 1988). Therefore it must be 
emphasized that a standard protocol be used and the animals should be 
fasted to try to minimize this influence.
In conclusion, the characteristics of siCr-EDTA as a marker - i.e. it 
is stable, biologically inert, chemically nontoxic, confined to an 
extracellular location and it can be easily measured in biologic fluids by 
means of a gamma-counter - and the consistency of the results obtained in 
the present study appear to confirm 51Cr-EDTA as a reliable probe to 
assess intestinal permeability in horses. To some extent the conclusions 
drawn here must be considered preliminary due to the small number of 
animals studied and the absence of parallel investigations such as electron 
microscopic studies or subcellular studies on the distribution of 
5iCr-EDTA in the equine intestinal gastrointestinal tract. Nevertheless,
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the results of this study suggest that novel approaches to assess large 
intestinal function should lead to improved understanding of equine 
chronic enteropathy.
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APPENDIX 1.
APPENDIX 1.1.
Experiment 1. Percentages of administered 5iCr-EDTA measured in urine in 
control ponies.
ANIMAL NUMBER
TIME
68 63 64 70
MEAN SD
0 -1 2 h. 3 . 1 0 1 . 0 1 3 . 7 2 5 . 7 9 3 . 4 1 1 . 9 7
1 2 - 2 4 h . 1 . 2 3 2 . 0 5 2 . 4 6 1 . 6 1 1 . 8 4 0 .  53
DAY 1 4 . 3 3 3 . 0 6 6 . 1 8 7 . 4 0 5 . 2 4 1 . 9 3
2 4 - 3 6 h. 0 . 5 6 0 . 3 6 0 . 8 9 0 . 7 3 0 .  6 4 0 . 2 3
3 6 - 4 8 h . 0 . 2 9 0 . 3 2 0 . 7 1 0 . 5 7 0 . 4 7 0 . 2 0
DAY 2 0 . 8 5 0 .  68 1 . 6 0 1 . 3 0 1 .1 1 0 . 4 2
4 8 - 6 0 h. 0 . 1 6 0 . 0 8 0 . 1 4 0 . 2 2 0 . 1 5 0 .  0 5
6 0 - 7 2 h . 0 . 1 2 0 . 1 1 0 . 2 1 0 . 1 1 0 . 1 4 0 .  05
DAY 3 0 . 2 8 0 . 1 9 0 . 3 5 0 . 3 3 0 . 2 9 0 . 0 6
TOTAL 5 . 4 6 3 . 9 3 8 . 1 3 9 . 0 2 6 . 6 4 2 . 3 6
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APPENDIX 1.2.
Experiment 2. Percentages of administered siCr-EDTA measured in 
ponies following premedication with 0.06 mg/kg atropine 
subcutaneously.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN
0 - 6  h . 1 .  06 1 . 4 0 0 . 5 6 1 .  05 1 . 0 2
6 - 1 2  h . 0 .  00 0 .  65 2 . 1 1 1 .  69 1 . 1 1
1 2 - 1 8  h . 1 . 2 0 0 . 4 7 1 .  02 0 . 7 1 0 . 8 5
1 8 - 2 4  h . 0 .  00 0 . 4 2 0 . 8 6 0 . 4 0 0 . 4 2
DAY 1 2 . 2 6 2 . 9 4 4 . 5 5 3 . 8 5 3 . 4 0
2 4 - 3 6  h . 1 . 3 0 0 . 4 4 1 . 0 4 0 . 7 3 0 . 8 8
3 6 - 4 8  h . 0 . 1 3 0 .  06 0 .  32 2 . 3 0 0 . 7 0
DAY 2 1 . 4 3 0 . 5 0 1 . 3 6 3 . 0 3 1 . 5 8
4 8 - 6 0  h . 0 . 1 8 0 . 1 1 0 . 1 0 1 . 2 7 0 . 4 2
6 0 - 7 2  h . 0 .  09 0 . 0 5 0 . 0 4 0 .  65 0 . 1 4
DAY 3 0 . 2 7 0 . 1 6 0 . 1 4 1 . 9 2 0 . 6 2
TOTAL 3 . 9 6 3 . 6 0 6 . 0 5 8 . 8 0 5 . 6 0
urine in 
sulphate
SD
0 . 3 5  
0 . 9 6  
0 .  32  
0 . 3 5
1 . 0 0
0 . 3 7
1 .  07
0 . 9 1
0 . 5 7  
0 .  05
0 . 7 5
2 . 3 9
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APPENDIX 1.3. 
Experiment 3. Percentages of administered 51Cr-EDTA measured in urine in 
ponies following premedication with 0.05 mg/kg bethanecol subcutaneously.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 . 5 1 1 . 2 3 0 .  61 1 . 5 1 0 . 9 7 0 . 4 8
6 - 1 2 h . 0 .  00 0 .  62 0 .  00 0 .  60 0 . 3 1 0 .  35
1 2 - 1 8 h . 1 . 3 9 0 . 7 6 1 . 2 1 . 0 . 8 7 1 . 0 6 0 . 2 9
1 8 - 2 4 h . 0 . 0 0 0 . 3 3 0 . 8 2 0 . 4 4 0 . 4 0 0 . 3 4
DAY 1 1 . 9 0 2 . 9 4 2 . 6 4 3 . 4 2 2 . 7 2 0 . 6 3
2 4 - 3 6 h . 0 .  66 0 . 5 1 0 . 3 8 2 . 2 2 0 . 9 4 0 . 8 6
3 6 - 4 8 h . 0 . 3 5 0 . 1 8 0 . 3 4 1 . 2 0 0 . 5 2 0 . 4 6
DAY 2 1 . 0 1 0 . 6 9 0 . 7 4 3 . 4 2 1 . 4 7 1 . 3 1
4 8 - 6 0 h . 0 . 1 0 0 . 0 6 0 . 0 8 0 . 8 3 0 . 2 7 0 .  38
6 0 - 7 2 h . 0 . 0 5 0 . 0 2 0 . 0 4 0 . 3 4 0 . 1 1 0 . 1 5
DAY 3 0 . 1 5 0 . 0 8 0 . 1 2 1 . 1 7 0 . 3 8 0 . 5 3
TOTAL 3 . 0 5 3 . 7 0 3 . 4 7 8 . 0 1 4 . 5 6 2 . 3 2
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APPENDIX 1.4.
Experiment 4. Percentages of administered 5iCr-EDTA measured in urine
in ponies with permanent caecal fistulation.
ANIMAL NUMBER
TIME
1 2
MEAN SD
0 - 6  h . 0 . 0 6 0 . 1 6 0 . 3 8 0 . 3 3
6 - 1 2  h . 0 . 3 5 0 . 6 1 3 . 7 1 1 . 0 5
1 2 -1 8  h . 0 . 2 2 0 . 2 8 3 . 0 5 3 . 2 6
1 8 -2 4  h . 0 . 1 6 0 . 1 0 0 . 7 9 0 . 1 1
DAY 1 0 . 7 9 1 . 1 5 0 . 9 7 0 . 2 5
2 4 - 3 6  h . 0 . 4 7 0 . 1 6 0 . 9 8 1 . 1 2
3 6 - 4 8  h . 0 . 1 8 0 . 2 0 0 . 3 2 0 . 2 5
DAY 2 0 . 6 5 0 . 3 6 0 . 5 1 0 . 2 1
4 8 - 6 0  h . 0 . 2 1 0 . 0 3 0 . 3 3 0 . 3 7
6 0 - 7 2  h . 0 . 1 1 0 . 0 1 0 . 1 0 0 . 0 9
DAY 3 0 . 3 2 0 . 0 4 0 . 1 8 0 . 2 0
TOTAL 1 . 7 5 1 . 5 6 1 . 6 6 0 . 1 3
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APPENDIX 1.5.
Experiment 5. Percentages of administered ^^Cr-EDTA measured in urine in 
ponies following oral administration of 8.8 m g/kg/day phenylbutazone for 28 
days.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 .  00 2 . 9 4 0 .  00 4 . 3 1 1 . 8 1 2 . 1 7
6 - 1 2 h . 0 . 0 0 0 .  64 3 . 4 5 0 . 7 0 1 . 2 0 1 . 5 4
1 2 -1 8 h . 0 . 8 7 0 . 8 9 0 . 0 0 0 . 5 1 0 . 5 7 0 . 4 2
1 8 - 2 4 h . 0 .  00 0 . 3 6 0 . 0 0 0 . 4 3 0 . 2 0 0 . 2 3
DAY 1 0 . 8 7 4 . 8 3 3 . 4 5 5 . 9 5 3 . 7 8 2 . 1 9
2 4 - 3 6 h. 3 . 0 5 1 .  03 2 . 2 2 1 . 5 5 1 . 9 6 0 . 8 7
3 6 - 4 8 h. 0 . 1 2 0 . 2 5 0 . 1 9 0 .  08 0 . 1 6 0 .  08
DAY 2 3 . 1 7 1 . 2 8 2 . 4 1 1.  63 2 . 1 2 0 . 7 3
4 8 - 6 0 h. 0 . 0 7 0 . 1 3 0 . 2 1 0 .  60 0 . 2 5 0 . 2 4
6 0 -7 2 h . 0 . 0 9 0 . 0 3 0 . 0 3 0 .  08 0 . 0 6 0 . 0 3
DAY 3 0 . 1 6 0 . 1 6 0 . 2 4 0 . 6 8 0 . 3 1 0 . 2 2
TOTAL 4 . 2 0 6 . 2 7 6 . 1 1 8 . 2 5 6 . 2 1 1 . 6 6
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APPENDIX 1.6.
Experiment 6. Percentages of administered siCr-EDTA measured in urine in 
control ponies.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 1 . 4 1 2 . 3 3 1 . 1 5 2 . 7 6 2 . 0 8 0 . 8 3
6 - 1 2 h . 0 .  58 1 .  03 0 .  00 0 .  00 0 .  34 0 .  60
1 2 -1 8 h . 1 . 3 6 0 . 8 1 0 . 8 7 0 . 4 6 0 . 7 1 0 . 2 2
1 8 -2 4 h . 0 .  00 0 .  37 1 . 2 2 0 . 8 9 0 . 8 3 0 .  43
DAY 1 3 . 3 5 4 . 5 4 3 . 2 4 4 . 1 1 3 . 9 5 0 . 6 6
2 4 - 3 6 h . 0 . 9 9 0 . 3 8 0 . 7 6 1 . 2 6 0 . 8 0 0 . 4 4
3 6 - 4 8 h. 0 . 2 3 0 . 0 9 0 . 2 1 0 . 4 6 0 . 2 5 0 . 1 9
DAY 2 1 . 2 2 0 . 4 7 0 . 9 7 1 . 7 2 1 . 0 5 0.  63
4 8 - 6 0 h. 0 . 1 6 0 .  06 0 . 1 0 0 . 2 1 0 . 1 2 0 .  08
6 0 - 7 2 h . 0 . 0 5 0 . 0 2 0 . 0 3 0 . 0 7 0 . 0 4 0 . 0 3
DAY 3 0 . 2 1 0 . 0 8 0 . 1 3 0 . 2 8 0 . 1 6 0 . 1 0
TOTAL 4 . 7 7 5 . 0 9 4 . 3 5 6 . 1 0 5 . 1 8 0 . 8 8
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APPENDIX 1.7.
Experiment 6. Percentages of administered 51Cr-EDTA measured in urine in 
ponies following trickle infection with 5.5 million cyathostome third-stage larvae 
(Day 22).
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 . 2 5 0 . 7 7 0 . 0 0 1 . 7 9 0 . 8 5 0 . 9 0
6 - 1 2 h . 0 .  00 2 . 4 9 3 . 4 3 0 . 5 1 2 . 7 4 0 .  60
1 2 -1 8 h . 1 . 2 7 0 . 8 4 0 . 0 0 0 . 5 2 0 . 4 5 0 . 4 2
1 8 - 2 4 h . 0 .  00 0 .  60 0 . 0 0 0 . 2 1 0 . 2 7 0 . 3 0
DAY 1 1 . 5 2 4 . 7 0 3 . 4 3 3 . 0 3 3 . 7 2 0 . 8 7
2 4 - 3 6 h . 0 . 9 2 1 . 0 5 1 . 4 8 0 . 2 7 0 . 9 3 0 . 6 1
3 6 - 4 8 h . 0 .  22 0 . 2 9 0 . 9 3 0 . 4 4 0 . 5 5 0 . 3 3
DAY 2 1 . 1 4 1 . 3 4 2 . 4 1 0 . 7 1 1 . 9 9 0 . 7 0
4 8 - 6 0 h . 0 .  69 0 . 2 8 1 . 7 1 0 . 6 5 0 . 8 0 0 . 7 4
6 0 - 7 2 h. 0 . 8 3 0 . 1 4 0 . 0 3 0 . 6 8 0 . 2 8 0 . 3 5
DAY 3 1 . 5 2 0 . 4 2 1 . 7 4 1 . 3 3 1 . 1 6 0 . 5 5
TOTAL 4 . 1 7 6 . 4 5 7 . 5 8 5 . 0 5 6 . 3 6 1 . 2 7
NOTE. Infected animals: 63, 64 and 70. Control animal: 68. Mean and standard 
deviation (SD) refer to infected animals.
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APPENDIX 1.8.
Experiment 6. Percentages of administered 51Cr-EDTA measured in urine in 
ponies following trickle infection with 11.5 million cyathostome third-stage 
larvae (Day 47).
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 .  00 2 . 7 3 2 . 6 5 1 . 5 0 2 . 2 9 0 . 6 9
6 - 1 2 h . 0 .  56 2 . 5 5 6 . 4 0 2 . 9 4 3 . 9 6 2 . 1 2
1 2 -1 8 h . 1 . 8 6 1 . 2 1 5 . 1 5 3 . 0 8 3 . 1 5 1 .  97
1 8 -2 4 h . 0 . 3 4 0 . 7 3 5 . 1 8 0 . 8 7 2 . 2 6 2 . 53
DAY 1 2 . 7 6 7 . 2 2 1 9 . 3 8 8 . 3 9 1 1 . 6 6 6 . 7 1
2 4 - 3 6 h. 0 . 5 3 1 . 3 4 4 . 8 7 1 . 2 4 2 . 4 8 2 . 0 7
3 6 - 4 8 h . 0 . 3 0 0 . 1 6 1 . 8 0 0 . 6 7 0 . 8 8 0 . 8 4
DAY 2 0 . 8 3 1 . 5 0 6 . 6 7 1 . 9 1 3 . 3 6 2 . 3 5
4 8 - 6 0 h . 0 . 2 4 0 . 2 2 1 . 4 8 0 . 2 5 0 . 6 5 0 . 7 2
6 0 - 7 2 h . 0 . 1 4 0 . 0 8 0 . 8 0 0 .  00 0 . 2 9 0 . 4 4
DAY 3 0 . 3 8 0 . 3 0 2 . 2 8 0 . 2 5 0 . 9 4 0 . 9 5
TOTAL 3 . 9 7 9 . 0 1 2 8 . 3 4  1 0 . 5 5 1 5 . 9 7 1 0 . 7 4
NOTE. Infected animals: 63, 64 and 70. Control animal: 68. Mean and standard
deviation (SD) refer to infected animals.
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APPENDIX 1.9. 
Experiment 6. Percentages of administered 51Cr-EDTA measured in urine in 
ponies following trickle infection with 11.5 million cyathostome third-stage 
larvae (Day 88).
ANIMAL NUMBER
TIME
68 63 70
MEAN SD
0 -6 h . 0 . 0 3 0 . 1 4 0 . 6 1 0 . 3 8 0 . 3 3
6 -1 2 h . 0 .  00 4 . 4 5 2 . 9 6 3 . 7 1 1 . 0 5
1 2 -1 8 h . 0 . 3 8 5 . 3 5 0 . 7 4 3 .  05 3 . 2 6
1 8 -2 4 h . 0 .  00 0 . 7 1 0 . 8 7 0 . 7 9 0 . 1 1
DAY 1 0 . 4 1 1 0 . 6 5 5 . 1 8 7 . 9 1 3 . 8 7
2 4 - 3 6 h . 0 .  64 0 . 1 9 1 . 7 7 0 . 9 8 1 . 1 2
3 6 - 4 8 h . 0 . 2 8 0 . 1 4 0 . 4 9 0 . 3 2 0 . 2 5
DAY 2 0 . 9 2 0 . 3 3 2 . 2 6 1 . 3 0 0 . 9 7
4 8 - 6 0 h . 0 . 5 0 0 . 0 7 0 . 5 9 0 . 3 3 0 . 3 7
6 0 -7 2 h . 0 . 0 7 0 . 0 3 0 . 1 6 0 . 1 0 0 . 0 9
DAY 3 0 . 5 7 0 .1 0 0 . 7 5 0 . 4 3 0 . 3 3
TOTAL 1 . 9 0 1 1 . 0 8 8 . 1 9 9 . 6 4 2 . 0 4
NOTE. Infected animals: 63 and 70. Control animal: 68. Mean and standard
deviation (SD) refer to infected animals.
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APPENDIX 1.10. 
Experiment 7. Percentages of administered 51Cr-EDTA measured in urine 
in horses with chronic enteropathy.
ANIMAL NUMBER
TIME
1 2 3
0 -6  h . 1 0 . 2 5 0 . 4 3
6 - 1 2  h . 1 . 1 1 0 . 3 2 1 . 8 7
1 2 -1 8  h . 1 0 . 3 1 2 . 0 2
1 8 -2 4  h . 1 . 1 7 0 . 2 2 1 . 8 9
DAY 1 2 . 2 8 1 .1 0 6 .2 1
2 4 - 3 6  h. 0 .  00 0 . 3 1 2 . 1 9
3 6 - 4 8  h. 1 . 4 0 0 . 1 4 0 . 7 9
DAY 2 1 . 4 0 0 . 4 5 2 . 9 8
4 8 - 6 0  h . 0 .  00 0 . 1 0 -
6 0 - 7 2  h. 1 .  06 0 .  02 -
DAY 3 1 . 0 6 0 .1 2 -
TOTAL 4 . 7 3 1 . 6 7 9 . 1 9
NOTE. Collection of urine in Case number 1 during the first day was 
divided in two 12-hour intervals. Collection of urine in Case number 3 was
limited to the first 48 hours.
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APPENDIX 2.
APPENDIX 2.1.
Experiment 1. Percentages of administered 51Cr-EDTA measured in faeces in 
control ponies.
TIME
6 8
ANIMAL NUMBER 
63 64 70
MEAN SD
0 - 1 2  h . 1 1 . 5 7 1 . 9 0 0 . 0 1 0 .  0 1 3 . 3 7 5 . 5 4
1 2 - 2 4  h . 4 1 . 4 7 5 6 . 7 0 33 . 9 4 3 3 . 5 2 4 1 . 4 1 1 0 .  83
DAY 1 5 3 . 0 4 5 8 . 6 0 3 3 . 9 5 3 3 . 5 3 4 4 . 7 8 1 2 . 9 5
2 4 - 3 6  h . 2 0 .  61 2 3 . 7 0 2 5 . 9 8 2 7 .  16 2 1 . 9 8 3 . 65
3 6 - 4 8  h . 13 . 07 7 . 2 4 1 7 . 2 6 1 7 . 6 1 1 3 . 8 0 4 . 8 3
DAY 2 3 3 . 6 8 3 0 . 9 4 4 3 . 2 4 4 4 . 7 7 3 8 . 1 6 5 . 9 5
4 8 - 6 0  h . 3 . 4 3 2 . 61 5 .  66 7 . 0 1 4 . 6 8 2 . 02
6 0 - 7 2  h . 2 . 1 3 0 .  84 2 . 6 6 3 . 2 9 2 . 2 3 1 . 0 4
DAY 3 5 . 5 6 3 . 4 5 8 . 3 2 1 0 . 3 0 6 . 9 1 2 . 6 1
TOTAL 9 2 . 2 9 9 2 . 9 9 8 5 . 5 1 8 8 . 6 1 8 9 . 8 5 3 . 4 7
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APPENDIX 2.2.
Experiment 2. Percentages of administered 51Cr-EDTA measured in faeces in 
ponies following premedication with 0.06 mg/kg atropine sulphate 
subcutaneously.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 .  00 0 .  00 0 .  00 0 .  00 0 .  00 0 .  00
6 - 1 2 h . 6 . 8 9 6 . 3 0 1 . 3 8 0 .  00 3 . 64 3 . 4 6
1 2 -1 8 h . 1 5 . 8 0 2 5 . 7 9 2 2 . 4 1 0 . 4 1 1 6 . 1 0 1 1 . 2 5
*»•CM100H h . 1 4 . 2 8 2 2 . 5 3 1 9 . 6 7 0 . 2 8 14 . 1 9 9 . 8 8
DAY 1 3 6 . 9 7 54 .  62 4 3 . 4 6 0 .  69 3 3 . 9 0 2 3 . 3 0
2 4 - 3 6 h. 2 1 . 3 4 2 0 . 2 8 2 8 . 2 5 3 . 2 3 1 8 . 2 7 1 0 . 6 3
3 6 - 4 8 h . 1 8 . 3 8 8 . 3 8 1 0 . 8 8 1 9 . 1 5 1 4 . 2 0 5 . 3 8
DAY 2 3 9 . 7 2 28 .  6 6 3 9 . 1 3 22 . 3 8 3 2 . 4 7 7 . 3 0
4 8 - 6 0 h . 4 . 8 6 1 . 7 6 2 . 6 1 2 5 . 1 4 8 . 5 9 1 1 .1 1
6 0 - 7 2 h . 1 . 1 5 0 . 3 7 0 .  61 1 5 .  33 4 . 3 6 7 . 3 2
DAY 3 6 . 0 1 2 . 1 3 3 . 2 2 4 0 . 4 7 1 2 . 9 6 1 9 . 9 5
TOTAL 8 2 . 7 1 8 5 . 4 1 - 8 5 . 8 1 6 3 . 5 3 7 9 . 3 6 1 0 . 6 5
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APPENDIX 2.3. 
Experiment 3. Percentages of administered 51Cr-EDTA measured in faeces in 
ponies following premedication with 0.05 mg/kg bethanecol subcutaneously.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 .  01 0 . 0 0 0 . 0 0 0 . 1 4 0 .  04 0 .  07
6 - 1 2 h . 8 . 1 8 0 . 8 3 6 .  62 0 .  66 4 . 0 7 3 . 9 0
1 2 -1 8 h . 2 8 . 2 9 2 5 .  67 4 0 . 3 4 0 . 1 1 23  . 60 1 6 . 9 1
1 8 -2 4 h . 1 6 . 2 1 2 7 . 1 7 1 6 . 5 1 0 .  0 1 1 4 . 9 7 1 1 . 2 0
DAY 1 5 2 . 69 5 3 . 67 6 3 . 4 7 0 . 9 2 4 2 . 7 0 2 8 . 3 0
2 4 - 3 6 h. 2 3 . 9 5 2 3 . 2 4 2 3 . 3 9 2 5 . 4 1 2 4 . 0 0 0 . 9 9
3 6 - 4 8 h. 1 2 . 0 8 1 3 . 9 2 5 . 5 5 2 5 . 5 3 1 4 . 2 7 8 . 3 2
DAY 2 3 6 . 0 3 3 7 . 1 6 2 8 . 9 4 5 0 . 9 4 3 8 . 2 7 7 . 9 7
4 8 - 6 0 h . 2 . 8 4 2 . 1 8 0 . 9 7 3 3 . 1 4 9 . 7 8 1 5 . 5 9
6 0 - 7 2 h. 0 . 7 5 0 . 3 6 0 . 1 7 0 . 8 7 0 . 5 4 0 . 3 3
DAY 3 3 . 5 9 2 . 5 2 1 . 1 4 3 4 . 0 1 1 0 . 3 2 1 3 . 7 1
TOTAL 9 2 . 3 1 9 3 . 3 5 9 3 . 5 5 8 5 . 8 7 9 1 . 2 6 3 . 6 5
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APPENDIX 2.4.
Experiment 4. Percentages of administered 5 1Cr-EDTA measured in faeces 
in ponies with permanent caecal fistulation.
ANIMAL NUMBER
TIME
1 2
MEAN SD
0 - 6  h . 0 .  00 0 . 1 4 0 .  38 0 . 3 3
6 - 1 2  h . 0 . 2 0 1 5 . 7 9 3 . 7 1 1 .  05
1 2 -1 8  h . 0 . 5 8 2 5 . 7 0 3 . 0 5 3 . 2 6
1 8 -2 4  h . 7 . 7 9 1 9 . 6 5 0 . 7 9 0 . 1 1
DAY 1 8 . 5 7 6 1 . 2 8 3 4 . 9 3 3 7 . 2 7
2 4 - 3 6  h . 3 7 . 0 9 9 . 9 8 0 . 9 8 1 . 1 2
3 6 - 4 8  h . 1 1 . 3 2 4 . 3 4 0 . 3 2 0 . 2 5
DAY 2 4 8 . 4 1 1 4 . 3 2 3 1 . 3 7 2 4 . 1 1
4 8 - 6 0  h . 1 2 . 6 0 0 . 9 0 0 . 3 3 0 . 3 7
6 0 - 7 2  h . 4 . 3 3 0 . 4 5 0 . 1 0 0 . 0 9
DAY 3 1 6 . 9 3 1 . 3 5 9 . 1 4 1 1 . 0 2
TOTAL 7 3 . 9 0 7 6 . 9 4 7 5 . 4 2 2 . 1 5
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APPENDIX 2.5. 
Experiment 5. Percentages of administered 51Cr-EDTA measured in faeces in 
ponies following oral administration of 8.8 mg/kg/day phenylbutazone for 28 
days.
TIME
6 8
ANIMAL NUMBER 
63 64 70
MEAN SD
0 - 6  h . 0 . 0 0 0 .  02 0 . 0 0 0 .  00 0 .  01 0 . 0 1
6 - 1 2  h . 3 . 03 2 1 . 3 5 1 . 2 5 0 .  00 6 . 4 1 1 0 .  04
1 2 -1 8  h . 3 2 . 0 9 2 1 . 3 9 6 . 1 1 1 . 9 6 1 5 . 3 9 1 3 . 9 2
1 8 -2 4  h . 1 8 . 1 0 1 2 . 2 8 1 4 . 3 5 0 .  00 1 1 . 1 8 7 . 8 3
DAY 1 5 3 . 2 2 5 5 . 0 4 2 1 . 7 1 1 . 9 6 3 3 . 0 0 2 5 . 7 0
2 4 - 3 6  h . 2 2 . 2 8 2 4 . 6 3 3 1 .  68 6 4 . 7 1 3 5 . 8 3 1 9 . 6 7
3 6 - 4 8  h . 5 . 1 0 4 . 9 2 7 . 3 3 2 2 . 3 5 9 . 9 3 8 . 36
DAY 2 2 7 . 3 8 2 9 . 5 5 3 9 . 0 1 8 7 . 0 6 4 5 . 7 5 2 4 . 2 5
4 8 - 6 0  h . 3 . 5 8 3 . 9 1 4 . 5 9 3 0 . 0 1 1 0 . 5 2 1 3 . 0 0
6 0 - 7 2  h . 0 . 5 8 0 . 2 2 2 . 2 2 0 . 6 8 0 . 9 3 0 . 8 9
DAY 3 4 . 1 6 4 . 1 3 6 . 8 1 3 0 . 6 9 1 1 . 4 5 1 1 . 1 6
TOTAL 8 4 . 7 7 8 8 . 7 2 6 7 . 5 3 1 1 9 . 7 1 9 0 . 2 0 2 1 . 7 0
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APPENDIX 2.6.
Experiment 6. Percentages of administered 51Cr-EDTA measured in faeces in 
control ponies.
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 . 0 0 0 . 0 0 0 . 0 0 0 .  00 0 . 0 0 0 .  00
6 - 1 2 h . 1 2 . 4 9 2 2 . 1 9 0 .  04 8 . 3 5 1 0 . 1 9 1 1 . 1 9
1 2 -1 8 h . 2 5 .  09 3 2 . 3 0 2 3 . 6 3 3 . 03 1 9 . 6 5 1 5 .  03
1 8 -2 4 h . 13 . 9 1 2 1 . 3 4 2 8 . 0 1 1 6 . 4 9 2 1 . 9 5 5 . 7 8
DAY 1 5 1 . 4 9 7 5 . 8 3 5 1 . 6 8 2 7 . 8 7 5 1 . 8 0 2 4 . 0 0
2 4 - 3 6 h . 3 1 . 5 9 1 1 . 3 0 2 9 . 5 6 4 5 . 8 5 2 8 . 9 3 1 7 . 2 9
3 6 - 4 8 h . 5 . 8 8 2 . 2 4 8 . 0 2 1 6 . 8 2 9 .  03 7 . 3 4
DAY 2 3 7 . 4 7 1 3 . 54 37 . 5 8 6 2 . 6 7 3 7 . 8 3 2 4 . 5 7
4 8 - 6 0 h . 3 . 8 2 0 . 6 7 1 . 5 3 5 . 7 5 2 . 65 2 . 7 2
6 0 - 7 2 h . 0 . 9 6 0 . 1 8 0 . 3 0 1 . 7 2 0 . 7 3 0 . 8 6
DAY 3 4 . 7 8 0 . 8 5 1 . 8 3 7 . 4 7 3 . 3 8 3 . 5 7
TOTAL 9 3 . 7 4 9 0 . 2 3 9 1 . 1 0 9 8 . 0 1 9 3 . 1 1 4 . 2 6
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APPENDIX 2.7. 
Experiment 6. Percentages of administered 51Cr-EDTA measured in faeces in 
ponies following trickle infection with 5.5 million cyathostome third-stage larvae 
(Day 22).
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h. 0 . 0 0 0 . 0 0 0 . 0 0 0 .  00 0 . 0 0 0 . 0 0
6 - 1 2 h . 0 . 0 0 2 . 1 5 0 . 0 0 0 .  00 0 . 7 2 1 . 2 4
1 2 -1 8 h . 0 . 1 3 1 0 . 7 3 2 . 2 2 1 . 4 1 4 . 7 9 5 . 1 6
1 8 -2 4 h . 0 .  00 2 1 . 1 5 8 .  60 0 .  00 9 . 9 2 1 0 . 6 4
DAY 1 0 . 1 3 3 4 . 0 3 1 0 . 8 2 1 . 4 1 1 5 . 4 2 1 6 . 7 9
2 4 - 3 6 h . 2 5 . 1 8 4 5 . 1 0 2 4 . 3 9 1 4 . 8 9 2 8 . 1 3 1 5 . 4 5
3 6 - 4 8 h . 2 0 . 8 2 9 . 8 9 1 7 . 3 2 1 9 . 2 0 1 5 . 4 7 4 . 9 2
DAY 2 4 6 . 0 0 5 4 . 9 9 4 1 . 7 1 3 4 . 0 9 4 3 .  60 8 . 6 4
0 \o100 h. 1 0 . 8 5 2 . 0 8 1 1 . 2 3 5 . 0 3 6 . 1 1 4 . 6 7
6 0 - 7 2 h . 1 7 . 8 0 0 . 8 8 3 . 4 3 1 5 . 6 3 6 . 6 5 7 . 8 8
DAY 3 2 8 . 6 5 2 . 9 6 1 4 . 6 6 2 0 . 6 6 1 2 . 7  6 7 . 3 5
TOTAL 7 4 . 7 8 9 1 . 9 8 6 7 . 2 0 5 6 . 1 6 7 1 . 8 0 1 8 . 4 0
NOTE. Infected animals: 63, 64 and 70. Control animal: 68. Mean and standard
deviation (SD) refer to infected animals.
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APPENDIX 2.8. 
Experiment 6. Percentages of administered 51Cr-EDTA measured in faeces in 
ponies following trickle infection with 11.5 million cyathostome third-stage 
larvae (Day 47).
ANIMAL NUMBER
TIME
6 8 63 64 70
MEAN SD
0 - 6 h . 0 .  00 0 . 7 5 0 .  00 0 .  00 0 . 2 5 0 . 4 3
6 - 1 2 h . 0 .  06 1 5 . 9 5 0 .  00 0 .  00 5 . 3 2 9 . 2 1
1 2 -1 8 h . 5 . 9 6 1 5 . 6 1 1 . 7 3 0 .  0 0 5 . 7 8 8 . 5 6
1 8 - 2 4 h . 1 0 .  07 2 7 . 9 8 3 . 5 5 9 . 8 5 1 3 . 7 9 1 2 . 6 8
DAY 1 1 6 . 0 9 6 0 . 2 9 5 . 2 8 9 . 8 5 2 5 . 1 0 3 0 . 5 0
2 4 - 3 6 h . 3 6 . 8 7 2 2 . 3 0 2 3 . 3 4 3 9 . 8 0 2 8 . 4 8 9 . 8 2
3 6 - 4 8 h . 2 4 . 8 7 6 . 2 5 9 . 1 3 1 2 . 5 9 9 . 3 2 3 . 1 7
DAY 2 6 1 . 7 4 2 8 . 5 5 3 2 . 4 7 5 2 . 3 9 3 7 . 8 0 1 0 . 4 4
4 8 - 6 0 h . 1 1 . 0 7 1 . 7 8 1 3 . 5 8 4 . 4 2 6 . 5 9 6 . 1 9
6 0 - 7 2 h. 5 .  00 0 . 8 2 4 . 3 8 1 2 . 7 5 5 . 9 8 6 . 1 2
DAY 3 1 6 . 0 7 2 . 6 0 1 7 . 9 6 1 7 . 1 7 1 2 . 5 8 7 . 0 6
TOTAL 9 3 . 9 1 9 1 . 4 3 5 5 . 7 1 7 9 . 4 2 7 5 . 5 0 1 8 . 2 0
NOTE. Infected animals: 63, 64 and 70. Control animal: 68. Mean and standard 
deviation (SD) refer to infected animals.
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APPENDIX 2.9. 
Experiment 6. Percentages of administered 51Cr-EDTA measured in faeces in
ponies following trickle 
larvae (Day 88).
infection with 11.5 million cyathostome third-stage
TIME
6 8
ANIMAL NUMBER
63 70
MEAN SD
0 - 6 h . 0 . 00 2 . 5 2 0 . 0 0 1 . 2 6 1 . 7 8
6 - 1 2 h . 0 .  00 3 9 .  35 0 . 0 0 1 9 . 7 0 2 7 . 8 0
1 2 -1 8 h . 4 . 4 8 4 1 . 8 5 1 . 5 7 2 1 . 7 0 2 8 . 5 0
1 8 -2 4 h . 1 5 . 0 5 0 . 8 0 1 5 . 8 8 8 . 3 4 1 0 . 6 6
DAY 1 1 9 . 5 3 8 4 . 5 2 1 7 . 4 5 5 1 . 0 0 4 7 . 4 0
2 4 - 3 6 h . 2 0 . 9 4 0 .  01 2 9 . 4 8 1 4 . 7 0 2 0 . 8 0
3 6 - 4 8 h . 2 2 . 5 4 0 . 2 1 1 5 . 5 8 7 . 8 9 1 0 . 8 7
DAY 2 4 3 . 4 8 0 . 2 2 4 5 . 0 6 2 2 . 6 4 2 2 . 4 2
4 8 - 6 0 h . 1 0 . 7 1 0 . 0 3 1 1 . 3 0 5 . 6 6 7 . 9 7
6 0 - 7 2 h . 4 . 3 4 0 . 0 0 4 . 8 7 2 . 4 3 3 . 4 4
DAY 3 1 5 . 0 5 0 . 0 3 1 6 . 1 7 8 . 1 0 8 . 0 7
TOTAL 7 8 . 0 6 8 4 . 7 8 7 8 . 6 8 8 1 . 7 3 4 . 3 1
NOTE. Infected animals: 63 and -70. Control animal: 68. Mean and standard
deviation (SD) refer to infected animals.
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APPENDIX 2.10.
Experiment 7. Percentages of administered 51Cr-EDTA measured in faeces
in horses with chronic enteropathy.
ANIMAL NUMBER
TIME
1 2 3
0 - 6  h . 1 0 .  0 1 0 . 0 0
6 - 1 2  h . 0 . 0 0 0 .  0 1 0 . 0 5
1 2 -1 8  h . 1 3 . 7 3 1 . 5 5
1 8 -2 4  h . 4 . 1 8 1 5 . 4 2 1 9 . 1 9
DAY 1 4 . 1 8 1 9 . 1 7 2 0 . 7 9
2 4 - 3 6  h . 1 2 . 6 1 4 7 .  67 3 0 . 4 2
3 6 - 4 8  h . 0 . 0 0 1 0 . 8 1 1 6 . 7 4
DAY 2 1 2 . 6 1 5 8 . 4 8 4 7 . 1 6
4 8 - 6 0  h . 2 0 . 8 3 6 . 4 8 -
6 0 - 7 2  h . 1 6 . 2 3 1 . 2 1 -
DAY 3 3 7 . 0 6 7 . 6 9 -
TOTAL 5 3 . 8 4 8 5 . 3 4 6 7 . 9 5
NOTE. Collection of faeces in Case number 1 during the first day wa
divided in two 12-hour intervals. Collection of faeces in Case number
was limited to the first 48 hours.
1 5 3
APPENDIX 3.
APPENDIX 3.1. 
Experiment 5. Fractional excretion of electrolytes (%) in urine.
PONY PERIOD Na K Cl Ca PO4
63 3 . 1 0 .  62 6 2 . 3 2 1 . 6 1 9 . 4 9 2 . 8 8
3 . 2 0 .  62 3 9 .  60 1 . 0 7 7 . 1 0 6 .  04
64 3 . 1 0 . 8 1 5 8 . 2 9 1 . 4 3 4 . 5 3 1 . 8 1
3 . 2 0 .  69 6 7 . 6 9 1 . 8 0 1 2 . 5 2 6 .  34
6 8 3 . 1 0 . 5 4 3 2 . 9 4 1 . 5 0 5 .  05 2 . 8 7
3 . 2 0 . 2 5 3 5 . 5 4 1 . 1 7 6 . 1 9 2 . 9 8
70 3 . 1 0 . 5 3 8 0 .  32 1 . 4 9 1 0 . 2 3 3 . 3 0
3 . 2 0 . 9 0 5 1 . 2 1 1 . 1 6 4 . 5 3 5 . 9 1
NORMAL RANGES: . 0 3 -
. 5 2
3 5 -
8 0
. 5 8 -
1 . 8 6
. 1 5 -
6 . 7 2
0 -  
0 . 2
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APPENDIX 3.2. 
Experiment 5. Renal clearance of electrolytes (m l/m in/kg).
PONY PERIOD CREAT Na K Cl Ca PO4
63 3 . 1
3 . 2
2 . 66  
1 . 2 4
0 .  02  
0 .  01
1 . 6 6
0 . 4 9
0 . 0 4  
0 .  0 1
0 . 2 5  
0 .  09
0 . 0 8  
0 .  07
64 3 . 1
3 . 2
4 . 3 3  
0 .  66
0 .  04  
0 .  00
2 . 5 2
0 . 4 5
0 .  06  
0 .  0 1
0 . 2 0
0 . 0 8
0 . 1 2
0 . 0 4
6 8  3 . 1
3 . 2
2 . 2 2
3 . 4 6
0 .  01  
0 .  01
0 . 7 3
1 . 2 3
0 .  03  
0 .  04
0 . 1 1
0 . 2 1
0 . 0 6
0 . 1 0
70 3 . 1
3 . 2
1 . 4 1
1 . 7 8
0 . 3 0  
0 .  02
1 . 1 3
0 . 9 1
0 . 0 2  
0 .  02
0 . 1 4  
0 .  08
0 . 0 5  
0 . 1 1
NORMAL
RANGES:
1 . 4 2 -  
2 . 32
0 . 0 0 2 -  
0 . 0 0 9
0 . 5 3 -
1 . 0 5
0 . 0 1 -
0 . 0 3
0 . 0 2 -
0 . 0 9
N. A.
NOTE. N A : Not available.
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APPENDIX 3.3.
Experiment 6:Mean Total White Cell Count
(A) In cyathostome infected ponies.
109/l
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20  -
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10 20 30 40 50 60 70 80 90 100-10 0
Time (Days)
I SD Mean WBCC
(B) In control, uninfected animal.
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APPENDIX 3.4.
Experiment 6: Mean neutrophil counts.
(A) In cyathostome infected animals.
109/l
35
30
25
20
10
0-10 10 20 30 40 50 60 70 80 90 100
Time (Days)
I SD ~ M e a n  neutrophil cts.
(B) In control, uninfected animal.
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APPENDIX 3.5.
Experiment 6: Mean lymphocyte counts.
(A) In cyathostome infected animals.
109/l
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20 30 40 50 60 70 80 90 100100-10
Time (Days)
I SD — Mean lymphocyte cts.
(B) In control, uninfected animal.
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159
APPENDIX 3.6.
Experiment 6: Mean Packed Cell Volume.
(A) In cyathostome infected animals.
%
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20 30 40 50 60 70 80 90 100-10 0 10
Time (Days)
I SD Mean PCV
(B) In control, uninfected animal.
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APPENDIX 3.7.
Experiment 6: Mean plasma albumin levels
(A) In cyathostome infected animals.
g/i
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30  -
20
10
0-10 10 20 30 40 50 60 70 80 90 100
Time (Days)
I SD — Mean albumin levels
(B) In control, uninfected animal.
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APPENDIX 3.8.
Experiment 6: Mean plasma globulin level
(A) In cyathostome infected animals.
50
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-10 0 10 20 30 40 50 60 70 80 90 100
Time (Days)
I SD — Mean globulin levels
(B) In control, uninfected animal
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APPENDIX 3.10.
Experiment 7: Plasma biochemistry and haematology results in three horses with
chronic enteropathy.
1
DAY 1
CASE NUMBER 
2
DAY 1 DAY 1
3
DAY 22
Normal Values
(range)
Sodium mmol/1 133 136 121 136 132-146
Potassium mmol/1 4.6 3.9 1.8 2.7 2.4-4.7
Chloride mmol/1 99 100 87 98 99-109
Calcium mmol/1 3.08 3.17 2.42 2.36 2Z7-3.2
Urea mmol/1 4.7 2.7 15.3 3.6 3.6-8.6
Creatinine umol/1 131 153 168 102 62-159
Alkaline Phosphatase IU/1 249 228 480 687 83-283
Aspartate Transaminase IU/1 367 304 ND 182 153-411
Gamma Glutamyltransferase IU/1 22 26 ND ND 11-44
Bilirubin umol/1 23 21 26 21 1.7-42.5
Total Protein g/1 71 62 37 63 59-84
Albumin g/1 28 27 12 16 28-32
Globulin g/1 43 35 25 47 31-52
Haemoglobin g/dl 12.8 12.1 20.8 14.3 8-15
Packed Cell Volume % 35.3 33.7 56.1 39.9 24-46
Red Cell Count xlO 12/1 6.6 6.82 12.14 8.46 5-10
White Cell Count xlO 9/1 7.5 9.8 18.1 12.0 5.4-14.3
Neutrophils xlO 9/l (%) 5.18(69) 6.27(64) 13.9(77) 10.2(85) 2.7-6.8 (30-75)
Lymphocytes xlO 9/l (%) 1.88(25) 3.23(33) 3.62(20) 1.26(11) 1.5-5.5 (10-70)
Monocytes xlO 9/l (%) 0.38 (5) 0.29 (3) 0.18 (1) 0.30(2) 0.03-0.84 (1-7)
Eosinophils xlO 9/l (%) 0.00 (0) 0.00 (0) 0.36 (2) 0.12 (1) 0-1.0 (0-11)
Basophils xlO 9/l (%) 0.08 (1) 0.00 (0) 0.00 (0) 0.12 (1) 0-0.2 (0-3)
NOTE. Figures in brackets indicate percentages of Total White Blood Cell Counts.
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